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We dance round in circles and suppose, 
But the secret sits in the middle and knows… 
(Robert Frost) 
A 
 
 
Background 
Elevated blood pressure is a major risk factor for cardiovascular diseases. Diet and 
lifestyle have a substanal impact on blood pressure, but the role of protein intake 
is not yet clear. This thesis focuses on total dietary protein, types of protein (i.e. 
plant and animal), protein from speciﬁc sources (i.e. dairy, meat, and grain), and 
speciﬁc amino acids in relaon to blood pressure levels and incident hypertension. 
 
Methods 
The associaons of dietary protein, protein types, and protein from speciﬁc sources 
with populaon blood pressure levels were cross-seconally examined in 20,820 
Dutch adults aged 25 to 65 y (MORGEN Study). The relaon with risk of hyperten-
sion was examined in 3,588 of these adults with 15 years of follow-up (Doenchem 
Study) and in 2,241 older Dutch adults (≥55y) with 6 years of follow-up (Ro6erdam 
Study). In the la6er cohort we also examined the relaon of speciﬁc amino acids 
(i.e. glutamic acid, arginine, lysine, cysteine, tyrosine, and essenal amino acids) 
with blood pressure levels and risk of hypertension. As an ancillary Study, a fully 
controlled randomized cross-over trial with diﬀerent protein-rich diets was con-
ducted to obtain objecve biomarkers for dietary protein types that may be used in 
future epidemiological studies. Finally, we performed several meta-analyses to 
summarize our ﬁndings for dietary protein and protein types in relaon to blood 
pressure and incident hypertension, combined with data from the literature. 
 
Results 
The epidemiological studies presented in this thesis and a meta-analysis of obser-
vaonal studies showed no associaons of total protein and animal protein with 
blood pressure or incident hypertension. A meta-analysis of 14 randomized con-
trolled trials, however, showed a pooled blood pressure eﬀect of protein supple-
mentaon (weighed mean contrast in intake of 41 g/d) of -2.1 mmHg systolic (95%-
CI: -2.9 to -1.4) when compared to carbohydrate intake. In the epidemiological 
studies in this thesis plant protein was signiﬁcantly inversely associated to blood 
pressure levels (-1.8/-1.0 mmHg with 14 grams higher energy adjusted intake), but 
not with incident hypertension (all HR per SD ~1.00). Meta-analyses of 
cross-seconal studies showed a small diﬀerenal associaon of plant and animal 
protein with blood pressure (-0.52 mmHg per SD of dietary plant protein versus 
+0.03 mmHg per SD of animal protein), but this associaon was not present in 
meta-analyses of prospecve studies and trials. The epidemiological analyses on 
meat protein and dairy protein in this thesis revealed no consistent associaons 
with blood pressure or incident hypertension. Grain protein was inversely associat-
ed with diastolic (but not systolic) blood pressure, and with borderline signiﬁcant 
lower risk of hypertension in a general Dutch populaon (HR: 0.75, 95% CI: 0.73 to 
1.00), but this associaon was absent in older adults. No associaons with blood 
pressure or incident hypertension were found for amino acid intakes. Finally, we 
idenﬁed a combinaon of 3 urinary amino acids as a potenal biomarker for meat 
protein intake and a combinaon of 7 plasma amino acids as a potenal biomarker 
for grain protein intake 
 
Conclusion 
Results from this thesis suggest a small beneﬁcial eﬀect of protein on blood pres-
sure if consumed instead of carbohydrates. Plant protein, e.g. from grain, may be 
more beneﬁcial to blood pressure than animal protein but data are too limited to 
draw ﬁrm conclusions. ANer validaon, future epidemiological studies could make 
use of biomarkers as more robust esmates for protein from speciﬁc sources and 
amino acid intakes. Randomized controlled trials are warranted to examine the 
blood pressure eﬀect of speciﬁc types of protein, reﬂecng habitual intakes in 
western sociees, compared to diﬀerent types of carbohydrate. At present, a 
prudent diet for the prevenon of hypertension with adequate amounts of dietary 
protein, preferable from plant sources, is recommended. 
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Elevated blood pressure is a strong, independent and modiﬁable risk factor for 
cardiovascular and renal diseases.
1
 There is evidence that systolic blood pressure is 
a be6er predictor for cardiovascular risk than diastolic blood pressure, especially 
aNer the age of 50.
2
 People are considered hypertensive when their blood pressure 
(systolic/diastolic) is ≥140/90 mmHg, or when anhypertensive medicaon is used. 
The risk for death from cardiovascular diseases, however, already begins to in-
crease at systolic blood pressure levels above 115 mmHg.
1
 Prevenve measures to 
reduce blood pressure in the populaon can have a large impact on cardiovascular 
morbidity and mortality.
1,3
 It has been esmated that a populaon-wide reducon 
in systolic blood pressure of only 2 mmHg results in a 6% reducon in fatal stroke, 
and a 4% reducon in fatal coronary heart disease.
4
 
Well-established measures that contribute to the prevenon of hypertension are 
physical acvity, maintenance of normal body weight, and a low intake of alcohol 
and salt.
1,3,5
 In addion, data from the large DASH trial among 459 (pre-)
hypertensive adults showed that blood pressure can be substanally reduced by a 
diet rich in fruits, vegetables, and low-fat dairy products compared to a typical US 
diet, with reducons in systolic blood pressure being -5.5 mmHg in the total DASH 
populaon and -11.4 mmHg in hypertensive parcipants.
6
 More recently, interest 
has grown in the inﬂuence of diet composion and macronutrient intake on blood 
pressure, but the importance of dietary protein for human blood pressure is not 
yet clear. 
The work presented and discussed in this thesis focuses on the relaon between 
dietary protein and blood pressure. In the present chapter, protein metabolism, 
the assessment of protein intake, and protein in the Dutch diet are described (PQRS 
I). The second part provides a brief overview of protein intake in relaon to blood 
pressure and hypertension, and potenal underlying mechanisms for a protein-
blood pressure eﬀect (PQRS II). Finally, an outline is given of the studies presented 
in this thesis. 
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Deﬁni-on, diges-on and absorp-on 
Dietary proteins consist of polypepdes of amino acids, and the order and proporon of 
amino acids determine the folding and characteriscs of the protein.
7
 Several amino acids 
(i.e. leucine, isoleucine, lysine, valine, threonine, methionine, tryptophan, phenylalanine, 
and hisdine) are considered essenal, which means that they cannot be synthesized by the 
body and should be covered by diet (Table 1.1).
8,9
 Semi-essenal amino acids (i.e. cysteine, 
tyrosine, arginine, proline, and glycine) can only be synthesized from other amino acids and 
an adequate dietary intake for these amino acids may be required during limited availability 
of precursors or stress condions.
8,9
 Non-essenal amino acids can be synthesized by the 
human body from a keto-acid or a carbon chain.
9
 
ANer dietary intake, protein is degraded to di- en tri pepdes and amino acids which are 
then absorbed in intesnal cells.
7
 In the intesne and splanchnic ssues, the absorbed di-
and tripepdes are broken down into amino acids, aNer which 30 to 50% of essenal amino 
acids and up to 90% of glutamate is used for synthesis of energy (ATP), proteins, and other 
nitrogen-containing compounds, or metabolized to other amino acids (proline, ornithine, 
glutamate, alanine, citrulline) that are released in the blood.
7
 The remaining amino acids are 
transported to the liver that takes up about 50% to 65%, except for the branched-chain ami-
Table 1.1. Overview of essen-al, condi-onally essen-al (with precursors), and non-essen-al 
amino acids. 
7-9 
 
Essen-al Condi-onally essen-al (precursors) Non-essen-al 
Leucine Cysteine (methionine, serine) Alanine 
Isoleucine Tyrosine (phenylalanine) Asparagine 
Lysine Arginine (glutamine, glutamate, 
aspartate, proline) 
Asparc acid 
Valine Proline (glutamate) Glutamic acid 
Threonine Glycine (serine, choline) Glycine 
Methionine Glutamine (glutamate, ammonia) Hydroxyproline 
Tryptophan  Serine 
Phenylalanine   
Hisdine   
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no acids which are released from the liver without being metabolized.
7
 The blood therefore 
contains a large pool of amino acids that originate partly from the diet, whereas another part 
is a result of metabolic processes. 
The rate of absorpon of dietary protein may diﬀer between sources. Bilsborough et al
10
 
summarized the results of ten studies on absorpon rates of protein from several speciﬁc 
sources. Casein and whey protein isolates were absorbed faster than protein from raw and 
cooked egg white, pea ﬂour, and milk protein, with absorpon rates ranging from 1.3 g/h for 
raw egg to 8-10 g/h for whey isolate. These diﬀerences in absorpon rates may be translated 
into postprandial plasma amino acid levels. In sixteen young healthy adults intake of whey 
protein, as a model for a “fast” protein, resulted in a short but high peak of plasma amino 
acids (e.g. peak of leucine lasng for ~220 minutes with a maximum of 350% from baseline), 
while with casein protein, as a model for a “slow” protein, the peak was lower but prolonged 
(e.g. peak of leucine lasng for >370 minutes, with a maximum of 190% from baseline).
11
 
Whether this diﬀerenal inﬂuence of protein types on postprandial plasma amino acid levels 
could be relevant to blood pressure is not known. 
Whether the intake of diﬀerent types of protein exerts more prolonged eﬀects, reﬂected in 
fasng amino acid levels, is currently unknown. In 73 individuals with high cardiovascular 
risk, diﬀerent fasng plasma amino acid proﬁles were found within parcipants aNer 4 weeks 
on a plant protein diet compared to baseline values; e.g. a lower rao of lysine to arginine 
(2.7 versus 3.4, p<0.001) and increased levels of arginine (72 versus 61 nmol/ml, p<0.001) 
and glycine (281 versus 235 nmol/ml, p<0.001).
12
 However, no control group was included in 
this study and observed diﬀerences may (partly) be explained by other factors such as in-
creased muscle metabolism during exercise that was part of the intervenon program. We 
could not idenfy other studies on how dietary protein types aﬀect fasng plasma amino 
acid levels are available. 
 
Assessment of intake of total protein, protein types and amino acids 
Accurate measurement of dietary exposure is a methodological challenge in observaonal 
studies. Dietary intake is usually esmated using memory-based methods, such as food fre-
quency quesonnaires (FFQ), 24-h recalls or food diaries.
13
 These assessment methods, how-
ever, are prone to error that may lead to biased esmates for the eﬀect of diet on disease. 
Random errors, such as recall errors on frequency of consumpon and poron sizes usually 
a6enuate associaons to the null.
14,15
 Systemac errors such as over- or underreporng of 
intake, or errors because foods in the FFQ are not quesoned in suﬃcient detail for the ex-
posure of interest, might result in diﬀerenal misclassiﬁcaon and could aﬀect the associa-
ons in various direcons.
13
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Total protein intake of an individual is relavely constant over me.
16,17
 In a study in in 63 
men and 58 women to validate the FFQ from the European Prospecve Invesgaon into 
Cancer and Nutrion (EPIC) study, the reproducibility for energy adjusted total protein in-
take of a 3 mes repeated assessment (6 month intervals) was good with Pearson correla-
on coeﬃcients of 0.73 in men and 0.70 in women.
18
 In addion, the main part of dietary 
protein is achieved from basic foods that are consumed on a daily basis in the Netherlands, 
such as meat, dairy and bread.
19
 The frequency of consumpon and poron sizes of these 
foods are remembered relavely well leading to adequate ranking of parcipants for total 
protein intake. In the validaon study of the FFQs of the EPIC study and the Ro6erdam 
Study, both used in this thesis, the correlaons with nitrogen or urea as biomarkers of total 
energy adjusted protein intake were between 0.6 and 0.7.
14,20
 The assessment of plant and 
animal protein intake, and protein types (e.g. from dairy, meat, or grain), faces greater diﬃ-
cules because most FFQs have not been designed for the esmaon of protein from spe-
ciﬁc sources. Protein rich foods may not have been quesoned in suﬃcient detail to be able 
to rank parcipants according to a speciﬁc protein type; e.g. meat products that may vary in 
protein content are quesoned in one item. Moreover, a systemac error in Western coun-
tries may result from over-reporng of plant food intake because of social desirability, which 
may bias beneﬁcial associaons for plant protein toward the null. 
A be6er esmaon of intake may be achieved using reliable biomarkers. Nitrogen is availa-
ble from all amino acids and a characterisc element of protein. In individuals that are in 
steady state, the amount of nitrogen in 24-h urine  is a useful biomarker of overall protein 
intake.
21
 With regard to protein types no such consensus exists. In several studies the uri-
nary amino acids 3-methylhisdine, 1-methylhisdine or taurine are used as biomarkers of 
meat- or animal protein intake.
22-24
 Also urinary excreon of the amino acid carnosine has 
been proposed as a biomarker for meat protein.
25
 However, none of these potenal bio-
Figure 1.1. Protein intake in the Dutch popula-on from 1988 to 2010 expressed in grams per 
day (A) and as energy percentage (B).
26,27,63
 
=total protein, = animal protein, and = plant protein 
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markers have suﬃciently been validated. Biomarkers for other major protein types, i.e. dairy 
and grain protein, are lacking. 
 
Habitual protein intake in the Netherlands 
Food consumpon surveys in the Netherlands have shown a stable protein intake of ~85 g/d 
in the past two decades (Figure 1.1)
26,27
, with average total protein intake being ~73 g/d for 
women and ~96 g/d for men.
27
 The contribuon of protein to energy, however, showed a 
small increase over me, i.e. from 14.3 en% in 1987-1988 to 15.2 en% in 2007-2010.
26,27
 Ap-
proximately two thirds of protein intake in the Dutch diet originates from animal sources, 
whereas one third originates from plant sources.
27
 Results from a standardized, computer-
assisted 24-h dietary recall in 3,980 Dutch adults from the EPIC study showed that the main 
contributors to total protein intake were dairy (23%), meat (38%), and grains (17%) (Figure 
1.2).
19
 No data are available on the habitual amino acid intake in the Netherlands, but che-
mical analysis of a diet with ~50% of protein from meat, dairy, and eggs, ~40% from cereals 
(mainly wheat products), and ~10% from vegetables and fruits showed that the most im-
portant amino acid was glutamic acid (21% of total protein), followed by proline (8%), leu-
cine (7%), asparc acid (7%) and lysine (6%).
28
 
Figure 1.2. Contribu-on of plant and animal protein sources to total protein intake 
in the Netherlands.
19
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A systemac overview of exisng literature on protein intake and blood pressure is presen-
ted in Chapter 2. A number of relevant studies in this ﬁeld is highlighted below to provide a 
raonale for the present thesis. 
 
Total dietary protein 
There is growing evidence for an inverse associaon of total dietary protein with blood pres-
sure. Observaonal follow-up data (6-years) of 11,342 normotensive US men from the 
MRFIT trial showed  a signiﬁcant inverse associaon between protein intake and blood pres-
sure, but the esmates were small (-0.06 mmHg systolic per en%, p<0.01).
29
 In the IN-
TERSALT study among 10,020 normotensive adults from 32 countries, stronger associaons 
were found, i.e. -0.5 mmHg systolic (p<0.01) per g of total 24-h urinary nitrogen (~6 g/d of 
dietary protein). The associaon was more pronounced in individuals aged 40-59 y com-
pared to those aged 20-39 y (-0.9 versus -0.2 mmHg per g of total 24-h urinary nitrogen).
30
 
Also in several randomized trials a beneﬁcial blood pressure eﬀect of dietary protein was 
demonstrated. In a trial among 99 Dutch untreated (pre-)hypertensive adults a signiﬁcant 
blood pressure reducon of 4.9 mmHg was found aNer 4 weeks supplementaon of 60 g 
protein/d (20% pea, 20% soy, 30% egg, and 30% milk-protein isolate), compared to malto-
dextrine.
31
 The Omniheart randomized crossover trial in 164 US adults included two sepa-
rate control treatments, namely carbohydrates and monounsaturated fat.
32
 In this study sys-
tolic blood pressure decreased 1.4 mmHg more aNer a 6-week high protein diet compared 
with a diet high in carbohydrates (p=0.002). The blood pressure eﬀect was more pro-
nounced in hypertensives (-3.5 mmHg, p=0.006) than in normotensives (-0.9 mmHg, 
p=0.05). Compared to a diet high in monounsaturated fat, however, there was no blood 
pressure eﬀect for protein (-0.1 mmHg, p=0.90).
32
  
Taken together, there is evidence, mainly from trials, that a higher protein intake could lo-
wer blood pressure. However, data on long term (>5 years) inﬂuence of protein on blood 
pressure is scarce. This needs to be invesgated in populaon-based cohort studies.  
 
Plant versus animal protein 
As summarized in 2010 by Craig et al. usually a lower blood pressure is reported in vegetari-
ans compared to omnivores.
33
 It is possible that the high proporon of plant protein in these 
diets partly explains this diﬀerence in blood pressure. In the large cross-seconal INTERMAP 
study among 4,680 adults from China, Japan, UK and USA, systolic blood pressure was 1.01 
mmHg lower with 2.8 en% (=2 SD) higher plant protein intake aNer adjustment for dietary 
Chapter 1 
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and lifestyle factors (p<0.01), whereas with 5.8 en% (=2 SD) higher animal protein intake 
there was no signiﬁcant blood pressure diﬀerence (+0.2 mmHg, p>0.05).
34
 The relaon of 
plant and animal protein with hypertension incidence has been addressed in a few prospec-
ve studies.
35,36
 In the PREMIER study among 810 pre- or mild hypertensives a stronger re-
ducon in hypertension risk was observed for increased intake of plant protein (-21%, 
p=0.08) compared to animal protein (-1%, p=0.90).
35
 Also in the SUN cohort of 5,880 Hispa-
nic university graduates, a 50% reduced hypertension risk was present in the highest quinle 
compared to the lowest quinle of plant protein intake (95%-CI: 0.2-0.9), whereas for ani-
mal protein there was no risk reducon. Conﬁrmaon of these ﬁndings in other prospecve 
studies would strengthen the evidence for a diﬀerenal eﬀect of plant and animal protein 
on blood pressure. 
 
Protein from speciﬁc sources 
Several protein-rich foods have been associated with blood pressure. In a meta-analysis on 
dairy, a 16% reduced risk for elevated blood pressure (i.e. ≥130/85 mmHg, or use of anhy-
pertensive medicaon) was found for low fat dairy (95%-CI: 0.74-0.95).
37
 In the CARDIA 
study an inverse associaon with hypertension risk was found for plant foods, including 
fruits, vegetables, nuts, legumes, and whole- and reﬁned-grain products, whereas meat was 
unfavourably associated.
38
 From these studies it cannot be concluded whether protein or 
other nutrients in these foods accounted for the lower risk of hypertension. We idenﬁed 
two trials on meat protein.
39,40
 In a 12-week parallel trial among 64 hospital staﬀ members, 
a diet with 40% of protein from meat sources (from beef, chicken, lamb, sausage, pork, and 
prawns) resulted in a non-signiﬁcant blood pressure eﬀect of -1.8 mmHg systolic and -1.2 
mmHg diastolic (p-value not given) compared with a diet in which meat protein was re-
placed by plant protein (from cereals, vegetables, legumes, and nuts).
39
 In a small cross-over 
trial among 35 men no diﬀerence in blood pressure eﬀect was seen (no p-value given) be-
tween a 6-week diet including 50% of protein from meat (from pork, beef, and chicken) 
compared with a diet in which the meat protein was replaced by non-meat protein (from 
vegetables, eggs, and dairy).
40
 The blood pressure eﬀect of dairy and soy protein has been 
invesgated in a large cross-over trial in 352 (pre-)hypertensive adults.
41
 For both types of 
protein 8 weeks of supplementaon resulted in approximately the same blood pressure re-
ducon compared to carbohydrates (-2.0 mmHg for soy protein and -2.3 mmHg for dairy 
protein, both p<0.01). No studies have been conducted on grain protein, the main source of 
plant protein in the Netherlands, in relaon to blood pressure. Taken together, it is not yet 
known to what extent diﬀerent sources of protein in the western diet are important in de-
termining populaon blood pressure levels. 
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Amino acids 
In the INTERMAP study in 4,680 adults it was esmated that individuals with high plant and 
low animal protein intake consumed greater proporons of glutamic acid, cysteine, proline, 
phenylalanine, and serine, and smaller proporons of a number of other amino acids (e.g., 
glycine, alanine, hisdine, threonine, methionine, lysine).
34
 Possibly, a diﬀerenal blood 
pressure eﬀect of protein types is due to the role of speciﬁc amino acids, but data on this 
subject are scarce. In the INTERMAP study, a 2 SD higher intake of glutamic acid (4.7% of to-
tal protein) was associated with 1.5 mmHg lower systolic blood pressure and 1.0 mmHg lo-
wer diastolic blood pressure (p<0.05) aNer adjustment for several confounders like physical 
acvity, alcohol consumpon and dietary factors.
42
 In a meta-analysis on 11 arginine supple-
mentaon trials the pooled blood pressure eﬀect was -5.4/-2.7 mmHg with arginine doses 
ranging from 4 to 24 g/d.
43
 Another amino acid that has been invesgated in a randomized 
controlled trial is tyrosine, of which a 2 weeks supplementaon of 7.5 g/d in 13 mildly hy-
pertensive adults did not aﬀect blood pressure.
44
 However, whether dietary intake levels of 
arginine (on average ~4 g/d) and tyrosine (~3 g/d) are important for human blood pressure 
is unknown. Epidemiological studies invesgang the relaon between speciﬁc amino acids 
and populaon blood pressure are therefore warranted. 
 
Mechanisms for an eﬀect of dietary protein on blood pressure 
The underlying mechanisms for a potenal blood pressure eﬀect of dietary protein have not 
yet been clariﬁed. However, several hypotheses have been suggested that involve renal 
funcon, the central nervous system, the role of speciﬁc amino acids or pepdes, and body 
weight regulaon. 
Dietary protein intake can induce changes in renal funcon including an increase in glomeru-
lar ﬁltraon rate, which may facilitate renal sodium excreon
31,45
, and consequently pre-
vents the sodium dependent blood pressure rise. On the other hand, chronic high intake of 
sulphur-containing amino acids (cysteine, methionine) in protein could inﬂuence the acid-
base balance in the blood.
46
 Compensatory increases in renal acid excreon and ammonia-
genesis may lead to impaired renal funcon on the long term and consequently increase 
blood pressure. Other mechanisms through which a disturbed acid-base balance have been 
suggested to inﬂuence blood pressure are increased corsol producon
47
, increased calcium 
excreon
48
, or decreased citrate excreon
49
. 
The central nervous system is a key regulator of blood pressure by modulang cardiac out-
put and peripheral resistance. Because protein content of the diet modiﬁes availability of 
amino acid precursors for neurotransmi6ers, macronutrient composion of the diet is hy-
pothesised to inﬂuence blood pressure regulaon.
50
 Indeed, increased postprandial sympa-
thec acvaon has been found aNer carbohydrate rich meals
51
, but speciﬁc data for dietary 
Chapter 1 
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protein intake are lacking. Tyrosine is a precursor of catecholamines in the brain (dopamine, 
norepinephrine, epinephrine) and has been hypothesised to reduce cardiovascular sympa-
thec tone and consequently blood pressure.
52
 
Several other amino acids have been hypothesised to inﬂuence blood pressure. Arginine is a 
precursor for the vasodilator nitric oxide. A high intake of arginine or its precursors, such as 
glutamic acid, could therefore be related to lower blood pressure. Lysine, on the other hand, 
competes with arginine in the transport system in the gut and could unfavourably aﬀect 
blood pressure.
53,54
 Cysteine binds excess aldehydes, which may be formed in the human 
body when glucose metabolism is impaired (present in ~50% of essenal hypertensives
55
).
56
 
Because aldehydes are thought to increase peripheral vascular resistance through modula-
on of calcium channels, intake of this amino acid is hypothesised to beneﬁcially inﬂuence 
blood pressure.
56
 
In the past decade there has been increasing interest in pepdes encrypted in dietary pro-
tein that can be derived from foods like tuna, eggs and milk.
57
 Pepdes with speciﬁc se-
quences of amino acids, such as lactotripepdes that consist of Isoleucine-Proline-Proline 
and Valine-Proline-Proline, have been shown to inhibit the angiotensin I-converng enzyme 
(ACE) in vitro.
57,58
 Although anhypertensive eﬀects have been reported in human trials with 
funconal foods containing high amounts of promising pepdes
59
, no evidence for ACE inhi-
bion was found in those trials assessing parameters of the renin-angiotensin system.
60
 It is 
at present unknown to what extent digeson via gastrointesnal enzymes in humans relea-
ses anhypertensive pepdes aNer normal protein intake and whether that could exert a 
physiological response either in the gut or elsewhere aNer entering the circulaon. 
Protein has been shown to have a stronger saang eﬀect than other macronutrients, and 
may therefore beneﬁcially inﬂuence weight.
61
 Because a lower body weight has been shown 
to beneﬁcially aﬀect blood pressure
62
, this may be another pathway through which protein 
could reduce the risk of hypertension. 
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There is growing evidence for a beneﬁcial eﬀect of dietary protein on blood pressure. This 
may be a6ributable to plant protein, but more research on this subject is needed. Whether 
there is a diﬀerenal eﬀect of protein from more speciﬁc sources, such as dairy, meat, and 
grain, and whether speciﬁc amino acids inﬂuence blood pressure is unknown. Also data on 
subject characteriscs that modify the blood pressure response to dietary protein are 
scarce. The objecves of this thesis were therefore: 1) to examine whether habitual intake 
of dietary protein is related to blood pressure level or the incidence of hypertension, 2) to 
examine whether plant and animal protein, protein from speciﬁc sources (dairy, meat, and 
grain), or speciﬁc amino acids are related to blood pressure levels or the incidence of hyper-
tension, and 3) to examine whether subject characteriscs like age, gender, BMI, and hyper-
tensive status, could modify the associaon between dietary protein and blood pressure.  
A schemac overview of this thesis is given in Figure 1.3. We ﬁrst conducted a systemac 
literature review on dietary protein in relaon to blood pressure, with a focus on speciﬁc 
types of protein and speciﬁc populaon subgroups (Chapter 2). Subsequently, we studied 
the relaon between dietary protein and blood pressure levels in the general Dutch popula-
on of the MORGEN cohort (Chapter 3). The relaon between protein intake and incident 
hypertension was prospecvely examined in the populaon-based Doenchem cohort 
(Chapter 4), and in the general older populaon of the Ro6erdam Study (Chapter 5). In the 
la6er cohort we addionally invesgated the relaon of several amino acids with blood 
pressure levels and hypertension incidence (Chapter 6). Finally, we conducted the Bi-
omarker study; a fully controlled dietary intervenon trial to idenfy objecve biomarkers 
for dairy, meat, and grain protein that may be used in future epidemiological studies 
(Chapter 7). 
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Figure 1.3. Schema-c overview of the studies described in this thesis. Addi-onally, in each 
blood pressure study stra-ﬁed analyses were conducted for the following 
subgroups: gender, age, overweight status, and blood pressure status. 
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Background 
Elevated blood pressure, which is a major risk factor for cardiovascular disease, is 
highly prevalent worldwide. Recently, interest has grown in the role of dietary 
protein in human blood pressure. We performed a systemac review of all 
published scienﬁc literature on dietary protein, including protein from various 
sources, in relaon to human blood pressure. 
Methodology/Principal Findings 
We performed a MEDLINE search and a manual search to idenfy English language 
studies on the associaon between protein and blood pressure, published before 
June 2010. A total of 46 papers met the inclusion criteria. Most observaonal 
studies showed no associaon or an inverse associaon between total dietary 
protein and blood pressure or incident hypertension. Results of biomarker studies 
and randomized controlled trials indicated a beneﬁcial eﬀect of protein on blood 
pressure. This beneﬁcial eﬀect may be mainly driven by plant protein, according to 
results in observaonal studies. Data on protein from speciﬁc sources (e.g. from 
ﬁsh, dairy, grain, soy, and nut) were scarce. There was some evidence that blood 
pressure in people with elevated blood pressure and/or older age could be more 
sensive to dietary protein. 
Conclusions/Signiﬁcance 
In conclusion, evidence suggests a small beneﬁcial eﬀect of protein on blood 
pressure, especially for plant protein. A blood pressure lowering eﬀect of protein 
may have important public health implicaons. However, this warrants further 
invesgaon in randomized controlled trials. Furthermore, more data are needed 
on protein from speciﬁc sources in relaon to blood pressure, and on the protein-
blood pressure relaon in populaon subgroups. 
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Elevated blood pressure is an independent risk factor for cardiovascular diseases (CVD) and 
renal impairment.
1
 There is no evidence for a threshold eﬀect: from systolic blood pressure 
levels as low as 115 mmHg onward, risk of CVD doubles for each increment of 20 mmHg.
1
 It 
has been esmated that, at populaon level, a reducon in systolic blood pressure of only 2 
mmHg would result in a 6% reducon in fatal stroke, and a 4% reducon fatal coronary 
heart disease (CHD).
2 
Well-known dietary and lifestyle intervenons to prevent hypertension include moderate 
physical acvity, maintenance of normal body weight, low alcohol and salt intake, and a diet 
rich in fruits, vegetables, and low-fat dairy products.
2,3
 More recently, interest has grown in-
to dietary pa6erns and macronutrient intakes, including protein.
4,5
 Whether protein content 
of the diet or type of protein is important for human blood pressure is, however, unclear. 
We systemacally reviewed all scienﬁc literature, published before June 2010, on dietary 
protein in relaon to human blood pressure, with a focus on speciﬁc types of protein and 
possible interacons with age, gender, blood pressure level, and overweight. 
 
M3G61 
Ethical approval was not required for this review because only published data were inclu-
ded. 
 
Search strategy 
A systemac search was performed in MEDLINE (www.ucbi.ulm.nih.go) to idenfy studies 
on the associaon between dietary protein and blood pressure, published before June 2010. 
Search terms on dietary protein and blood pressure or hypertension were used to search for 
words in tle or abstract and Medical Subject Headings. The search was limited to studies in 
human adults and English-language literature. In addion, we performed a manual search 
using reference lists of original arcles and previous reviews.
6-9
 For all studies, we retrieved 
the original publicaon. 
We selected any observaonal study or trial that examined the relaonship between dietary 
protein and blood pressure in humans. All tles, abstracts, and full papers of potenally re-
levant studies were assessed for eligibility based on predeﬁned inclusion and exclusion crite-
ria. Papers were excluded: 1) if data on exposure (dietary protein) or outcome (blood pres-
sure, hypertension) was not reported, 2) if no data were reported on the relaonship be-
tween exposure and outcome, 3) if the exclusive eﬀect of protein could not be calculated 
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(e.g. blood pressure studies that focused on dietary pa6erns, or soy combined with isoﬂa-
vones). Furthermore, review papers were excluded, as were drug trials and studies conduc-
ted in paent groups or pregnant women. 
 
Data collec-on and data synthesis 
From each included paper we extracted data on protein intake, source of protein, and blood 
pressure values or esmated risk of hypertension according to a predeﬁned standard form. 
In addion, we extracted data on design, place of study, number of parcipants, populaon 
characteriscs (including inial blood pressure, sex, and age), dietary assessment method 
(food frequency quesonnaire (FFQ), 24-hour recall, food diary, biomarker), adjustment for 
confounders, and measures of variaon. 
To allow be6er comparison of results from observaonal studies we expressed associaons 
in these studies by standard units of protein intake that correspond to approximately 1 SD of 
protein intake in the Dutch populaon, i.e. 25 g/d (3.5 en%) for total protein, 11 g/d (1.4 
en%) for plant protein, and 23 g/d (2.9 en%) for animal protein.
10,11 
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 
The systemac search in MEDLINE resulted in 2,681 tles to be screened. Inclusion criteria 
were fulﬁlled by 40 papers, and the hand search yielded another 6 papers (Figure 2.1). In to-
tal, 15 observaonal studies, 13 biomarker studies and 20 trials were selected. 
 
Total dietary protein and blood pressure: observa-onal data 
Twelve observaonal studies focused on habitual total protein intake and blood pressure or 
risk of hypertension (Table 2.1). Most of these studies had a cross-seconal design and 
showed predominantly weak inverse associaons.
12-20
 However, although hypothesis-
generang, a major drawback of a cross-seconal design is that protein intake and blood 
pressure are assessed at the same moment in me, which makes it diﬃcult to address the 
temporality of the associaon. Subjects with elevated blood pressure, or otherwise at in-
creased cardiovascular risk, may have changed their food intake (including protein intake) 
upon medical advice. Causality can, therefore, be be6er established in prospecve studies. 
So far, only three studies prospecvely examined the associaon of total dietary protein 
with change in blood pressure or incident hypertension. Total protein intake was not clearly 
associated with change in systolic blood pressure aNer 8 years of follow up in 1714 US men 
(+0.16 mmHg per y per 3.5 en% systolic, p=0.04) 
21
, and aNer 7 years of follow up in 4146 
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Chapter 2 — Protein intake and blood pressure 
34 
young US adults (-0.20 mmHg per year per 3.5 en% systolic, p>0.05) 
22
. It should be noted 
that in these two studies respondents using anhypertensive medicaon were not excluded 
from the analyses, which may have aﬀected the associaons. In 5880 university graduates of 
the prospecve SUN cohort, not using anhypertensive medicaon, a non-signiﬁcant 20% 
lower 2-year hypertension risk was found (p=0.26).
23
 In this study the populaon was quite 
young (mean age ~36 y), and blood pressure may not have been as sensive to inﬂuence 
from protein intake as in an older populaon. 
Concluding, most cross-seconal studies on total protein intake and blood pressure or inci-
dent hypertension showed a weak inverse associaon, whereas no clear conclusion could be 
drawn from prospecve studies. A small beneﬁcial eﬀect on blood pressure may exist, but 
well conducted prospecve studies and randomized controlled trials may provide be6er es-
mates of a protein eﬀect on blood pressure. 
 
Biomarkers of total dietary protein and blood pressure: observa-onal data 
Daily urinary nitrogen excreon, about 85% excreted in the form of urea, correlates with 
dietary protein as calculated from weighed food records (r= 0.4-0.8) and reﬂects ~80% of to-
tal protein intake.
24
 As shown in Table 2.2, in ﬁve cross-seconal studies urinary total nitro-
gen 
25
 or urinary urea nitrogen 
11,25-28
 was used to esmate the associaon between total 
protein intake and blood pressure. 
In the large INTERSALT-study, including 10,020 adults from 32 countries, an inverse associa-
on of -0.5 mmHg systolic (p<0.01) per g of total 24-h urinary nitrogen was observed.
25
 Also 
in 4,680 respondents from the INTERMAP study, 24h urea nitrogen was inversely related to 
systolic blood pressure (-0.9 mmHg per 5.34 g), although this was not stascally signiﬁ-
cant.
11
 In the remaining studies, summarized in Table 2.2, single spot or overnight urines 
were used to esmate protein intake.
26-28
 Although these esmates are less reliable than es-
mates from 24-h urine, the results were in line with those of the studies menoned above.  
Concluding, in studies among parcipants that are in nitrogen balance, good agreement has 
been found between one or two 24-h urine collecons and diet-history esmates of protein 
intake.
24
 Findings from biomarker studies, therefore, suggest that protein intake may have a 
beneﬁcial eﬀect on blood pressure. 
 
Total dietary protein and blood pressure: trial data 
In 16 trials the blood pressure eﬀect of a high protein diet was assessed (Table 2.3). Most 
trials were only small (number of parcipants per intervenon group: n=7 to n=30), and the 
conﬂicng results may be due to chance ﬁndings.
29-39
 In one of the larger trials, a parallel 
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Chapter 2 — Protein intake and blood pressure 
40 
trial in which 121 type 2 diabetes paents received counselling on normal or reduced pro-
tein intake, an increase in blood pressure was found (+5.4 mmHg systolic, p=0.07).
40
 How-
ever, the low range of intake may have inﬂuenced the results. Another large parallel trial 
among 311 obese women, in which diﬀerent weight loss diets were compared, showed a de-
crease in systolic blood pressure of -5.7 mmHg systolic (p value not given).
41
 However, con-
trast in protein intake was low (2.3 en%), and blood pressure decrease may be a result of ex-
change in carbohydrates and fat instead of increase in protein intake. Other large studies 
showed a decrease in blood pressure on a high protein diet, although no clear dose-
response relaon could be disnguished.
5,42,43
 In 100 obese parcipants with metabolic syn-
drome, systolic blood pressure changed -6 mmHg (p<0.05) with 6 en% higher protein intake 
42
, and in 141 obese adults 6 en% higher protein intake resulted in a blood pressure change 
of -4.6 mmHg (p=0.04) 
43
. 
In almost all trials the high protein diet was compared with a high carbohydrate diet. The 
only study in which two diﬀerent control diets were included was the OmniHeart trial.
5
 In 
this 6-week, fully controlled cross-over feeding trial in 164 healthy US adults paral substu-
on of carbohydrates (10 en%) with protein signiﬁcantly lowered systolic blood pressure 
with -1.4 mmHg systolic (p=0.002). No diﬀerence in blood pressure response was observed 
when the protein-rich diet was compared with a diet high in mono-unsaturated fat (-0.1 
mmHg systolic, p=0.90). Recently, a trial was conducted in which only a high fat diet was in-
cluded as control diet.
38
 In this trial, however, the number of parcipants was very low 
(n=17), and the systolic blood pressure eﬀect of -9 mmHg may be a chance ﬁnding. 
In conclusion, the results of trials suggest that increased intake of protein may be beneﬁcial 
to blood pressure, although no clear dose – response associaon could be disnguished. 
From the results of the OmniHeart study, the only trial in which two diﬀerent isocaloric con-
trol diets (high in carbohydrates and high in fat) were used, a conclusion can be drawn that 
both protein and mono-unsaturated fat have blood pressure lowering properes. However, 
it is also possible that a reduced intake of carbohydrates, rather than a higher intake of 
mono-unsaturated fat or protein, is responsible for a reduced blood pressure. In a trial on 
macronutrients and blood pressure it is important to keep energy intake in both treatment 
groups constant, to rule out blood pressure eﬀects of energy and change in weight. Mea-
surements of blood pressure eﬀects aNer high intake of one of the macronutrients, there-
fore, will always be relave to the intake of the other two macronutrients, and the answer 
to the queson whether total protein intake itself inﬂuences blood pressure may never be 
given, unless speciﬁc mechanisms are found through which protein intake may aﬀect blood 
pressure. 
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Dietary plant protein and blood pressure: observa-onal data 
The associaon between dietary plant protein and blood pressure or hypertension was exa-
mined in 8 observaonal studies (Table 2.4). Most cross-seconal studies showed an inverse 
associaon 
11,14,15,19,20,44
, and this was conﬁrmed in prospecve studies 
20,21,23
. In a prospec-
ve study among 1714 men a systolic blood pressure diﬀerence of -0.34 mmHg per year per 
1.4 en% (p<0.01) was found aNer a follow-up of 8 y.
21
 It should be noted, however, that es-
mates were not adjusted for important potenal confounders like sodium and potassium. In 
two other studies, in which esmates were adjusted for these confounders, a 21% reducon 
in hypertension risk per en% of plant protein intake (p=0.08) was found aNer 18 months of 
follow-up in 810 untreated pre- or mild hypertensives of the PREMIER study 
20
, and a 50% 
lower 2 year hypertension risk for the highest quinle of plant protein intake versus the lo-
west quinle (p=0.06) was found in 5880 university graduates of the SUN cohort 
23
. 
In conclusion, results from observaonal studies indicate an inverse associaon between 
dietary plant protein and blood pressure. However, despite adjustment for many potenal 
confounders in mulvariable models, residual confounding (e.g. by other macronutrients, ﬁ-
ber or ﬂavonoid intake) in observaonal studies cannot fully be excluded. 
 
Dietary animal protein and blood pressure: observa-onal data 
In 7 observaonal studies the relaonship between dietary animal protein and blood pres-
sure was invesgated (Table 2.5), with results from cross-seconal studies being inconclu-
sive 
11,15,19,20,45
. In studies with a prospecve design no associaon or only weak associaons 
were observed, with systolic blood pressure diﬀerences of -0.06 mmHg per 2.9 en% (p=0.84) 
aNer 6 months in 810 untreated pre- or mild hypertensives 
20
, and +0.16 mmHg per 2.9 en% 
per year (p<0.01) in 1714 men.
21
 Furthermore, no diﬀerence in hypertension risk with high 
intake of animal protein was observed in 5880 university graduates of the SUN cohort.
23
 
In conclusion, observaonal studies provide no evidence for an associaon of animal protein 
with blood pressure. However, also for these studies, despite inclusion of many potenal 
confounders in their mulvariate model, residual confounding (e.g. by intake of other ma-
cronutrients or salt) cannot be excluded. 
 
Biomarkers of dietary plant protein or animal protein and blood pressure: observa-onal data 
We did not ﬁnd any studies that used a biomarker speciﬁcally for plant protein intake. With 
regard to animal protein intake, urinary excreon of 3-methylhisdine (3-MH) has been sug-
gested as marker of meat consumpon because it is synthesized in the muscle of mammals 
and released and excreted in urine aNer intake of muscle protein.
46
 Six cross-seconal stu-
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dies included in this review used urinary 3-MH excreon to esmate animal protein intake in 
predominantly Asian populaons (Table 2.6). Overlap between studies may exist, since all 
populaons formed part of the study populaon of the World Health Organizaon Cardio-
vascular Disease and Alimentary Comparison (CARDIAC) study, which is an internaonal 
populaon-based cross-seconal study in more than 20 countries, among which are China 
and Japan. All studies showed inverse associaons with blood pressure. However, because 
studies were conducted mainly in Asian populaons, results may not be generalizable to 
other populaons. Furthermore, urinary 3-MH may partly reﬂect muscle catabolism in the 
human body itself, i.e. during starvaon, cachexia, or heavy physical acvity.
47
 This phe-
nomenon was not taken into account in the various studies, and overesmaon of associa-
ons between animal protein and blood pressure could have occurred. The ﬁndings of these 
biomarker studies, therefore, should not be overemphasized. A challenge for future protein 
research will be to ﬁnd reliable biomarkers for plant and animal protein and intake of pro-
tein from speciﬁc dietary sources. 
 
Dietary plant protein or animal protein and blood pressure: trial data 
The blood pressure response aNer protein intake from plant and animal sources was inves-
gated in only 2 randomized controlled trials (Table 2.7). A systolic blood pressure eﬀect of 
+1 mmHg systolic (p=0.90) was seen in 23 type 2 diabecs aNer a diet containing protein on-
ly from plant sources (from soy, vegetables, and legumes) compared to a diet in which 60% 
of the plant protein was replaced by animal protein (from beef, poultry, ﬁsh, and milk).
48
 
However, the number of 23 parcipants is low, and this blood pressure eﬀect was not sig-
niﬁcant. Furthermore, these parcipants suﬀered from albuminuria, which may have inﬂu-
enced the results on blood pressure. In 49 healthy students a soy protein isolate resulted in 
a non signiﬁcant systolic blood pressure response of +0.6 mmHg (p-value unknown) com-
pared to a casein protein isolate.
49
 However, because in this trial only soy protein and casein 
protein were invesgated, we cannot extrapolate these ﬁndings to plant protein and animal 
protein from a mix of sources. 
In summary, only 2 small trials evaluated the blood pressure eﬀect of plant protein versus 
animal protein. More evidence on the blood pressure eﬀect of plant and animal protein is 
needed from large randomized controlled blood pressure trials. 
 
Dietary protein from speciﬁc sources and blood pressure 
Only few observaonal studies addressed the relaon of protein from speciﬁc sources (e.g. 
ﬁsh, meat) to blood pressure. In ﬁve studies the associaon with blood pressure was exa-
mined for urinary taurine 
50-52
 or serum taurine 
45,53
 which the authors regarded as a bi-
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omarker of seafood protein intake (data not in Table). Three of these studies were conduc-
ted among Asian populaons (n=705 to n=1,681) 
45,51,52
, whereas the others were conducted 
in Brazil (n=57) and USA (n=168).
50,53
 In all these studies inverse associaons with blood 
pressure were observed, but no informaon about the strength of the associaons was gi-
ven. 
The blood pressure eﬀect of meat protein was only invesgated in two trials (data not in Ta-
ble).
54,55
 In a parallel trial among 64 hospital staﬀ members, a diet with 40% of protein from 
meat sources (from beef, chicken, lamb, sausage, pork, and prawns) resulted in a non-
signiﬁcant blood pressure eﬀect of -1.8 mmHg systolic and -1.2 mmHg diastolic (p-value not 
given) compared with a diet in which the meat protein was replaced by plant protein (from 
cereals, vegetables, legumes, and nuts).
54
 In a small cross-over trial among 35 men no diﬀe-
rence in blood pressure eﬀect was seen (no p-value given) between a diet including 50% of 
protein from meat (from pork, beef, and chicken) compared with a diet in which the meat 
protein was replaced by non-meat protein (from vegetables, eggs, and dairy).
55
 
Because isoﬂavones may inﬂuence blood pressure 
56
, several studies on soy could not be 
taken into account because observaonal data were not adjusted for isoﬂavone intake 
57-61
, 
or because, in trials, soy protein contained isoﬂavones 
62-66
. To the best of our knowledge, 
there are at present no other studies on speciﬁc protein sources and blood pressure. Epide-
miological studies and randomized controlled trials in this ﬁeld are, therefore, warranted. 
 
Dietary protein and blood pressure in subgroups of the popula-on 
In several studies speciﬁc subgroup analyses were conducted to idenfy subgroups whose 
blood pressure is more sensive for protein intake. We explored, furthermore, whether 
diﬀerences in protein-blood pressure associaons could be idenﬁed in the results of stu-
dies among speciﬁc populaons. 
In the OmniHeart trial the eﬀect of total dietary protein was more pronounced in hyperten-
sives than in prehypertensives (-3.5 mmHg versus -0.9 mmHg for systolic blood pressure). 
This diﬀerence of protein eﬀect in subgroups of blood pressure could not be recognized in 
observaonal studies. In trials, however, populaons with, on average, elevated blood pres-
sure were more sensive to the blood pressure lowering eﬀect of protein than populaons 
with, on average, normal blood pressure (Out of 9 trials in populaons with elevated blood 
pressure 
5,29,30,35,37,38,40,42,43
 7 trials showed a decrease in blood pressure with high protein in-
take 
5,30,35,37,38,42,43
, whereas out of 7 trials in populaons with normal blood pressure 
31-
34,36,39,41
 only 2 trials 
34,41
 showed a decrease). 
With regard to age, in the INTERSALT study a stronger inverse associaon of urinary nitrogen 
with blood pressure was observed in respondents aged 40-59 y than in respondents aged 20
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-39 y (systolic blood pressure: -0.9 mmHg/g versus -0.2 g/d).
25
 Furthermore, inverse associa-
ons were found more oNen in studies conducted in parcipants aged over 50 (out of 5 
studies 
5,29,30,35,40
, in 3 studies an inverse associaon or a blood pressure lowering eﬀect was 
found 
5,30,35
) than in studies conducted in younger parcipants (out of 9 studies 
16,22,23,31-
34,39,41
, in 4 studies an inverse associaon was found 
16,23,34,41
). However, the number of stu-
dies that were conducted among these speciﬁc populaons was small, and solid conclusions 
cannot be drawn. 
In a study on urinary 3-MH and blood pressure, the inverse associaon was more pro-
nounced in respondents with a BMI higher than 26 kg/m
2
 than in respondents with a normal 
BMI (Δ systolic blood pressure=-6.8 mmHg versus -2.39 mmHg per 88 µmol urinary 3-MH/
d).
67
 Among the other studies, however, only one study was explicitly conducted among nor-
mal weight respondents
14
, so no conclusion can be drawn on diﬀerence in sensivity related 
to weight, although studies in overweight/obese parcipants oNen showed inverse associa-
ons (Out of 11 studies 
5,18,20,29,32,34-37,41,42
, 7 studies showed an inverse associaon or a de-
crease in blood pressure with high protein intake 
5,29,34,35,37,41,42
). 
Finally, in two studies subgroup-analyses were conducted for men and women, but no eﬀect 
modiﬁcaon was shown.
19,28
 Also in studies that were speciﬁcally conducted in men 
12,13,17,21,25,33
 or women 
36,37,41
, no diﬀerence in sensivity was seen. 
In conclusion, the possible beneﬁcial eﬀect of protein intake on blood pressure seems 
stronger in people with higher inial blood pressure and, possibly, in older people. Addio-
nal predeﬁned subgroup analyses in future epidemiologic studies and trials in which sub-
groups are compared, may provide be6er insight into the role of dietary protein in blood 
pressure. 
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A reducon in systolic blood pressure of only 2 mmHg may already result in a 6% reducon 
in fatal stroke, and a 4% reducon fatal coronary heart disease (CHD).
2
 Knowledge on the 
eﬀect of dietary protein, therefore, may have an important public health impact. A substan-
al body of evidence suggests a, possibly weak, beneﬁcial eﬀect of total dietary protein on 
blood pressure, which may be most apparent in populaons with elevated blood pressure 
and possibly older populaons. We cannot exclude, however, that this eﬀect is due to a lo-
wer carbohydrate intake. In observaonal studies more oNen an inverse associaon was 
found for plant protein than for animal protein. The beneﬁcial eﬀect of protein, therefore, 
may be mainly due to protein from plant sources. Data on protein from speciﬁc sources are 
too scarce to draw any conclusions.  
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The aim of the current systemac review was to give a comprehensive overview of the evi-
dence on dietary protein and human blood pressure, published unl June 2010. Papers were 
independently screened by 2 reviewers, and data of 46 studies were extracted using a pre-
deﬁned procedure. Several other reviews on protein and blood pressure have already been 
conducted in the past.
6-9
 However, the most comprehensive review of these is already 14 
years old.
9
 Furthermore, the present review is the ﬁrst to focus on possible blood pressure 
eﬀects of diﬀerent protein types and on sensivity of populaon subgroups. 
Several methodological issues of studies need to be addressed. First, in observaonal stu-
dies, even aNer extensive adjustment for potenal confounders, residual confounding may 
exist from other nutrients associated with protein intake, or from energy, which is not only 
correlated to protein, but also to several other blood pressure-determinants like exercise, 
BMI, and dietary pa6ern. It is diﬃcult to say how much the remaining confounding from 
known or unknown nutrients that are correlated to plant or animal protein have inﬂuenced 
the esmates in observaonal studies. Randomized controlled trials in which the eﬀects of 
plant protein and animal protein are compared, keeping other nutrients constant, are nee-
ded. Second, a diet high in one type of protein (animal protein or plant protein) does not 
necessarily mean that the other protein type is replaced, as a diet may be high or low in 
both types of protein. Most of the observaonal studies invesgang types of protein did 
not adjust their esmates for intakes of other protein types. In randomized trials these fac-
tors are more standardized.
68
 Third, respondents in observaonal studies may be misclassi-
ﬁed according to their self-reported protein intake, which may dilute the protein-blood pres-
sure associaon.
69
 Fourth, for invesgaon of long-term eﬀects of protein on blood pres-
sure, an observaonal study is the most suitable type of study, because of the costs of a 
trial. However, contrasts between high and low protein intake are oNen larger in trials than 
in observaonal studies. Short term eﬀects of protein on blood pressure can, therefore, be 
more easily detected in trials. Finally, all observaonal studies were conducted in the ge-
neral populaon, whereas trials were more oNen conducted in selected populaons that are 
possibly more sensive to blood pressure intervenons. However, in several trials blood 
pressure was the secondary outcome 
29,31-34,36,37,40-42,48
. If parcipants in these studies were 
not blinded for the results of the blood pressure-measurements, bias may have been intro-
duced, because awareness of blood pressure may inﬂuence parcipants’ lifestyle or other 
behaviour. 
The underlying mechanism for a potenal beneﬁcial eﬀect of protein on blood pressure has 
not yet been clariﬁed. Several hypotheses have been put forward. First, dietary protein has 
been related to synthesis of cellular ion channels, which may indirectly inﬂuence the path-
ways in blood pressure regulaon.
25
 High protein intake may induce natriuresis, leading to 
lower blood pressure.
26,62,70
 Second, experiments suggest that dietary protein or protein 
fracons could improve insulin sensivity and thereby blood pressure.
71-73
 Third, dietary pro-
tein supplementaon may result in a higher concentraon of the amino acids tyrosine and 
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tryptophan in regions of the brain or blood vessel wall, triggering a vasodilatory response.
7
 
The amino acid arginine, which is a substrate for nitric oxide, may play a role in vasodilata-
on, although it is unclear whether dietary intake of arginine is relevant in this respect.
73,75
 
Finally, as has already been stated in this review we cannot exclude that a lower blood pres-
sure is related to a lower carbohydrate intake instead of a higher protein intake. 
In conclusion, evidence suggests a small beneﬁcial eﬀect of protein on blood pressure, espe-
cially for plant protein. More data on protein from speciﬁc sources like dairy, grain or nuts 
and data in populaon subgroups should be obtained from epidemiological studies. Further-
more, there is a need for blood pressure trials that focus on plant and animal protein and 
protein from speciﬁc sources. Preferably, these trials should be conducted in untreated (pre)
hypertensive people. Finally, studies aimed at potenal blood pressure lowering mecha-
nisms related to protein intake are warranted. 
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Background 
Li6le is known about the relaon of diﬀerent dietary protein types with blood 
pressure. We examined whether intake of total, plant, animal, dairy, meat, and 
grain protein was related to blood pressure in a cross-seconal cohort of 20,820 
Dutch adults, aged 20-65 y and not using anhypertensive medicaon. 
Design 
Mean blood pressure levels were calculated in quinles of energy-adjusted protein 
with adjustment for age, sex, BMI, educaon, smoking, and intake of energy, alco-
hol, and other nutrients including protein from other sources. In addion, mean 
blood pressure diﬀerence aNer substuon of 3 en% carbohydrates or MUFA with 
protein was calculated. 
Results 
Total protein and animal protein were not associated with blood pressure 
(ptrend=0.62 and 0.71 respecvely), both at the expense of carbohydrates and 
MUFA. Systolic blood pressure was 1.8 mmHg lower (ptrend<0.01) in the highest 
(>36 g/d) than in the lowest (<27 g/d) quinle of plant protein. This inverse associa-
on was present both at the expense of carbohydrates and MUFA and more pro-
nounced in individuals with untreated hypertension (-3.6 mmHg) than in those 
with normal (+0.1 mmHg) or prehypertensive blood pressure (-0.3 mmHg; pinterac-
on<0.01). Meat and grain protein were not related to blood pressure. Dairy protein 
was directly associated with systolic blood pressure (+1.6 mmHg, ptrend<0.01), but 
not with diastolic blood pressure (ptrend=0.24).  
Conclusions 
Total protein and animal protein were not associated with blood pressure in this 
general untreated Dutch populaon. Plant protein may be beneﬁcial to blood pres-
sure, especially in people with elevated blood pressure. However, because high 
intake of plant protein may be a marker of a healthy diet and lifestyle in general, 
conﬁrmaon from randomized controlled trials is warranted. 
The MORGEN Study 
3 
61 
I761C267 
Elevated blood pressure is a major risk factor for cardiovascular disease and renal impair-
ment. It has been esmated that already from systolic blood pressure levels as low as 115 
mmHg onward, risk of cardiovascular disease increases linearly with increasing blood pres-
sure.
1
 Therefore, health authories emphasize the importance of dietary and lifestyle inter-
venons beneﬁcially inﬂuencing blood pressure including physical acvity, obtaining a 
healthy body weight, moderate alcohol consumpon, reduced salt intake, and increased 
potassium intake.
2,3
 More recently, interest has grown into dietary pa6erns and macronutri-
ent intakes, including dietary protein.
4,5
 A substanal body of evidence suggests a, possibly 
weak, beneﬁcial eﬀect of protein on blood pressure, although ﬁndings are not conclusive.
6,7
  
Protein intake is a rather heterogeneous exposure and types of protein (i.e. animal and plant 
protein and protein from speciﬁc sources like dairy, meat, grain) might diﬀerenally inﬂu-
ence blood pressure. In several observaonal studies 
8-14
 the associaon with blood pressure 
was invesgated separately for plant protein and animal protein. Results were inconclusive, 
although there is a trend towards a slightly more beneﬁcial eﬀect of plant protein than of 
animal protein on blood pressure. Data on speciﬁc protein sources in relaon to blood pres-
sure are scarce. We observed no associaon between intake of dairy, meat, and grain pro-
tein with 6-year incidence of hypertension in a previous analysis including 2241 adults (≥55 
y) from the populaon based Ro6erdam Study.
12
 He et al. recently published ﬁndings of a 
randomized, double-blind cross-over trial among 352 prehypertensive and hypertensive 
parcipants in which blood pressure eﬀects of supplementaon with soy protein, milk pro-
tein and complex carbohydrates was invesgated.
15
 Compared with carbohydrate, soy pro-
tein and milk protein (40g/d) resulted in a -2.0 mmHg and -2.3 mmHg net change in systolic 
blood pressure, respecvely, but the achieved blood pressure reducons did not diﬀer be-
tween soy and milk protein supplementaon.  
blood pressure response to protein intake may diﬀer between populaon subgroups, which 
may be an important issue because of public health recommendaons.
5,16
 In the INTERSALT 
study among 10,020 adults from 32 countries the inverse associaon between protein in-
take and blood pressure was more pronounced in parcipants aged >40 y than in younger 
parcipants.
16
 Furthermore, in the OmniHeart trial in 164 adults, blood pressure reducons 
during a high-protein diet were larger in hypertensive parcipants than in prehypertensive 
parcipants.
5
 However, more research is needed to be able to draw ﬁrm conclusions on 
potenally sensive populaon subgroups. 
In the present analysis, we examined whether intake of total protein, plant protein, animal 
protein, and protein from speciﬁc sources was related to blood pressure level in a general 
Dutch populaon of 20,820 adults. With respect to protein sources our main focus was on 
protein from dairy, meat, and grain, as these are the main sources of animal and plant pro-
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tein in the Netherlands.
17
 Addionally, we assessed whether protein-blood pressure associa-
ons were modiﬁed by gender, age, BMI, and blood pressure level. 
 
M3G61 
Study popula-on  
We used data from the populaon-based Monitoring Project on Risk Factors for Chronic 
Diseases (MORGEN project), which is part of the Dutch EPIC cohort. Details of the study have 
been described elsewhere.
18
 In brief, between 1993 and 1997 22,606 men and women aged 
20-65 y completed quesonnaires on diet, lifestyle, and health and underwent a physical 
examinaon. The Medical Ethics Commi6ee of the Netherlands Organizaon for Applied 
Scienﬁc Research (TNO) approved the study protocol and all parcipants signed informed 
consent form. We excluded 16 parcipants with missing data on blood pressure and 1,093 
parcipants who used anhypertensive medicaon. Addionally, we excluded 677 parci-
pants who were diabec, had a history of myocardial infarcon or stroke, or were pregnant, 
leaving 20,820 men and women for the present analyses. 
 
Dietary assessment and exposure categories  
Dietary intake was assessed using a self-administered semi-quantave food frequency 
quesonnaire (FFQ) on 178 foods and beverages consumed during the preceding year.
19
 
Colored photographs were used to facilitate esmaon of poron sizes, and seasonal varia-
on in food intake was taken into account. Total energy and nutrient intakes were calculat-
ed using an extended version of the Dutch Food Composion Table of 1996.
20
  
Animal protein was deﬁned as protein from dairy, meat, ﬁsh, eggs, and animal protein from 
mixed dishes. Plant protein included protein from grain, potatoes, fruits, vegetables, nuts, 
legumes, soy, and plant protein from mixed dishes. Dairy protein was calculated as protein 
from all kind of milk, yogurt, coﬀee creamer, curd, pudding, porridge, custard, ice-cream, 
whipped cream, and cheese. Meat protein included protein from all meat and meat based 
products, and grain protein was calculated as plant protein from rice, bread, pasta and bak-
ery products. In addion, we calculated protein from potatoes (including fries), vegetables, 
fruits, and legumes (without green beans and peas). 
In a validaon study among 63 men and 58 women good reproducibility was shown for 
energy adjusted total protein intake with Pearson correlaon coeﬃcients of 0.73 in men and 
0.70 in women.
21
 The relave validity of the FFQ was assessed against 12 monthly 24-h 
recalls over a 1-year period. Pearson correlaon coeﬃcients for energy adjusted total pro-
tein intake aNer correcon for intra-individual variaon were 0.71 for men and 0.67 for 
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women.
21
 Energy adjusted total protein intake as assessed from the FFQ also correlated well 
with urinary nitrogen excreon in four 24h urine samples at 3-month intervals, i.e. Pearson 
correlaon coeﬃcients of 0.56 for men and 0.69 for women. 
21
 For types of protein the FFQ 
was not validated, but correlaons for milk and milk products and bread, as surrogate mark-
ers for dairy and grain protein, were good (all r>0.65), whereas correlaons for meat were 
lower, especially for men (rmen=0.39; rwomen=0.59).
19
 
 
Blood pressure 
Systolic and diastolic blood pressure (ﬁrst and ﬁNh Korotkoﬀ sounds, respecvely) was 
measured by trained nurses using a random zero sphygmomanometer on the leN arm in 
supine posion, aNer a 5-minute rest. Blood pressure was measured twice, 30 seconds 
apart, and the mean of the two readings was used. During physical examinaon, regular 
audits were performed to check adherence to the blood pressure measuring protocol (e.g. 
resng me, adequate cuﬀ size). Normotension was deﬁned as systolic blood pressure ≤120 
mmHg and diastolic blood pressure ≤80 mmHg. Hypertension was deﬁned as a systolic blood 
pressure of ≥140 mmHg and/or diastolic blood pressure of ≥90 mmHg (parcipants using 
anhypertensive medicaon were excluded). All other parcipants were considered to be 
prehypertensive. 
 
Lifestyle factors 
Body weight (to nearest 0.1 kg) and height (to nearest 0.5 cm) were measured with parci-
pants wearing light indoor clothing without shoes and body mass index (BMI) was calculated 
(kg/m
2
). Data on age, gender, educaon, lifestyle factors, history of major diseases, medica-
on use, and any prescribed diets were collected by quesonnaires. A quesonnaire on 
physical acvity pa6ern in the preceding year was introduced in 1994 and was completed by 
16,073 parcipants (77%) of our cohort. Parcipants were classiﬁed in categories of alcohol 
intake (none, moderate, high), smoking status (current smoker/non-smoker), educaonal 
level (3 categories), and physical acvity (4 categories, ranging from inacve to very ac-
ve
18
). 
 
Sta-s-cal analysis 
Data analysis was performed using SAS version 9.1 (SAS Instute Inc.). Protein intake was 
ﬁrst adjusted for total energy intake according to the residual method.
22
 Baseline character-
iscs of the study populaon were calculated in quinles of energy-adjusted total protein 
intake, and are presented as means ± standard deviaon, percentages, or medians with 
interquarle range.  
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We used general linear models to calculate average blood pressure levels with 95% conﬁ-
dence intervals (CI) in quinles of energy-adjusted protein intake (total, animal, plant, dairy, 
meat and grain). The basic model (model 1) included age and gender. In model 2, further 
adjustment was made for BMI, educaon, smoking, and alcohol consumpon. The fully 
adjusted model (model 3) addionally included daily intake of total energy, saturated fa6y 
acids, carbohydrates, ﬁber, calcium, magnesium, potassium, and protein intake from other 
sources than the one under study. Because grain comprised only 48% of plant protein intake 
we conducted post hoc analyses in which we calculated fully adjusted mean blood pressure 
in terles of dietary protein intake from potatoes, vegetables, fruits, and legumes. 
To invesgate whether physical acvity confounded the protein-blood pressure associa-
ons, post hoc analyses were conducted per 5 grams of total, animal and plant protein in 
the subgroup with data on physical acvity using the full model (model 3) with or without 
addional adjustment for physical acvity. In addion we performed substuon analyses 
to invesgate the blood pressure diﬀerence with exchange of nutrients. By including total 
protein and carbohydrate as connuous variables in the same mulvariable model (model 3) 
we invesgated the blood pressure diﬀerence with 3 energy percentage (en%) higher total 
protein intake at the expense of carbohydrates. The diﬀerence in the coeﬃcients of total 
protein and carbohydrates plus their covariance was used to esmate blood pressure diﬀer-
ence and 95% conﬁdence interval for the substuon. Similarly we invesgated the blood 
pressure diﬀerence of 3 en% higher total protein at the expense of mono-unsaturated fat. 
The same substuon analyses were performed for animal protein and plant protein. 
Finally, for total, plant and animal protein, pre-deﬁned subgroup analyses were performed 
in strata of gender, age (<50 y and ≥50 y), BMI (<25 kg/m
2
 and ≥25 kg/m
2
), and blood pres-
sure level (normotensives, prehypertensives and untreated hypertensives), using the full 
model (model 3). 
 
R3C: 
Descrip-ve sta-s-cs 
The mean age of the populaon was 42 ± 11 y and 45% were men. Average blood pressure 
was 120.0 ± 15.6 mmHg systolic and 76.1 ± 10.4 mmHg diastolic, and 15% of the populaon 
had untreated hypertension. The mean energy-adjusted total protein intake of the study 
populaon was 84 ± 12 g/d (~15 energy%), with 52 ± 13 g/d derived from animal sources. 
ANer energy adjustment of dietary protein, age and sex adjusted Pearson paral correlaon 
coeﬃcients were 0.89 for total protein with animal protein, 0.07 for total with plant protein, 
and -0.39 for plant protein with animal protein. Major sources of animal protein intake were 
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 Quin-les of energy adjusted total protein intake (g/d)  
 <74 (n=4173) 
74 to 81 
(n=4166) 
81 to 86 
(n=4159) 
86-93 
(n=4166) >93 (n=4156) 
Median intake, g/d 70 78 83 89 98 
      
Age, y 41 ± 11 42 ± 11 42 ± 11 43 ± 11 43 ± 11 
Gender, % male 49 43 42 43 50 
High educaon, % 22 26 26 26 22 
Systolic BP, mmHg 119.5 ± 15.6 119.5 ± 15.8 119.6 ± 15.9 120.8 ± 15.7 120.7 ± 15.3 
Diastolic BP, mmHg 75.8 ± 10.3 75.7 ± 10.3 76.0 ± 10.4 76.7 ± 10.5 76.5 ± 10.3 
Hypertension, %
1 
13.6 14.1 14.5 15.8 15.6 
Body mass index, kg/m
2 
24.0 ± 3.6 24.5 ± 3.8 24.9 ± 3.7 25.2 ± 3.8 25.8 ± 4.1 
Overweight, % 35 38 43 48 53 
High physical acvity, %
2 
9 ± 12 8 ± 11 8 ± 11 9 ± 11 10 ± 13 
Alcohol among consumers, 
glass/d
3, 4 
2.0 (1.0-3.6) 1.4 (0.7-2.9) 1.4 (0.7-2.4) 1.3 (0.7-2.1) 1.3 (0.7-2.1) 
Current smoking, % 46 38 36 30 32 
      
Dietary intake      
Total energy, kJ/day 10186 ± 3282 9204 ± 2799 9054 ± 2634 9157 ± 2589 10131 ± 3157 
Total protein, g/d (en%) 72 ± 23 (12) 75 ± 21 (14) 80 ± 20 (15) 86 ± 20 (16) 105 ± 27 (18) 
Animal protein, g/d (en%) 40 ± 15 (7) 44 ± 14 (8) 49 ± 13 (9) 55 ± 12 (11) 71 ± 19 (12) 
Plant protein, g/d (en%) 33 ± 12 (5) 31 ± 10 (6) 31 ± 10 (6) 31 ± 10 (6) 34 ± 12 (6) 
Dairy protein, g/d (en%)
5 
14 ± 9 (2) 17 ± 9 (3) 20 ± 10 (4) 24 ± 10 (6) 33 ± 16 (6) 
Meat protein, g/d (en%)
6 
16 ± 10 (3) 18 ± 10 (3) 20 ± 9 (4) 22 ± 10 (5) 27 ± 12 (5) 
Grain protein, g/d (en%)
7 
15 ± 7 (2) 15 ± 7 (3) 15 ± 6 (3) 15 ± 7 (3) 17 ± 8 (3) 
Total fat, g/d (en%) 95 ± 37 (35) 87 ± 31 (36) 87 ± 30 (36) 88 ± 29 (36) 97 ± 35 (36) 
Saturated fat, g/d (en%) 38 ± 15 (14) 35 ± 13 (15) 36 ± 13 (15) 36 ± 12 (15) 41 ± 16 (15) 
Carbohydrates, g/d (en%) 288 ± 96 (48) 254 ± 80 (47) 245 ± 77 (46) 245 ± 75 (44) 263 ± 92 (44) 
Fiber, g/d 24 ± 8 24 ± 7 24 ± 7 25 ± 7 27 ± 8 
Calcium, mg/d 849 ± 340 918 ± 342 1014 ± 357 1145 ± 382 1498 ± 581 
Magnesium, mg/d 350 ± 110 345 ± 97 354 ± 92 370 ± 94 423 ± 117 
Potassium, mg/d 3534 ± 1037 3493 ± 927 3587 ± 867 3762 ± 885 4294 ± 1090 
Table 3.1. Characteris-cs by quin-les of energy adjusted total protein intake of 20,820 Dutch 
adults. 
Unless indicated otherwise, data are presented as mean ± SD or %. 
1
Hypertension is deﬁned as systolic blood pressure≥140 mmHg or diastolic blood pressure≥90 mmHg (par-cipants 
using an-hypertensive medica-on were excluded); 
2
Data from a subgroup (n=16,073). In consecu-ve quin-les 
n=3,255, n=3,229, n=3,190, n=3,184, and n=3,215. High physical ac-vity was deﬁned as ≥3.5 hours moderate 
ac-vity (4.0>MET≥6.5) and ≥2 h/wk vigorous ac-vity (MET ≥6.5) ; 
3
Percentage of alcohol consumers in consecu-ve 
quin-les 63%, 63%, 63%, 60% and 58%; 
4
Presented as median with interquar-le range because of skewed 
distribu-on; 
5
Protein intake from all kind of milk, yogurt, coﬀee creamer, curd, pudding, porridge, custard, whipped 
cream, and cheese; 
6
Protein intake from all kind of meats, meat products and poultry; 
7
Plant protein intake from all 
kinds of breads, cake and cookies, grains and grain products. 
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dairy (42%) and meat (40%). Plant protein intake mainly comprised grain protein (48%), 
whereas other sources were potatoes (10%), vegetables (7%), fruits (4%), and legumes (2%). 
Parcipants with a higher intake of total protein had a somewhat higher blood pressure and 
were more likely to be overweight or obese, whereas they were less likely to be a current 
smoker than parcipants with a low intake (Table 3.1). Fat intake and carbohydrate intake 
did not diﬀer between quinles, whereas higher intake of protein was accompanied with 
higher intake of minerals (i.e. calcium, magnesium, and potassium). 
 
Protein intake and blood pressure 
Intake of total and animal protein was not clearly associated with blood pressure (Table 
3.2), whereas in the highest quinle of dietary plant protein mean blood pressure 
was -1.8/ -1.0 mmHg lower than in the lowest quinle (ptrend<0.01). Sensivity analysis with-
in the subgroup of 16,073 parcipants for whom data on physical acvity were available, 
showed essenally similar esmates when physical acvity was addionally included in the 
mulvariable model. Betas for systolic blood pressure per 5 grams of total protein was 
Figure 3.1. Fully adjusted systolic blood pressure diﬀerence (mmHg) associated with 
replacement of 3 en% of carbohydrates or fat by total, plant or animal protein 
and by replacement of animal protein by plant protein. 
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0.13±0.06 mmHg with physical acvity in the model versus 0.14±0.05 without physical acvi-
ty. For animal and plant protein betas per 5 grams were 0.15±0.03 versus 0.16±0.02 mmHg 
and -0.43±0.005 versus -0.41±0.006 respecvely. 
Substuon analysis in which 3 energy% of carbohydrates or MUFA was substuted by total 
or animal protein did not show a diﬀerence in blood pressure (Figure 3.1). However, when 3 
en% of carbohydrates was substuted by plant protein, blood pressure was -2.1/ -1.0 mmHg 
lower (p<0.01). Also substuon of 3 en% of mono-unsaturated fa6y acids by plant protein 
resulted in a lower blood pressure (-1.3/-1.2 mmHg, p<0.05) 
 Median intake(g) SBP SBP 
Dairy protein  
Q1 9 119.0 (118.4 - 119.7) 76.0 (75.5 - 76.4) 
Q2 15 119.8 (119.4 - 120.3) 76.0 (75.7 - 76.3) 
Q3 21 119.9 (119.5 - 120.3) 76.1 (75.8 - 76.4) 
Q4 26 120.6 (120.2 - 121.1) 76.2 (75.9 - 76.5) 
Q5 36 120.6 (119.9 - 121.3) 76.4 (75.9 - 76.9) 
ptrend   <0.01 0.24 
Meat protein    
Q1 9 119.5 (119.0 - 120.0) 75.8 (75.5 - 76.1) 
Q2 16 120.3 (119.9 - 120.8) 76.2 (75.9 - 76.5) 
Q3 21 120.4 (120.0 - 120.8) 76.7 (76.4 - 77.0) 
Q4 25 120.2 (119.8 - 120.6) 76.0 (75.7 - 76.3) 
Q5 32 119.5 (119.1 - 120.0) 76.0 (75.6 - 76.3) 
ptrend   1.00 0.83 
Grain protein    
Q1 9 119.9 (119.5 - 120.4) 76.3 (76.0 - 76.6) 
Q2 13 120.5 (120.0 - 120.9) 76.4 (76.1 - 76.7) 
Q3 15 119.7 (119.3 - 120.1) 76.0 (75.7 - 76.3) 
Q4 18 120.2 (119.7 - 120.6) 76.3 (76.0 - 76.6) 
Q5 22 119.7 (119.2 - 120.2) 75.7 (75.4 - 76.0) 
ptrend  0.42 0.03 
Table 3.3. Fully adjusted systolic and diastolic blood pressure in 20,820 untreated Dutch 
adults in quin-les of dairy, meat and grain protein intake. 
Values are average blood pressure and 95% conﬁdence interval, adjusted for age, gender, BMI, educa-onal level, 
smoking, alcohol consump-on, total energy, saturated fa6y acids, carbohydrates, ﬁber, calcium, magnesium, 
potassium, and protein intake from other sources than the one under study, if applicable. 
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With respect to protein from speciﬁc sources, systolic blood pressure in the highest quinle 
of dairy protein intake was 1.6 mmHg higher than in the lowest quinle (ptrend<0.01), which 
we did not observe for diastolic blood pressure (Table 3.3). Intake of meat protein or grain 
protein was not associated with blood pressure. With respect to plant protein from other 
sources than grain, systolic blood pressure was +0.8 mmHg higher in the highest (median 
intake=5.2 g/d) than in the lowest (1.4 g/d) terle of potato protein. (ptrend=0.01). For pro-
tein intake from vegetables (2.9 g/d in highest vs. 1.3 g/d in lowest terle), fruits (2.0 vs. 0.4 
g/d), and legumes (1.2 vs. 0.1 g/d) this diﬀerence in systolic blood pressure was -0.9 mmHg 
(ptrend<0.01), +0.1 mmHg (ptrend=0.50), and +0.8 mmHg (ptrend<0.01), respecvely. 
Age, gender, and BMI did not independently modify the associaons between protein intake 
and blood pressure (data not shown). The associaon between total protein intake and 
blood pressure was not signiﬁcantly modiﬁed by blood pressure level (pinteracon=0.14, Figure 
3.2). With regard to protein types we observed no eﬀect modiﬁcaon of blood pressure 
level on the relaon between animal protein and blood pressure (pinteracon=0.16), whereas 
plant protein was inversely associated with systolic blood pressure in untreated hyperten-
sives (-3.6 mmHg, ptrend<0.01) but not in normotensives (-0.1 mmHg, ptrend=0.39) and prehy-
pertensives (+0.2 mmHg, ptrend=0.97, pinteracon<0.01). 
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In this cross-seconal study in 20,820 Dutch adults aged 20-65 years, total dietary protein 
and animal protein were not related to blood pressure. High intake of plant protein was 
associated with lower blood pressure, which was most pronounced in untreated hyperten-
sive individuals. Protein from meat and grain were not related to blood pressure, whereas 
dairy protein was directly associated with systolic, but not diastolic blood pressure. 
We conducted the current study among a large populaon of 20,820 Dutch adults. Protein 
intake is usually ghtly regulated 
23
 and we consider it likely that protein intake measured in 
this study gives a good esmate of lifelong exposure. Nevertheless, due to the 
cross-seconal design of the study it is possible that parcipants at increased cardiovascular 
risk, changed their diet upon medical advice. For this reason, we excluded individuals with 
diabetes, prevalent cardiovascular diseases, and clinically diagnosed hypertension (i.e. using 
anhypertensive medicaon). Because elevated blood pressure is oNen asymptomac we 
consider intenonal dietary changes unlikely in parcipants that are not aware that they 
have a high blood pressure. However, a total of 3,999 parcipants (19%) reported that high 
blood pressure had ever been observed. Intakes of protein types of this group were not 
diﬀerent from those in other parcipants (total protein: 15±2 en% for both groups; animal 
protein: 9.3±2.5 en% vs. 9.7±2.5 en%; plant protein 6±1 en% for both groups). Also intake of 
nutrients that are indicators of a healthy lifestyle were similar between the groups; ﬁber 
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intake in the group with a history of high blood pressure was 24±7 g/d versus 25±8 g/d in 
the other group, and potassium intake was 3675±961 mg/d versus 3748±1019 mg/d. There-
fore, we do not expect that reverse causality has inﬂuenced our ﬁndings.  
Extensive data collecon in this large populaon based cohort allowed adjustment for many 
potenal confounders. Nevertheless, physical acvity, which is an important blood pressure 
determinant, was not assessed unl 1994 and data were available for only 77% of our co-
hort. In this subgroup physical acvity appeared not to confound the associaon between 
Figure 3.2. Systolic blood pressure in quin-les of protein intake, stra-ﬁed by hypertension 
status 
 SBP=systolic blood pressure, Values are average blood pressure and 95% conﬁdence interval, 
adjusted for age, gender, BMI, educa-on, smoking, alcohol consump-on, total energy, saturated 
fa6y acids, carbohydrates, ﬁber, calcium, magnesium, potassium, and protein intake from other 
sources than the one under study, if applicable. 
 pinterac-on for total protein=0.14, pinterac-on for animal protein=0.16, pinterac-on for plant protein=<0.01 
The MORGEN Study 
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dietary protein and blood pressure. We therefore consider it unlikely that lack of adjustment 
for physical acvity has aﬀected our ﬁndings. 
Protein intake in the present study was assessed using a self-administered semi-quantave 
FFQ. Validaon against 24-hour dietary recalls and 24-hour urine samples showed good 
correlaons for total dietary protein (all correlaon coeﬃcients >0.55), indicang that par-
cipants could be adequately ranked according to their protein intake.
21
 However, the FFQ 
was not validated for protein types. Although correlaons with 24-h recalls were good for 
milk and bread, as surrogate markers for protein from dairy and grain, correlaons for meat, 
as surrogate marker for meat protein, were lower, especially in men (r=0.39).
19
 Misclassiﬁca-
on of parcipants, especially for meat protein, may have led to a6enuated associaons 
with blood pressure, and these ﬁndings should therefore be interpreted with cauon. 
The lack of signiﬁcant associaon between total protein and blood pressure in our study is in 
agreement with previous observaonal studies showing inconclusive results.
6
 Results of 
trials, however, suggest that protein may have a small beneﬁcial eﬀect on blood pres-
sure.
5,6,24,25
 Most of these trials had a carbohydrate-rich control diet. The fully controlled 
Omniheart trial in 164 US adults addionally compared a protein rich diet with an isocaloric 
diet that was rich in mono-unsaturated fat.
5
 blood pressure was similar during these diets, 
and the authors therefore argued that reduced carbohydrate rather than increased protein 
intake lowers blood pressure. We could not conﬁrm this hypothesis with our substuon 
analysis that yielded no associaon of dietary protein with blood pressure, irrespecve of 
whether protein was exchanged with carbohydrates or monounsaturated fat. This discrep-
ancy may be explained by contrast in protein intake, which was only 4 en% between ex-
treme quinles in the present study whereas it was 10 en% in Omniheart. Moreover, blood 
pressure in our cohort was low (120/76 mmHg) compared to that of (pre)hypertensive trial 
parcipants. 
In our analysis plant protein was inversely associated with blood pressure, whereas we 
observed no associaon for animal protein. In OmniHeart 
5
, blood pressure reducons may 
have been due to extra intake of plant protein, which accounted for two thirds of the diﬀer-
ence in protein intake between the diets. A diﬀerenal eﬀect of dietary plant and animal 
protein on blood pressure might be explained by diﬀerences in amino acid composion. In 
the INTERMAP study in 4,680 adults, individuals with a high intake of plant protein also had 
a relavely high intake of glutamic acid.
26
 With a 2 SD higher intake of glutamic acid (4.7% of 
total protein) the authors observed 1.5 mmHg lower systolic and 1.0 mmHg lower diastolic 
blood pressure levels. On the other hand, although we adjusted our esmates for many 
potenal confounders including potassium and ﬁber as healthy diet indicators, we cannot 
exclude the possibility that unmeasured beneﬁcial nutrients that are closely correlated to 
plant protein (e.g. polyphenols) or healthy lifestyle in general have contributed to the ob-
served associaons between plant protein and blood pressure. 
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The inverse associaon of plant protein with blood pressure could not be explained by grain 
protein, which comprised 48% of plant protein intake. Therefore we performed post-hoc 
analysis to explore whether other sources of plant protein could explain the observed in-
verse associaon for plant protein. This was not the case for protein intake from potatoes, 
legumes, and fruits, which was either directly or not associated with blood pressure. Howev-
er, intake of vegetable protein, which contributed 7% to plant protein intake in our popula-
on, showed a small inverse relaonship with blood pressure and could possibly (partly) 
explain a beneﬁcial associaon of plant protein with blood pressure. On the other hand, a 
high vegetable protein intake may also be a marker for a healthy diet and lifestyle, which 
may have contributed to the observed inverse associaons. 
With respect to protein from animal sources, meat protein (40% of animal protein intake) 
was not associated with blood pressure. This is in line with results from previous analysis in 
2241 older Dutch adults of the Ro6erdam cohort, where intake of meat protein was not 
related to hypertension risk.
12
 Moreover, protein from several meat sources did not aﬀect 
blood pressure compared to plant protein or non-meat protein in a randomized controlled 
trial among 64 hospital staﬀ members and a randomized controlled cross-over trial among 
35 men respecvely.
27,28
 For dairy protein (42% of animal protein intake) we found a direct 
associaon with systolic, but not with diastolic blood pressure. In the Ro6erdam cohort 
dairy protein was not associated with incident hypertension.
12
 Also, in a fully controlled 
weight loss trial including 65 adults, a diet containing 15 en% milk protein did not aﬀect 
blood pressure compared to a diet in which the milk protein was exchanged for fat.
29
 More-
over, in a double-blind randomized cross-over trial including 352 (pre)hypertensive parci-
pants milk protein supplementaon (40 g/d) resulted in a blood pressure reducon of -2.3 
mmHg compared to carbohydrate supplementaon.
15
 Therefore, the direct associaon 
between dairy protein and systolic blood pressure that we observed in the current study 
may well be a chance ﬁnding. 
Our results suggest that untreated hypertensive individuals could be more sensive to a 
beneﬁcial eﬀect of plant protein than normotensive or prehypertensive individuals. This is in 
line with ﬁndings from the OmniHeart study 
5
, in which larger blood pressure reducons 
were found for increased protein intake (largely from plant sources) in untreated hyperten-
sives than in prehypertensives. Because over 30% of the global adult populaon is esmated 
to be hypertensive, this ﬁnding could have important public health implicaons and war-
rants further invesgaon.  
In conclusion, intake of total protein and animal protein was not associated with blood pres-
sure in this general Dutch populaon not using anhypertensive medicaon. Our results 
suggest that plant protein may lower populaon blood pressure level by ~2 mmHg, especial-
ly in those with elevated blood pressure levels. This may have important public health impli-
caons because a downward shiN in populaon blood pressure by 2 mmHg may reduce 
cardiovascular mortality by ~5%.
3
 However, due to the cross-seconal design a deﬁnive 
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conclusion on causality cannot be drawn. Moreover, we cannot exclude that high plant 
protein is a marker for a healthy lifestyle in general. Therefore, conﬁrmaon from random-
ized controlled trials is warranted. 
 
A;76Y:31Z3937 
The authors would like to thank the logiscs managers, data managers, and the epidemiolo-
gists and ﬁeld workers of the Municipal Health Services in Amsterdam, Doenchem, and 
Maastricht for their important contribuon to the data collecon for this study. The project 
steering commi6ee of the MORGEN-Study consisted of dr. H.B. Bueno de Mesquita, prof. 
H.A. Smit, dr. W.M.M. Verschuren, and prof. J.C. Seidell (project director). 
Chapter 3 — Protein intake and blood pressure 
74 
R3F3373 
1. Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo Jr JL, Jones DW, Materson BJ, Oparil S, 
Wright Jr JT, Roccella EJ. Seventh report of the Joint Naonal Commi6ee on Prevenon, Detecon, 
Evaluaon, and Treatment of High Blood Pressure. Hypertension 2003;42(6):1206-1252. 
2. Appel LJ, Brands MW, Daniels SR, Karanja N, Elmer PJ, Sacks FM. Dietary approaches to prevent and 
treat hypertension: A scienﬁc statement from the American Heart Associaon. Hypertension 2006;47
(2):296-308. 
3. Whelton PK, He J, Appel LJ, Cutler JA, Havas S, Kotchen TA, Roccella EJ, Stout R, Vallbona C, Winston MC, 
Karimbakas J. Primary prevenon of hypertension: Clinical and public health advisory from the Naonal 
High Blood Pressure Educaon Program. Journal of the American Medical Associaon 2002;288
(15):1882-1888. 
4. Appel LJ, Moore TJ, Obarzanek E, Vollmer WM, Svetkey LP, Sacks FM, Bray GA, Vogt TM, Cutler JA, 
Windhauser MM, Lin PH, Karanja N, Simons-Morton D, McCullough M, Swain J, Steele P, Evans MA, 
Miller Iii ER, Harsha DW. A clinical trial of the eﬀects of dietary pa6erns on blood pressure. New England 
Journal of Medicine 1997;336(16):1117-1124. 
5. Appel LJ, Sacks FM, Carey VJ, Obarzanek E, Swain JF, Miller ER, Conlin PR, Erlinger TP, Rosner BA, Laranjo 
NM, Charleston J, McCarron P, Bishop LM. Eﬀects of protein, monounsaturated fat, and carbohydrate 
intake on blood pressure and serum lipids: results of the OmniHeart randomized trial. JAMA 2005;294
(19):2455-64. 
6. Altorf - van der Kuil W, Engberink MF, Brink EJ, van Baak MA, Bakker SJL, Navis G, van 't Veer P, Geleijnse 
JM. Dietary Protein and Blood Pressure: A Systemac Review. PLoS ONE 2010;5(8):e12102. 
7. Savica V, Bellinghieri G, Kopple JD. The eﬀect of nutrion on blood pressure. Annual Review of Nutrion. 
Vol. 30, 2010;365-401. 
8. Ellio6 P, Stamler J, Dyer AR, Appel L, Dennis B, Kesteloot H, Ueshima H, Okayama A, Chan Q, Garside DB, 
Zhou B. Associaon between protein intake and blood pressure: the INTERMAP Study. Archives of 
internal medicine 2006;166(1):79-87. 
9. Alonso A, Beunza JJ, Bes-Rastrollo M, Pajares RM, Marnez-Gonzalez MA. Vegetable protein and ﬁber 
from cereal are inversely associated with the risk of hypertension in a Spanish cohort. Archives of 
medical research 2006;37(6):778-86. 
10. Wang YF, Yancy Jr WY, Yu D, Champagne C, Appel LJ, Lin PH. The relaonship between dietary protein 
intake and blood pressure: results from the PREMIER study. Journal of Human Hypertension 2008;22
(11):745-754. 
11. Stamler J, Liu K, Ruth KJ, Pryer J, Greenland P. Eight-year blood pressure change in middle-aged men: 
relaonship to mulple nutrients. Hypertension 2002;39(5):1000-6. 
12. Altorf-van der Kuil W, Engberink MF, van Rooij FJ, Hofman A, Van't Veer P, Wi6eman JC, Geleijnse JM. 
Dietary protein and risk of hypertension in a Dutch older populaon: the Ro6erdam study. Journal of 
Hypertension 2010;28(12):2394-400. 
13. Umesawa M, Sato S, Imano H, Kitamura A, Shimamoto T, Yamagishi K, Tanigawa T, Iso H. Relaons 
between protein intake and blood pressure in Japanese men and women: the Circulatory Risk in 
Communies Study (CIRCS). The American journal of clinical nutrion 2009;90(2):377-384. 
14. Masala G, Bendinelli B, Versari D, Saieva C, Cero M, Santagiuliana F, Caini S, Salvini S, Sera F, Taddei S, 
Ghiadoni L, Palli D. Anthropometric and dietary determinants of blood pressure in over 7000 
Mediterranean women: the European Prospecve Invesgaon into Cancer and Nutrion-Florence 
cohort. J Hypertens 2008;26(11):2112-20. 
15. He J, Woﬀord MR, Reynolds K, Chen J, Chen C, Myers L, Minor DL, Elmer PJ, Jones DW, Whelton PK. 
Eﬀect of Dietary Protein Supplementaon on Blood Pressure: A Randomized, Controlled Trial. Circulaon 
2011;124:589-595. 
16. Stamler J, Ellio6 P, Kesteloot H, Nichols R, Claeys G, Dyer AR, Stamler R. Inverse relaon of dietary 
protein markers with blood pressure. Findings for 10,020 men and women in the INTERSALT Study. 
INTERSALT Cooperave Research Group. INTERnaonal study of SALT and blood pressure. Circulaon 
1996;94(7):1629-34. 
17. Halkjær J, Olsen A, Bjerregaard LJ, Deharveng G, Tjønneland A, Welch AA, Crowe FL, Wirfält E, Hellstrom 
V, Niravong M, Touvier M, Linseisen J, Steﬀen A, Ocké MC, Peeters PHM, Chirlaque MD, Larrañaga N, 
Ferrari P, Conero P, Frasca G, Engeset D, Lund E, Misirli G, Kos M, Riboli E, Slimani N, Bingham S. 
Intake of total, animal and plant proteins, and their food sources in 10 countries in the European 
Prospecve Invesgaon into Cancer and Nutrion. European Journal of Clinical Nutrion 2009;63
(SUPPL. 4):S16-S36. 
The MORGEN Study 
3 
75 
18. Blokstra A, Bueno-de-Mesquita HB, Seidell JC, Verschuren WMM. Monitoring of risk factors and health in 
The Netherlands (MORGEN-project) 1993-1997. Lifestyle and risk factors: prevalences and trends 2005. 
RIVM report 263200008. Bilthoven: RIVM, 2005. 
19. Ocké MC, Bueno-De-Mesquita HB, Goddijn HE, Jansen A, Pols MA, Van Staveren WA, Kromhout D. The 
Dutch EPIC Food Frequency Quesonnaire. I. Descripon of the quesonnaire, and relave validity and 
reproducibility for food groups. Internaonal Journal of Epidemiology 1997;26(SUPPL. 1). 
20. Dutch food composion table (NEVO). Nederlands voedingsstoﬀenbestand. The Hague: 
Voorlichngsbureau voor de Voeding, 1996. 
21. Ocké MC, Bueno-De-Mesquita HB, Pols MA, Smit HA, Van Staveren WA, Kromhout D. The Dutch EPIC 
Food Frequency Quesonnaire. II. Relave validity and reproducibility for nutrients. Internaonal 
Journal of Epidemiology 1997;26(SUPPL. 1). 
22. Wille6 WC, Howe GR, Kushi LH. Adjustment for total energy intake in epidemiologic studies. American 
Journal of Clinical Nutrion 1997;65(4 SUPPL.). 
23. Simpson SJ, Batley R, Raubenheimer D. Geometric analysis of macronutrient intake in humans: The 
power of protein? Appete 2003;41(2):123-140. 
24. Muzio F, Mondazzi L, Harris WS, Sommariva D, Branchi A. Eﬀects of moderate variaons in the 
macronutrient content of the diet on cardiovascular disease risk factors in obese paents with the 
metabolic syndrome. American journal of clinical nutrion 2007;86(4):946-51. 
25. Delbridge EA, Prendergast LA, Pritchard JE, Proie6o J. One-year weight maintenance aNer signiﬁcant 
weight loss in healthy overweight and obese subjects: does diet composion ma6er? Am J Clin Nutr 
2009;90(5):1203-14. 
26. Stamler J, Brown IJ, Daviglus ML, Chan Q, Kesteloot H, Ueshima H, Zhao L, Ellio6 P. Glutamic acid, the 
main dietary amino acid, and blood pressure: The intermap study (internaonal collaborave study of 
macronutrients, micronutrients and blood pressure). Circulaon 2009;120(3):221-228. 
27. Presco6 SL, Jenner DA, Beilin LJ, Marge6s BM, Vandongen R. A randomized controlled trial of the eﬀect 
on blood pressure of dietary non-meat protein versus meat protein in normotensive omnivores. Clinical 
science 1988;74(6):665-72. 
28. Kesn M, Rouse IL, Correll RA, Nestel PJ. Cardiovascular disease risk factors in free-living men: 
comparison of two prudent diets, one based on lactoovovegetarianism and the other allowing lean 
meat. American journal of clinical nutrion 1989;50(2):280-7. 
29. Hochstenbach-Waelen A, Westerterp KR, Soenen S, Westerterp-Plantenga MS. No long-term weight 
maintenance eﬀects of gelan in a supra-sustained protein diet. Physiology and Behavior 2010;101
(2):237-244. 

  
 
 
Sources of dietary protein 
and risk of hypertension in a 
general Dutch popula-on 
 
 
Wieke Altorf-van der Kuil, Mariëlle F. Engberink, 
Johanna M. Geleijnse, Jolanda M.A. Boer,  
and W.M. Monique Verschuren 
 
 
 
 
Bri-sh Journal of Nutri-on, e-publica-on ahead of print 
Chapter 4 — Protein intake and risk of hypertension 
78 
A 
Background 
Evidence suggests a small beneﬁcial eﬀect of dietary protein on blood pressure, 
especially for plant protein. We examined the relaon between several types of 
dietary protein (total, plant, animal, dairy, meat, and grain) and risk of 
hypertension in a general populaon of 3588 Dutch adults, aged 26-65 y, who were 
free of hypertension at baseline. 
Methods 
Measurements were done at baseline and aNer 5 and 10 years of follow-up. Hazard 
raos (HRs), with 95%-conﬁdence intervals (95%-CI) for incident hypertension were 
obtained in terles of energy-adjusted protein, using me dependent Cox 
regression models. Models were adjusted for age, sex, BMI, educaon, smoking, 
baseline systolic blood pressure, dietary confounders, and protein from other 
sources (if applicable).  
Results 
Mean blood pressure was 118/76 mmHg at baseline. Protein intake was 85±22 g/
day (~15 en%) with 62% originang from animal sources. The main sources of 
protein were dairy (28%), meat (24%), and grain (19%). During follow-up 1568 new 
cases of hypertension were idenﬁed (44% of parcipants). Energy-adjusted intake 
of total protein, plant protein, and animal protein was not signiﬁcantly associated 
with hypertension risk (all HRs ~1.00, p>0.60). Protein from grain showed a 
signiﬁcant inverse associaon with incident hypertension, with a HR of 0.85 (95% 
CI: 0.73-1.00, ptrend=0.04) for the upper terle (≥ 18 g/d) vs. lower terle (<14 g/d), 
whereas protein from dairy and meat were not associated with incident 
hypertension. 
Conclusions 
higher intake of grain protein may contribute to the prevenon of hypertension, 
which warrants conﬁrmaon in other populaon-based studies and randomized 
controlled trials. 
The Doenchem Study 
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Health authories emphasize the importance of dietary and lifestyle factors for the preven-
on of hypertension, which is a strong risk factor for cardiovascular disease.
1
 Even small 
eﬀects of these dietary and lifestyle factors on blood pressure can have great public health 
impact. It has been esmated that a reducon in systolic blood pressure of only 2 mmHg 
may already result in a 6% reducon in fatal stroke, and a 4% reducon in fatal coronary 
heart disease (CHD).
2
 Dietary and lifestyle recommendaons include physical acvity, 
maintenance of a healthy body weight, reduced salt intake and moderaon of alcohol con-
sumpon.
2,3
 More recently, interest has grown into the inﬂuence of dietary pa6erns and 
macronutrient intakes on blood pressure.
4,5
 
A substanal body of evidence suggests a, possibly weak, beneﬁcial eﬀect of protein on 
blood pressure, although ﬁndings are not conclusive.
6,7
 An important study in this respect is 
the large INTERSALT study in 10 020 adults from 32 countries, in which a signiﬁcant 0.5 
mmHg lower systolic blood pressure was observed with each gram of 24-h urinary nitrogen 
(mean nitrogen excreon of 9.95 ± 3.11), as a biomarker for total protein intake.
8
 This in-
verse associaon was conﬁrmed by results of the OmniHeart randomized cross-over trial, in 
which systolic blood pressure of 164 healthy US adults decreased 1.4 mmHg more aNer a 6-
week high protein diet compared with a diet high in carbohydrates.
5
 However, no diﬀerence 
in blood pressure change was found compared with a diet high in mono-unsaturated fat. 
Protein intake is a rather heterogeneous exposure and speciﬁc types of protein (i.e. animal, 
plant) or protein from speciﬁc sources (e.g. dairy, meat, grain) may diﬀerenally inﬂuence 
blood pressure. In several observaonal studies 
9-15
 the associaon with blood pressure was 
invesgated separately for plant protein and animal protein. Results were inconclusive, al-
though there was a trend to a slightly more beneﬁcial eﬀect of plant protein on blood pres-
sure. In a prospecve cohort study among 810 untreated pre- or mild hypertensives aged 25
-79 y (PREMIER), risk for developing hypertension was 21% lower per en% of plant protein 
intake, whereas for animal protein no associaon was observed.
11
 Also in a prospecve co-
hort study among 5880 Hispanics (SUN cohort), a 50% reducon in hypertension risk with 
high intake of plant protein was observed in the highest quinle compared to the lowest 
quinle, whereas intake of animal protein did not inﬂuence hypertension risk.
10
 So far, data 
on speciﬁc protein sources in relaon to blood pressure is scarce. In a previous analysis in 
the Ro6erdam Study, including 2241 Dutch adults aged ≥55y, we found no clear associaons 
between protein from diﬀerent dietary sources and 6-year incidence of hypertension.
13
 
In the present analysis, we examined whether total protein intake and intake of plant and 
animal protein was associated with risk of hypertension during 10 years of follow-up in a 
more general Dutch populaon-based cohort of 3,588 adults, aged 26 to 65 y. In the Nether-
lands approximately two thirds of dietary protein is from animal origin with the main 
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sources being dairy and meat, whereas plant protein is mainly obtained from grains.
16
 We 
also analysed the associaons for these protein sources. 
 
M3G61 
Design and study popula-on 
We used data from the ongoing prospecve Doenchem cohort study, which has been de-
scribed in detail elsewhere.
17
 In brief, 12 405 volunteers, aged 26-65 years, were examined 
between 1987 and 1991. A sample of these respondents (n=6386) was invited for follow-up 
examinaon in 1993-1997, in 1998-2002 and in 2003-2007. An extensive food frequency 
quesonnaire (FFQ) was implemented from 1993 onwards.  
In 1993 (subsequently referred to as ‘baseline’) 6113 parcipants underwent physical exami-
naon, and blood pressure measurements were obtained in 6100 parcipants. We excluded 
1652 parcipants (27%) with prevalent hypertension, deﬁned as blood pressure ≥140/90 
mmHg and/or use of anhypertensive medicaon. Furthermore, we excluded 732 parci-
pants without informaon on hypertension status during both follow-up measurements, Fi-
nally, we excluded 128 parcipants with a history of cardiovascular disease, self-reported 
diabetes at baseline, because of pregnancy at baseline or during follow-up, or because mis-
sing dietary data, leaving 3588 parcipants for the present analysis. 
 
Dietary assessment 
Dietary intake was assessed at baseline and during both follow-up measurements using a 
self-administered semi-quantave FFQ, developed for the internaonal EPIC study 
(European Prospecve Invesgaon into Cancer and Nutrion), on 178 foods and beverages 
consumed during the preceding year.
18
 Colored photographs were used to facilitate esma-
on of poron sizes, and seasonal variaon in food intake was taken into account. Total 
energy and nutrient intakes were calculated using an extended version of the Dutch Food 
Composion Table of 1996.
19
  
Animal protein was deﬁned as protein from dairy, meat, ﬁsh, eggs, and animal protein from 
mixed dishes. Plant protein included protein from soy, nut, grain, fruits, vegetables, le-
gumes, and plant protein from mixed dishes. Dairy protein was calculated as protein from 
milk, yogurt, coﬀee creamer, curd, pudding, porridge, custard, whipped cream, and cheese, 
meat protein included protein from all meat, meat products and poultry. Grain protein was 
deﬁned as protein from rice, bread, pasta and plant protein in grain-containing bakery pro-
ducts.  
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The FFQ was validated in 63 men and 58 women and Pearson correlaon coeﬃcients of 0.73 
in men and 0.70 in women were found for reproducibility of energy adjusted total protein 
intake.
20
 Addionally, the relave validity of the FFQ was assessed against 12 monthly 24-h 
recalls over a 1-year period. Pearson correlaon coeﬃcients for energy adjusted protein in-
take aNer correcon for intra-individual variaon were 0.71 for men and 0.67 for women.
20
 
The correlaon coeﬃcients with urinary nitrogen excreon in four 24h urine samples at 3-
month intervals were 0.56 for men and 0.69 for women, although data suggested slight un-
deresmaon of protein intake by the FFQ (mean percentage of underesmaon: 7% for 
men and 12% for women).
20
For types and sources of protein (e.g. from plant, animal, dairy, 
grain) the FFQ was not validated. However, correlaons with 24-h recalls were good for milk 
and milk products (rmen=0.69; rwomen=0.77) and bread (rmen=0.76; rwomen=0.78), whereas cor-
relaons for meat were lower, especially for men (rmen=0.39; rwomen=0.59).
18
 
 
Blood pressure 
blood pressure was measured by a trained technician using a random-zero sphygmomano-
meter, with the parcipant in siPng posion. Systolic blood pressure was recorded at the 
appearance of sounds (ﬁrst-phase Korotkoﬀ) and diastolic blood pressure was recorded at 
the disappearance of sounds (ﬁNh-phase Korotkoﬀ). Blood pressure was measured twice, 
separated by a pulse count. The mean of two measurements was used for data-analysis. 
During physical examinaon, regular audits were performed to check adherence to the 
blood pressure measuring protocol (e.g. resng me, adequate cuﬀ size). Hypertension was 
deﬁned as systolic blood pressure at least 140 mmHg or diastolic blood pressure at least 90 
mmHg or use of anhypertensive medicaon. 
 
Assessment of poten-al confounders 
Informaon on potenal confounders was collected at baseline and during both follow-up 
examinaons. Body weight (to nearest 0.1 kg) and height (to nearest 0.5 cm) were measured 
with parcipants wearing light indoor clothing without shoes and body mass index (BMI) 
was calculated (kg/m
2
). Data on age, gender, educaon, lifestyle factors, history of major 
diseases, medicaon use, and any prescribed diets were collected by quesonnaires. An ex-
tensive quesonnaire on physical acvity was introduced in 1994 and was completed by 
2936 parcipants (81%). Quesonnaire data were used to create variables on alcohol intake 
(none, moderate, high), smoking status (current smoker/non-smoker), educaonal level (3 
categories), and physical acvity (4 categories, ranging from inacve to very acve 
21
). 
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Sta-s-cal analysis 
Intake of total protein and diﬀerent types of protein was ﬁrst adjusted for total energy in-
take according to the residual method.
22
 Baseline characteriscs of the study populaon 
across terles of energy-adjusted total protein intake, are presented as means ± standard 
deviaon, percentages, or medians with interquarle range. 
We used me dependent Cox regression models to calculate hazard raos (HR) with 95%-
conﬁdence intervals (95% CI) for the associaon between dietary protein intake and 10-y in-
cidence of hypertension. We deﬁned the exposure as the cumulave average energy adjus-
ted protein intake to reduce measurement error and to esmate long-term intake. P for 
trend was esmated by modelling median intake of baseline terles. 
For parcipants who did not develop hypertension during follow-up we computed survival 
me as years from baseline to the end of the study period (i.e. 10-y examinaon visit) or un-
l end of follow-up. For parcipants who developed hypertension, we a6ributed 2.5 y of fol-
low-up if hypertension was present at the 5-y examinaon visit, and 7.5 y of follow-up if hy-
pertension was present at the 10-y examinaon visit. 
The basic model (model 1) included age and gender. In model 2, we further adjusted for 
BMI, educaonal level, smoking, alcohol use, and baseline systolic blood pressure. The full 
model (model 3) addionally included daily intake of total energy, saturated fa6y acids, poly
-unsaturated fa6y acids, carbohydrates, ﬁber, calcium, magnesium, and potassium, and pro-
tein intake from other sources than the one under study, if applicable. Age, gender, and life-
style covariates were updated each measurement round. For dietary covariates the cumula-
ve average intake was calculated up to each measurement round. Dietary calcium was 
strongly correlated to dairy protein intake (r=0.82). Therefore we conducted an addional 
analysis without calcium in the model to check for mulcollinearity.  
To mimic a situaon in which dietary protein was exchanged for dietary carbohydrates, we 
performed an addional analysis using the full model (model 3) with mono-unsaturated 
fa6y acids as addional covariate instead of carbohydrates. To invesgate whether physical 
acvity confounded the protein-blood pressure associaons, we performed a sensivity 
analysis per 5 grams of total, plant, and animal protein in the subgroup of 2892 parcipants 
(81%) with complete data on physical acvity, using the full model with and without addi-
onal adjustment for physical acvity.  
Finally, we performed a number of pre-deﬁned subgroup analyses for total, plant and animal 
protein, in strata of age, (< 45 y and ≥45 y), gender, overweight status (<25 kg/m
2
 and ≥25 
kg/m
2
), and baseline systolic blood pressure (<130 mmHg and ≥130 mmHg), using the full 
model. Data analysis was performed using SAS version 9.1 (SAS Instute Inc.) and a two-
sided p-value of <0.05 was considered stascally signiﬁcant. 
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Ter-le of energy adjusted total protein intake   
<81 g/d (n=1184) 81 to 89 g/d (n=1184) >89 g/d (n=1220) Ptrend 
Median intake (g/d) 75 85 95  
     
Age, y 44±10 44±9 45±10 0.03 
Gender, % men 52 56 57 0.02 
Body mass index, kg/m
2 
24.4±3.3 24.7±3.1 25.3±3.3 <0.01 
Overweight,%
1 
38 43 48 <0.01 
Educaon, % high 19 23 20 0.21 
Systolic blood pressure, mmHg 118.2±10.6 117.6±10.8 117.8±10.3 0.39 
Diastolic blood pressure, mmHg 75.6±7.7 75.7±7.7 75.8±7.6 0.58 
Alcohol among consumers, glasses/d
2 
1.4±(0.7-2.9) 1.1±(0.7-2.1) 1.0±(0.6-2.0) <0.01 
Current smokers, % 38 28 28 <0.01 
     
Dietary intake     
Total energy, kJ/day 9752±2802 9198±2399 9627±2690 0.27 
Total protein, g/d (en%) 75±20 (13) 82±18 (15) 98±23 (18) <0.01 
Plant protein, g/d (en%) 32±10 (6) 31±9 (6) 32±10 (6) 0.94 
Grain protein
5
 g/d (en%) 16±7 (3) 16±6 (3) 17±7 (3) <0.01 
Animal protein, g/d (en%) 43±13 (8) 51±12 (10) 65±16 (12) <0.01 
Dairy protein
3
, g/d (en%)  18±8 (3) 22±9 (4) 32±13 (6) <0.01 
Meat protein
4
 g/d (en%) 17±9 (3) 20±8 (4) 24±9 (4) <0.01 
Total fat, g/d (en%) 92±31 (35) 89±28 (36) 93±31 (36) 0.57 
Saturated fat, g/d (en%) 38±13 (14) 37±12 (15) 40±13 (15) <0.01 
Mono-Unsaturated fat, g/d (en%) 35±12 (13) 34±11(14) 35±12 (13) 0.70 
Poly-unsaturated fat, g/d (en%) 19±7 (7) 17±6 (7) 17±7 (7) <0.01 
Carbohydrates, g/d (en%) 274±80 (48) 248±69 (46) 251±77 (44) <0.01 
Potassium, mg/d 3638±908 3739±796 4171±939 <0.01 
Magnesium, mg/d 358±99 367±84 409±103 <0.01 
Calcium, mg/d 936±313 1083±320 1409±471 <0.01 
Fiber, g/d 25±7 25±6 26±7 <0.01 
Table 4.1. Baseline characteris-cs by baseline ter-les of energy adjusted total protein intake 
of 3,588 Dutch adults (26-65 y), without hypertension or use of an-hypertensive medica-on 
at baseline. 
Data are presented as mean±SD or %, unless stated otherwise. 
1
BMI ≥25 kg/m
2; 2
Percentage of alcohol consumers in all terles ~62%; alcohol consumpon is presented as median 
with interquarle range because of skewed distribuon; 
3
Protein intake from milk, yogurt, coﬀee creamer, curd, 
pudding, porridge, custard, whipped cream, and cheese;  
4
Protein intake from meat, meat products and poultry;  
5
Protein intake from rice, bread, pasta and plant protein in grain-containing bakery products. 
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Hazard ra-o of hypertension (95%CI)  
Model 1  Model 2  Model 3  
Total protein (g/d)  
<81 1.00 (ref)  1.00 (ref)  1.00 (ref)  
81-89 1.05 (0.93- 1.18) 1.06 (0.93- 1.19) 1.00 (0.88- 1.15) 
≥89 1.16 (1.02- 1.31) 1.11 (0.98- 1.25) 1.01 (0.85- 1.19) 
ptrend
1 
0.02   0.11   0.93   
Plant protein (g/d)  
<30 1.00 (ref)  1.00 (ref)  1.00 (ref)  
30-34 0.87 (0.77- 0.98) 0.91 (0.81- 1.03) 0.92 (0.80- 1.06) 
≥34 0.80 (0.71- 0.90) 0.91 (0.80- 1.03) 0.96 (0.80- 1.16) 
ptrend
1 
<0.01   0.12   0.65   
Animal protein (g/d)  
<48 1.00 (ref)  1.00 (ref)  1.00 (ref)  
48-57 1.01 (0.89- 1.14) 0.97 (0.85- 1.10) 0.90 (0.79- 1.03) 
≥57 1.23 (1.09- 1.39) 1.11 (0.98- 1.26) 0.97 (0.81- 1.15) 
ptrend
1 
<0.01   0.08   0.70   
Dairy protein (g/d)  
<19 1.00 (ref)  1.00 (ref)  1.00 (ref)  
19-27 0.89 (0.79- 1.01) 0.94 (0.83- 1.06) 0.91 (0.78- 1.05) 
≥27 1.01 (0.89- 1.14) 1.07 (0.94- 1.21) 1.00 (0.81- 1.25) 
ptrend
1 
0.77   0.28   0.97   
Meat protein (g/d)  
<17 1.00 (ref)  1.00 (ref)  1.00 (ref)  
17-24 1.12 (0.99- 1.26) 1.01 (0.89- 1.14) 0.97 (0.85- 1.10) 
≥24 1.29 (1.14- 1.46) 1.09 (0.95- 1.23) 0.99 (0.85- 1.16) 
ptrend
1 
<0.01   0.22   0.92   
Grain protein (g/d)  
<14 1.00 (ref)  1.00 (ref)  1.00 (ref)  
14-18 0.88 (0.79- 0.99) 0.91 (0.81- 1.03) 0.91 (0.80- 1.03) 
≥18 0.76 (0.68- 0.87) 0.82 (0.72- 0.93) 0.85 (0.73- 1.00) 
ptrend
1 
<0.01   <0.01   0.04   
 
Table 4.2. Cumula-ve average protein intake in rela-on to 10 incidence of hypertension in 
3,588 Dutch adults (25-65 y). 
All types of protein were energy adjusted according to the residuals method
22
 
Model 1: Adjusted for age and gender; Model 2: Addi-onally adjusted for BMI, educa-onal level, smoking, alcohol 
use and baseline systolic blood pressure; Model 3: addi-onally adjusted for intake of total energy, saturated fa6y 
acids, poly-unsaturated fa6y acids, carbohydrates, ﬁber, calcium, magnesium, potassium, and (in analyses of 
protein types) for other protein types. 
1
 P for trend was es-mated by modeling median intake of baseline ter-les. 
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Descrip-ve sta-s-cs 
The mean age of the total study populaon was 44±10 years and 44% was male. Mean BMI 
was 25±3 kg/m
2
 and 43% of parcipants was overweight or obese (BMI ≥25 kg/m
2
). Baseline 
blood pressure was 118/76 mmHg. Mean protein intake was 85±22 g/d (~15 en%), of which 
63% originated from animal sources. Major sources of animal protein intake were dairy (45% 
of animal protein intake) and meat (38%). Plant protein intake mainly comprised grain pro-
tein (51%), whereas the next main sources were potatoes (11%), vegetables (7%), fruits 
(4%), and legumes (2%). 
Baseline characteriscs and dietary intake of the study populaon according to terles of 
energy adjusted total protein intake are shown in Table 4.1. The percentage males increased 
signiﬁcantly across terles of energy adjusted protein intake as well as the number of over-
weight parcipants. With regard to dietary intake, the higher intake of total dietary protein 
in the highest terles was mainly reﬂected in diﬀerences in animal protein intake, whereas 
the intake of plant protein intake was relavely constant over terles of energy adjusted to-
tal protein intake. Also, intake of fat and carbohydrates did not diﬀer signiﬁcantly across 
consecuve terles, although carbohydrate intake was somewhat higher in the lowest cate-
gory of total protein. The intake of potassium, magnesium, and calcium increased signiﬁ-
cantly across terles of energy adjusted total protein intake. 
 
Protein intake and incident hypertension 
ANer a mean follow-up me of 7.5±2.9 years (26 500 person years), 1568 new cases of hy-
pertension were idenﬁed. The number of incident hypertension cases in increasing base-
line terles of energy adjusted total protein were respecvely 57, 58, and 63 per 1000 per-
son years. Associaons between protein intake and incident hypertension are shown in Ta-
ble 4.2. Intake of total, plant and animal protein intake was not clearly associated with inci-
dent hypertension, with all fully adjusted HRs being close to 1.00 (All ptrend>0.60). When the 
full model was adjusted for mono-unsaturated fa6y acids instead of carbohydrates, the HRs 
of upper terle versus lower terle were 1.04 (95%-CI: 0.89-1.23) for total protein (ptrend= 
0.62), 0.96 (0.79- 1.15) for plant protein (ptrend= 0.59), and 1.00 (0.84- 1.19) for animal pro-
tein (ptrend= 0.98). 
Within the subgroup of 2892 parcipants for whom data on physical acvity was available 
(21 566 person years) 1217 new cases of hypertension were idenﬁed. In this subgroup we 
found idencal HRs per 5 grams of total, plant and animal protein both with and without ad-
dional adjustment for physical acvity (respecvely 1.02, 0.97-1.06; 1.01, 0.90-1.13; 
1.02,0.97-1.06). Predeﬁned subgroup analyses showed that the associaon between protein 
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and hypertension risk did not vary among strata of age, gender, BMI, or baseline blood pres-
sure (all pinteracon>0.15) 
When focusing on the main protein sources, intake of dairy protein and meat protein was 
not associated with incident hypertension. (Table 4.2) Sensivity analysis excluding dietary 
calcium from the mulvariable analysis on dairy protein indicated some degree of mulcol-
linearity (i.e. the width of the conﬁdence intervals slightly decreased). Leaving calcium out of 
the model, however, yielded essenally similar results: HR of the third terle compared to 
the lowest terle: 0.99, 0.84-1.17. Intake of grain protein showed a signiﬁcant 15% lower 
risk of hypertension in the upper terle compared to the lowest terle. (Mulvariate HR 
0.85, 95%CI 0.73-1.00; ptrend=0.04). Other sources of plant protein (i.e. potatoes, legumes, 
vegetables, and fruits) were not related to hypertension risk (all p>0.30, data not shown) 
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In this prospecve cohort study among 3588 parcipants without hypertension at baseline, 
intake of total, plant, and animal protein was not associated with 10-year incidence of hy-
pertension. Also, intake of protein from dairy and meat, the main sources of animal protein, 
was not associated with hypertension risk. A high intake of grain protein, was signiﬁcantly 
associated with a 15% lower risk for hypertension. 
The present analyses were conducted in a populaon based cohort with repeated measure-
ments of dietary intake and lifestyle over 10 years of follow-up.
17
 Because dietary intake was 
assessed 3 mes during follow-up, we were able to reduce measurement error and esmate 
long-term protein intake by using the cumulave average in me dependent Cox models. Ex-
tensive data were available on potenal confounders, although baseline assessment of 
physical acvity was not performed in parcipants who were enrolled before 1994. How-
ever, similar protein-blood pressure associaons were obtained with and without adjust-
ment for physical acvity in parcipants with complete data. 
The self-administered FFQ of the current study has been validated against 24-hour dietary 
recalls and 24-hour urine samples.
20
 Correlaons were good with correlaon coeﬃcients for 
total protein, plant protein and animal protein being >0.60, indicang that parcipants could 
be adequately ranked according to their protein intake. The FFQ was not validated for pro-
tein from speciﬁc sources, but correlaons for milk and bread, as surrogate markers for 
dairy and grain protein, where good (>0.65). However, correlaons for meat were lower, es-
pecially for men (r=0.39).
18
 This may have caused misclassiﬁcaon of parcipants according 
to meat protein intake and, as a consequence, the results for this type of protein may have 
been biased towards no associaon. To explore the potenal inﬂuence of protein sources on 
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blood pressure in future epidemiological studies, idenﬁcaon of biological markers for in-
take of protein from speciﬁc sources like meat could be useful. 
A substanal body of evidence suggests a, possibly weak, beneﬁcial eﬀect of protein on 
blood pressure, as previously summarized.
6
 We adjusted our esmates among others for 
energy, carbohydrates, saturated fa6y acids and poly-unsaturated fa6y acids, and in this 
way we mimicked a situaon in which only intake of protein and mono-unsaturated fa6y 
acids do vary. However, in the large OmniHeart cross-over feeding trial among 164 parci-
pants, no diﬀerence in blood pressure eﬀect was found aNer a high protein diet compared 
to a high MUFA diet, which may explain our lack of result for total protein and hypertension 
risk. In contrast, in the OmniHeart study, a beneﬁcial blood pressure eﬀect was observed 
aNer the high protein diet compared to a diet high in carbohydrates.
5
 Therefore, to mimic 
exchange of protein with carbohydrates, we performed an addional analysis using the full 
model, with adjustment for MUFA instead of carbohydrates. However, this did not essenal-
ly change our results. Further research is needed to invesgate the blood pressure eﬀect 
aNer exchange of diﬀerent macronutrients.  
Several observaonal studies have been conducted that invesgated the associaon with 
blood pressure separately for plant and animal protein, showing inconclusive results, al-
though in some studies plant protein seemed to be more beneﬁcial than animal protein. In 
our study we did not see a diﬀerence between these two types of protein in our study. The 
discrepancy of our ﬁndings with those in the Premier Study in which risk for developing hy-
pertension was 21% lower per en% of plant protein intake
11
 may be found in the fact that 
only individuals with elevated blood pressure were included. Possibly these adults were 
more sensive to blood pressure lowering eﬀects of plant protein. In the Spanish SUN co-
hort a 50% risk reducon for hypertension was found for plant protein.
10
 However, possibly 
the distribuon of protein sources between the current study and the SUN cohort was 
diﬀerent. In Spain, on average more legumes are eaten, and residual confounding from iso-
ﬂavones in soy may play a role. 
Evidence on speciﬁc sources of protein in relaon to blood pressure is scarce.
6
 A few obser-
vaonal studies have been conducted in which urinary taurine was used as a biomarker of 
dietary seafood protein, showing inverse associaons.
23-25
 In the Netherlands, the intake of 
seafood protein is very low (~3% of total protein intake 
16
), so we could not invesgate this 
associaon in the current study. Furthermore, in two trials the eﬀect of meat protein on 
blood pressure was invesgated, but no signiﬁcant eﬀect was observed. However, in a previ-
ous analysis in the Ro6erdam Study, including 2241 Dutch adults aged ≥55y, we observed a 
direct associaon of meat protein with incidence of hypertension in those aged ≥70 y.
13
 In 
the current analysis we did not observe an associaon between meat protein and hyperten-
sion. However, because of ageing kidney funcon in the elderly of the Ro6erdam Study may 
have been declined 
26
, which aﬀects handling of high protein intake, and, consequently, in-
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crease risk of hypertension. The diﬀerence with the results of the Ro6erdam Study may, 
therefore, be explained by the younger age of the current populaon. 
With high grain protein intake, we observed a signiﬁcant 15% reduced hypertension risk. Al-
though the mechanisms via which protein (sources) may reduce blood pressure are largely 
unknown, amino acid composion may play a role. In the INTERMAP study a 2 SD higher in-
take of glutamic acid (4.7% of total protein) was associated with 1.5 mmHg lower systolic 
blood pressure and 1.0 mmHg lower diastolic blood pressure.
27
 A major contributor to grain 
protein intake in the Netherlands is wheat from bread 
28
, which contains high levels of glu-
tamic acid (31.4% 
29
). However, we can also not exclude that residual confounding by 
healthy dietary and lifestyle factors, associated with high grain protein intake, are responsi-
ble for the observed associaons in this study. 
In conclusion, higher intake of grain protein may contribute to the prevenon of hyperten-
sion, which warrants conﬁrmaon in other populaon-based studies and randomized con-
trolled trials.  
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Background 
Several observaonal studies suggest an inverse associaon of protein with blood 
pressure. However, li6le is known about the role of dietary protein from speciﬁc 
sources in blood pressure. 
Method 
We examined the relaon between several types of dietary protein (total, plant, 
animal, dairy, meat, grain, ﬁsh, soy, and nut) and incident hypertension in 2241 
parcipants from the Ro6erdam Study, aged at least 55 years, who were free of 
hypertension at baseline. Hazard raos, with 95% conﬁdence intervals (CIs), for 
incident hypertension during 6 years of follow-up were obtained per standard 
deviaon (SD) of energy-adjusted intake of protein. Hazard raos were adjusted for 
age, gender, body mass index (BMI), baseline systolic blood pressure (SBP) 
smoking, educaonal level, alcohol, intake of carbohydrates, other nutrients,  and 
other types of protein (if applicable). We conducted straﬁed analyses by age (cut-
oﬀ 70 years), gender, and BMI (cut-oﬀ 25 kg/m2). 
Results 
The risk of hypertension in the total cohort (1113 cases) was not related to intake 
of total protein or types of protein (all hazard raos ~1.00 per SD). Gender and BMI 
did not signiﬁcantly modify the associaons of dietary protein with hypertension. 
In 559 parcipants aged at least 70 years, the intake of animal protein was 
posively related to risk of hypertension (hazard rao 1.37 per SD, 95% CI 1.09–
1.72). For parcipants aged below 70 years no associaon was found (hazard rao 
0.92, 95% CI 0.81– 1.06). 
Conclusion 
Total dietary protein or types of protein are not related to incident hypertension in 
this older populaon. In the more aged, however, high intake of animal protein 
may increase the risk of hypertension, which warrants further invesgaon. 
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Elevated blood pressure, a major risk factor for cardiovascular disease, is highly prevalent 
worldwide.
1
 In the year 2000, 25% of the adult populaon had hypertension, deﬁned as 
average systolic blood pressure (SBP) at least 140mmHg, diastolic blood pressure (SBP) at 
least 90 mmHg, or use of anhypertensive medicaon. This proporon is likely to increase 
to 29% in 2025.
1
 
Several observaonal studies and trials have shown an inverse relaon between protein in-
take and blood pressure.
2-5
 Observaonal follow-up data (6 years) from the large MRFIT trial 
among 11 342 normotensive US men with a mean protein intake of 17 energy percentage, 
showed a 0.06mmHg lower SBP per energy percentage protein intake.
2
 Furthermore, a 20% 
reduced risk of hypertension for high versus low total protein intake was reported in 5880 
Hispanic university graduates, although these ﬁndings were not stascally signiﬁcant.
3
 In 
the INTERSALT study among 10 020 normotensive adults from 32 countries, 24 h urinary to-
tal nitrogen and urinary urea nitrogen, as biomarkers for total protein intake, were inversely 
related with blood pressure.
4
 The blood pressure of 164 healthy US adults in the OmniHeart 
randomized cross-over trial decreased more aNer a 6-week high protein diet compared with 
a diet high in carbohydrates
5
, whereas no diﬀerence in blood pressure was found with a diet 
high in monounsaturated fat. 
Speciﬁc types of protein may have diﬀerent eﬀects on blood pressure. In several observa-
onal studies animal protein intake was not associated with blood pressure, whereas an in-
verse associaon was observed for plant protein.
3,6-8
 Although the relaon between blood 
pressure and protein-rich foods such as dairy
9-11
, ﬁsh
12
, soy
13
, and nuts
14
 has been examined, 
data on the associaon between protein from these foods and blood pressure is scarce. 
Finally, there may be subgroups in which blood pressure is diﬀerenally aﬀected by protein 
intake. A stronger inverse associaon between urinary 3-methylhisdine, a marker for ani-
mal protein intake, and blood pressure was found for overweight and obese people in the 
cross-seconal CARDIAC study among 669 Chinese parcipants aged 48–56 years
15
. In the 
OmniHeart trial blood pressure eﬀects were more pronounced in hypertensive than in pre-
hypertensive parcipants
5
. The sensivity of blood pressure to dietary inﬂuences, including 
protein intake, may furthermore increase with age as the cardiovascular system becomes 
less resilient during ageing. Indeed, in the INTERSALT study the inverse associaon was 
stronger for parcipants aged 40–59 years, than for parcipants aged 20–39 years.
4
 
To clarify the role of diﬀerent types of protein in the development of hypertension, we 
examined the intake of total protein, types of protein (plant and animal), and protein from 
speciﬁc sources (dairy, meat, ﬁsh, soy, nuts) in relaon to incident hypertension in the ge-
neral older populaon of the Ro6erdam study. Addionally, we examined these associaons 
by gender, age and body mass index (BMI), to idenfy potenally sensive subgroups. 
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Ro6erdam study 
The present analyses formed part of the Ro6erdam study, a populaon-based cohort study 
on the occurrence and progression of chronic diseases and their risk factors in people aged 
at least 55 years.
16
 A schemac design of the Ro6erdam study is given in Table 5.1. In brief, 
between 1990 and mid-1993 all residents of a suburb of Ro6erdam in this age category 
were invited to parcipate and 7983 people (78%) responded. Parcipants were interviewed 
at home and 89% was physically examined at the research center. The cohort was re-
examined during follow-up in 1993–1995 and 1997–1999. Wri6en informed consent was ob-
tained from all parcipants. The medical ethics commi6ee of Erasmus University approved 
the study protocol. 
Dietary assessment 
At baseline, parcipants completed a checklist at home about foods and drinks they had 
consumed at least twice a month during the preceding year, as well as dietary habits, use of 
alimentary supplements, and prescribed diets. Next, during their visit to the research center, 
they underwent a standardized interview with a trained diecian based on the checklist, 
using a computerized 170- item semi-quantave Food Frequency Quesonnaire (FFQ), ta-
king into account seasonal variaons in fruit, vegetable and ﬁsh intake.
17
 For each item the 
frequency was recorded in mes per day, week, or month. The number of servings per fre-
quency was expressed in natural units (for example, slice of bread or apple), household 
measures (for example, cup or spoon), or grams (cooked vegetables or mixed dishes). These 
dietary data were converted into total energy intake and nutrient intakes per day using the 
Dutch Food Composion Table of 1993.
18
 
 Baseline 2 y follow-up 6 y follow-up 
Period 1989-1993 1993-1995 1997-1999 
N 7,983 6,315 4,797 
Measurements · Clinical examinaon 
(Including blood 
pressure 
measurement) 
· Interview on 
educaon, health 
status, behavior and 
diet (FFQ) 
· Clinical examinaon 
(including blood 
pressure measurement) 
· Interview on educaon, 
health status, and 
behavior 
· Clinical examinaon 
(including blood 
pressure measurement) 
· Interview on educaon, 
health status, and 
behavior 
Table 5.1. Schema-c design of the Ro6erdam study. 
blood pressure=blood pressure; FFQ=food frequency ques-onnaire. 
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In a validaon study the FFQ was compared with ﬁNeen 24-h food records, collected over 1 
year in six collecon periods of 2 or 3 consecuve days, and with 24 h urinary urea excreon 
during 4 non-consecuve days.
19
 The Pearson correlaons with the food records, adjusted 
for age, gender, energy, and within-person variaon, were 0.69 for energy intake, 0.50 for 
fat intake, 0.79 for carbohydrate intake, 0.66 for total protein intake, and 0.59 for plant pro-
tein intake. The Spearman correlaon with urinary urea was 0.67 for total protein intake.
19
 
For the present analyses we assessed protein intake from several speciﬁc sources next to to-
tal, animal and plant protein. Dairy protein was calculated from various types of milk, yo-
gurt, coﬀee creamer, curd, pudding, porridge, custard, whipped cream, and cheese. Meat 
protein was calculated from all kinds of meat (including poultry) and meat products, and ﬁsh 
protein included protein from all kinds of ﬁsh, crustacean, and shellﬁsh. Grain protein was 
calculated from bread, cake, cookies, grains and other grain products. Soy protein included 
protein from tofu and other soy-containing meat substutes, and nut protein was calculated 
from nuts and peanut bu6er. The FFQ was not speciﬁcally validated for protein from these 
sources. However, correlaons for nutrients that are known to be associated with several 
types of protein intake were good with 0.52 for potassium, 0.72 for calcium, 0.71 for magne-
sium, and 0.52 for saturated fat.
19
 
 
Blood pressure measurements 
Blood pressure measurements were taken at the research center by a trained research assis-
tant at baseline and during follow-up examinaons aNer 2 years and aNer 6 years.
16,20
 blood 
pressure was measured in duplicate at the right upper arm using a random-zero sphygmo-
manometer with a 32 x17 cm cuﬀ, aNer the parcipant had been siPng quietly for at least 5 
min. SBP was recorded at the appearance of sounds (ﬁrst-phase Korotkoﬀ) and SBP at the 
disappearance of sounds (ﬁNh-phase Korotkoﬀ). SBP and SBP were calculated as the average 
of the two measurements. Hypertension was deﬁned as SBP at least 140mmHg or SBP at 
least 90mmHg or the use of anhypertensive medicaon. At the research center a physician 
ascertained the indicaon for which the medicaon had been prescribed. 
 
Collec-on of risk factor data 
Informaon on current health status, medical history, medicaon use, smoking behaviour, 
and educaon was obtained by trained research assistants. Parcipants were classiﬁed as 
current smokers, former smokers, or never smokers. Educaon was deﬁned as low (primary 
educaon), intermediate (secondary general or vocaonal educaon), and high (higher vo-
caonal educaon or university). Height and body weight were measured while the parci-
pants wore indoor clothing without shoes. BMI was calculated as weight in kilograms divi-
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ded by the square of height in meters. Alcohol intake was assessed based on self-reported 
number of beverages consumed weekly, and converted into grams of ethanol per day. Infor-
maon on prevalent cardiovascular disease, deﬁned as a history of myocardial infarcon or 
stroke, was assessed during a home interview and veriﬁed in medical records at the GP 
oﬃce. Parcipants who did not take andiabec medicaon received a 37.5% oral glucose 
soluon (75 g of glucose) while in a non-fasng state. Venous glucose levels were then 
measured before and aNer 2 h. Diabetes mellitus was deﬁned as the use of andiabec 
medicaon or a random or post load serum glucose level at least 11.1 mmol/l. 
 
Popula-on for analysis 
At baseline 7129 parcipants underwent physical examinaon, and reliable blood pressure 
measurements were obtained in 6985 parcipants. For the present analyses we excluded 
3872 parcipants (55%) who had hypertension at baseline, 469 parcipants without infor-
maon on hypertension status at both follow-up measurements and 403 without data on 
dietary intake, leaving 2241 parcipants for the present analyses. 
 
Data analysis 
Intake of total protein, types of protein, and protein from speciﬁc sources was ﬁrst adjusted 
for total energy intake according to the residual method
21
, except for protein from ﬁsh, soy, 
and nuts for which consumpon was low. Baseline characteriscs of the study populaon 
were calculated across terles of energy-adjusted total protein intake. Data in text and ta-
bles are presented as mean ±standard deviaon (SD), unless stated otherwise. 
We used Cox proporonal hazard modelling to esmate hazard raos with 95% conﬁdence 
intervals (95% CIs) for 6-year incidence of hypertension and dietary protein intake. We ﬁrst 
calculated hazard raos per SD of energy-adjusted protein intake (total, plant, animal, dairy, 
meat and grain protein, in g/day) or, because of low intakes and skewed distribuons, across 
two categories indicang use or non-user (protein from ﬁsh, soy and nuts). To allow be6er 
comparison between types of protein we repeated the analyses per 5 g of energy-adjusted 
protein intake. 
For parcipants who did not develop hypertension during follow-up we computed survival 
me as years from baseline to the end of study period (i.e. 6-year examinaon visit). For 
parcipants who developed hypertension, we a6ributed 1 year of follow-up if hypertension 
was idenﬁed during the 2-year examinaon visit, and 4 years of follow-up if hypertension 
was idenﬁed during the 6-year examinaon visit. The basic model (model 1) included ad-
justment for age (connuous) and gender. Subsequently, we performed mulvariable analy-
sis (model 2) with adjustment for age, gender, BMI (connuous, kg/m2), baseline SBP 
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(connuous, mmHg), smoking status (current/past/never), alcohol consumpon (terles), 
and educaonal level (three categories). In model 3 further adjustment was performed for 
intake of total energy (connuous, kJ/day), potassium, sodium (only from foods), calcium, 
magnesium, ﬁber, carbohydrates, saturated fa6y acids, polyunsaturated fa6y acids (all con-
nuous, g/day) and other types of protein (if applicable). Because dairy protein and calcium 
were strongly correlated (r=0.87), hazard raos for dairy protein were calculated without 
and with adjustment for calcium. A quesonnaire on physical acvity was implemented in 
the Ro6erdam study in 1997, and data are available for 27% of our parcipants (n=616). 
Post-hoc analyses were conducted in this subgroup using the full model with and without 
adjustment for physical acvity to invesgate whether this variable confounded the protein
–blood pressure associaons. 
A number of predeﬁned subgroup analyses were performed for all types of protein that 
were regularly eaten (total, plant, animal, dairy, meat, grain), in strata of gender, age (cut-
oﬀ 70 years), and overweight status (cut-oﬀ 25 kg/m2), using the full model (model 3). Data 
analysis was performed using SAS soNware (SAS Instute, Cary, North Carolina, USA) version 
9.1 and a two-sided P value of less than 0.05 was considered stascally signiﬁcant. 
 
R3C: 
Descrip-ve data 
The mean age of the study populaon was 65±7 years and 43% was male. The mean BMI 
was 25.7±3.4 kg/m2, with 54% of the parcipants being overweight. Because hypertensive 
parcipants were excluded from the analysis, mean blood pressure at baseline was rather 
low for this older populaon, that is 122±12mmHg systolic and 68±9mmHg diastolic. The 
diet contained 81±7 g/day of energy-adjusted protein (range 37–150), and the rao of ani-
mal-to-plant protein was approximately 2 : 1. Dairy (30%) and meat (27%) provided most of 
the protein intake, whereas 3.6% of total protein intake came from ﬁsh, 19% from grain, 
2.1% from nuts, 0.3% from soy, and 19% from other sources (e.g. potatoes, vegetables, 
fruits and eggs). 
Baseline characteriscs of the populaon by terles of energy-adjusted total protein intake 
are presented in Table 5.2. Parcipants with a high protein intake were younger and were 
more likely to be overweight or obese. The highest terle of protein intake comprised less 
current smokers. Furthermore, with a higher intake of energy-adjusted protein parcipants 
had a higher intake of ﬁber and minerals (potassium, magnesium, calcium, and sodium from 
foods), and a lower intake of fat and carbohydrates. 
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Energy-adjusted ter-le of total protein intake (g/d)  
<75 (n=747)  75-85 (n=747)  >85 (n=747  
Age, y 67 ± 7 65 ± 7 64 ± 7 
Males, % 45   41  43  
Body mass index, kg/m
2 
25.1 ± 3.2 25.7 ± 3.2 26.2 ± 3.5 
Overweight or obese,% 46   54   63   
High educaonal level, % 11   13   12   
Alcohol consumers, % 81   84   81   
Physical acvity, MET hours/week
1 
104 ± 46 104 ± 53 109 ± 48 
Current smokers, % 29   24   23   
Systolic blood pressure, mmHg 122.4 ± 11.9 121.8 ± 11.7 121.3 ± 12.2 
Diastolic blood pressure, mmHg 68.2 ± 8.6 68.3 ± 8.2 68.6 ± 8.8 
Diabetes mellitus, % 5.0   5.1   6.6   
Prevalent coronary heart disease, % 10.0   10.2   10.2   
Dietary intakes             
Total energy, kJ/day 8611 ± 2259 8303 ± 1970 8575 ± 2207 
Total protein, g/d 70 ± 15 81 ± 14 97 ± 19 
Animal protein, g/d 42 ± 10 52 ± 10 67 ± 16 
Plant protein, g/d 28 ± 8 29 ± 8 30 ± 9 
Dairy protein
2
, g/d 18 ± 8 23 ± 9 33 ± 13 
Meat protein
3
, g/d 18 ± 8 22 ± 8 26 ± 11 
Grain protein
4
, g/d 15 ± 6 16 ± 5 16 ± 6 
Fish protein
5
, % users 62   70   77  
Soy protein
6
, % users 1   3   5  
Nut protein
7
, % users 52   53   58  
Total fat, g/d 86 ± 29 81 ± 26 82 ± 29 
Saturated fat, g/d 34 ± 12 32 ± 11 32 ± 13 
Mono-unsaturated fat, g/d 29 ± 11 27 ± 10 28 ± 11 
Poly-unsaturated fat, g/d 17 ± 8 16 ± 8 15 ± 7 
Total carbohydrates, g/d 230 ± 69 214 ± 58 214 ± 59 
Sodium
8
, mg/d 2006 ± 592 2234 ± 588 2518 ± 724 
Potassium, mg/d 3400 ± 716 3690 ± 695 4172 ± 834 
Magnesium, mg/d 285 ± 70 311 ± 65 351 ± 74 
Calcium, g/d 899 ± 264 1099 ± 307 1416 ± 438 
Fiber, g/d 16 ± 5 17 ± 4 19 ± 5 
 
Table 5.2. Baseline characteris-cs by ter-les of energy adjusted total protein intake of 2,241 
par-cipants from the Ro6erdam Study who were free of hypertension at baseline. 
Data are presented as mean ± SD or %, unless stated otherwise. 
1
n=616; 
2
Includes protein from milk, yogurt, coﬀee creamer, curd, pudding, porridge, custard, whipped cream, and 
cheese; 
3
Includes protein from meat, meat products and poultry; 
4
Includes protein from bread, cake and cookies, 
grains and grain products; 
5
Includes protein from ﬁsh, crustacean, and shellﬁsh; 
6
Includes protein tofu and meat 
subs-tutes consis-ng of protein; 
7
Includes protein from nuts, cocktail nuts and peanut bu6er; 
8
Only from foods, 
discre-onary salt intake not measured. 
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Protein intake and incidence of hypertension 
During 6 years of follow-up a total of 1113 cases of hypertension were idenﬁed. Incident 
hypertension was not associated with intake of total protein, plant protein, or animal pro-
tein (all hazard raos ~1.00 per SD; Table 5.3). When analysing the associaon per 5 g of dai-
ly protein intake fully adjusted hazard raos were similar to each other; that is total protein 
1.01 (0.97– 1.05), plant protein 1.02 (0.94–1.11), and animal protein 1.01 (0.97–1.05). 
Within the subgroup of 616 parcipants for whom data on physical acvity were available, 
207 new cases of hypertension developed (3465 person-years). In this subgroup, inclusion of 
physical acvity in the full model did not change the esmates (hazard rao 1.10 per SD of 
total protein intake, with and without adjustment). 
We observed no clear associaon between protein intake and hypertension when we fo-
cused on protein from speciﬁc sources (Tables 5.3 and 5.4). All hazard raos were close to 
1.00, with a possible excepon for protein from dairy foods, which showed a non-signiﬁcant 
hazard rao of 0.91 (0.82–1.01) without adjustment for calcium. Addional adjustment for 
calcium resulted in a hazard rao of 1.00 per SD with a relavely wide 95% CI (0.78– 1.28). 
Analyses per 5 g of protein intake resulted in fully adjusted hazard raos of 0.96 (0.92–1.01) 
for protein from dairy without adjustment for calcium, 1.01 (0.96–1.06) for protein from 
meat, and 0.98 (0.87–1.10) for protein from grain. 
ANer we straﬁed by age using the full model (Figure 5.1), we observed an increased risk of 
developing hypertension in parcipants aged at least 70 years with higher intake of animal 
protein (hazard rao 1.37 per SD, 95% CI 1.09– 1.72, pinteracon=0.22) and protein intake from 
  SD (g/d) 
Hazard ra-o of hypertension (95% CI)  
Model 1  Model 2  Model 3  
Total protein 13.2 1.01 (0.96- 1.08) 1.00 (0.94- 1.07) 1.03 (0.92- 1.15) 
Plant protein 5.8 0.99 (0.94- 1.05) 1.02 (0.95- 1.08) 1.03 (0.93- 1.13) 
Animal protein 13.4 1.02 (0.96- 1.08) 1.00 (0.94- 1.06) 1.02 (0.91- 1.15) 
Dairy protein 11.2 0.95 (0.90- 1.01) 0.94 (0.89- 1.00) 0.91
a 
(0.82- 1.01) 
Meat protein 9.1 1.06 (1.00- 1.13) 1.06 (1.00- 1.13) 1.02 (0.93- 1.10) 
Grain protein 3.4 1.03 (0.97- 1.09) 1.02 (0.96- 1.08) 1.02 (0.95- 1.08) 
 
Table 5.3. Hazard ra-o for hypertension per SD of energy adjusted protein intake aRer 6 
years of follow-up. 
Number of cases: 1,113, for 8,707 person-years 
Model 1: adjusted for age (con-nuous) and gender; Model 2: addi-onally adjusted for BMI (con-nuous, kg/m
2
), 
baseline SBP (con-nuous, mmHg), smoking status (current/past/never), alcohol consump-on (ter-les) and 
educa-onal level (3 categories); Model 3: addi-onally adjusted for intake of total energy (con-nuous, kJ/d), 
potassium, sodium (only from foods), calcium, magnesium, ﬁber, carbohydrates, saturated fa6y acids, poly-
unsaturated fa6y acids and, if applicable, other types of protein (all con-nuous, g/d) 
a
Not adjusted for calcium due to mul-collinearity 
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meat (hazard rao 1.29 per SD, 95% CI 1.09–1.51, Pinteracon=0.03). No such associaon with 
animal protein intake was observed in parcipants aged 55–69 years (hazard rao 0.92 per 
SD, 95% CI 0.81–1.06). 
Gender and overweight did not signiﬁcantly modify the associaon between protein intake 
and hypertension risk. Straﬁcaon by gender resulted in a hazard rao of 1.02 (0.88–1.19) 
per SD of total protein intake for men and 1.14 (0.95–1.36) for women. When we examined 
risk of hypertension by overweight status, hazard raos were 1.09 (0.90–1.31) for normal-
weight and 0.99 (0.86–1.14) for overweight and obese parcipants. 
 
D2C267 
In a general older Dutch populaon we found no associaon of total dietary protein or se-
veral types of protein with 6-year risk of hypertension. In those aged at least 70 years, how-
ever, a high intake of animal protein, especially from meat, was associated with 37% in-
creased risk of hypertension. 
Protein intake was assessed by self-report, which can cause misclassiﬁcaon because of er-
rors in dietary recall. The FFQ that we used was validated against ﬁNeen 24-h food records 
in 80 parcipants from the Ro6erdam study.
19
 Cross-classiﬁcaon into quinles resulted in 
correct classiﬁcaon of 83% of the parcipants in the same or adjacent quinle for energy-
adjusted total protein intake, whereas 0% was classiﬁed in the most disnct quinle. For 
  
Median 
intake (g/d) Cases 
Person-
years HR (95% CI)  
Fish protein  
No (n=677) 0.0 331 2669 1.00 (ref)  
Yes (n=1545) 3.3 782 6037 1.06 (0.93- 1.21) 
Soy protein  
No (n=2153) 0.0 1083 8415 1.00 (ref)  
Yes (n=69) 5.2 30 292 0.95 (0.65- 1.39) 
Nut protein  
No (n=1018) 0.0 529 3782 1.00 (ref)  
Yes (n=1204) 2.4 584 4924 1.05 (0.92- 1.19) 
Table 5.4. Hazard ra-o for hypertension aRer 6 years of follow-up in categories of ﬁsh, soy 
and nut protein intake. 
Model 3: adjusted for age (con-nuous), gender, BMI (con-nuous, kg/m
2
), baseline SBP (con-nuous, mmHg), 
smoking status (current/past/never), alcohol consump-on (ter-les), educa-onal level (3 categories), intake of 
total energy (con-nuous, kJ/d), potassium, sodium (only from foods), calcium, magnesium, ﬁber, carbohydrates, 
saturated fa6y acids, poly-unsaturated fa6y acids and other types of protein (all con-nuous, g/d). 
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energy-adjusted plant protein these percentages were 73 and 1.3%, respecvely. For total, 
plant and animal protein, therefore, we do not expect much bias from misclassiﬁcaon. For 
protein from speciﬁc sources (dairy, ﬁsh, grain, soy, nut) the FFQ was not validated. How-
ever, correlaons for nutrients that are known to be associated with (types of) protein in-
take were good. Also for these types of protein, therefore, we do not expect much misclassi-
ﬁcaon. 
In general, the range of protein intake was relavely small, which may have resulted from 
the homogeneous eang habits of this older populaon. The SD of the unadjusted mean to-
tal protein intake in our populaon was 20 g/day, which is smaller than the SD of 27 g/day in 
a 
big sample of the Dutch populaon with a larger age range (18–65 years).
22
 Due to the small 
contrasts in protein intake an exisng associaon between dietary protein and blood pres-
sure may have been missed in the present study. However, repeang our mulvariate analy-
sis in quarles instead of per SD, forcing more contrast in exposure, did not reveal diﬀerent 
risk esmates. 
Figure 5.1. Hazard ra-os for incident hypertension per SD of protein intake, by age. 
  Age <70y Age ≥70y 
 All esmates are adjusted for age (connuous), gender, BMI (connuous, kg/m2), baseline SBP 
(connuous, mmHg), smoking status (current/past/never), alcohol consumpon (terles), 
educaonal level (3 categories), intake of total energy (connuous, kJ/d), potassium, sodium (only 
from foods), calcium, magnesium, ﬁber, carbohydrates, saturated fa6y acids, poly-unsaturated fa6y 
acids and other types of protein (all connuous, g/d). 
 *
Not adjusted for calcium, due to mulcollinearity. 
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Extensive data collecon in the Ro6erdam study made it possible to control for many poten-
al confounders. Data on physical acvity, however, were only available for part of our par-
cipants (27%). Addional adjustment for physical acvity within this subgroup did not 
change the conclusions, probably because the mulvariable model already included total 
energy intake and BMI, which are known markers of energy expenditure. An important 
blood pressure determinant for which the analyses were not fully controlled is sodium in-
take, as our FFQ did not measure salt use during cooking and at the table. If salt intake is 
correlated with dietary protein, residual confounding from added salt may have biased in-
verse associaons towards the null, whereas posive associaons would be ampliﬁed. 
We excluded parcipants who were hypertensive at baseline from our analyses. Because the 
greatest risk factor for developing hypertension is ageing, the remaining populaon might 
have been intrinsically resistant to high blood pressure. However, the percentage of parci-
pants who developed hypertension during 6 years of follow-up was similar to the percen-
tage of hypertensive parcipant excluded at baseline (both ~50%). Furthermore, signiﬁcant 
associaons between dietary factors and hypertension have been demonstrated in the same 
study populaon.
11
 We do, therefore, not expect that the null associaon we found is due to 
hypertension resistance in the selected populaon. 
Previous observaonal studies suggested an inverse relaon between protein intake and 
blood pressure or incident hypertension
2-4,23-25
, although not consistently
6,8,26
. Several ran-
domized controlled trials conﬁrmed a beneﬁcial eﬀect of dietary protein on blood pres-
sure
5,27-29
, but this may also be a6ributable to a lower intake of carbohydrates. In the Omni-
Heart trial
5
, a randomized fully controlled feeding trial, a stronger decrease in blood pres-
sure was shown aNer 6 weeks on a high-protein diet as compared with an isocaloric high-
carbohydrate diet. This diﬀerence was not seen with a diet rich in monounsaturated fat. 
Therefore, we adjusted the hazard raos for intake of carbohydrates. However, omiPng this 
adjustment from the full model did not essenally change our results (hazard rao per SD of 
total protein intake 1.02, 95% CI 0.93–1.13). In observaonal studies on types of protein 
(plant, animal) and change in blood pressure or incident hypertension, inverse associaons 
were found for plant protein but not for animal protein 
3,6-8
. However, a 6-week plant pro-
tein diet was not superior to an isocaloric mixed protein diet in a blood pressure trial in 23 
diabec paents
30
, which was in agreement with earlier ﬁndings in normotensive people, 
when blood pressure was similarly aﬀected by soy protein and casein protein
31
, and non-
meat and meat protein
32,33
. The discrepancy in ﬁndings for plant or animal protein intake be-
tween observaonal studies and trials may be explained by the limitaons of observaonal 
studies in separang the eﬀects of several nutrients on blood pressure.
24
 In our study, ha-
zard raos for dairy protein were not adjusted for calcium due to a high correlaon between 
dairy protein and calcium, which resulted in a hazard rao of 0.91 (0.82–1.01) per SD. How-
ever, it is not possible to know whether this risk reducon is due to the intake of dairy pro-
tein or calcium. When calcium was included in the full model the overall hazard rao of pro-
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tein intake from dairy changed to 1.00 per SD with a relavely wide 95% CI (0.78–1.28), sug-
gesng collinearity between dairy protein and calcium intake. Similarly, the intake of soy 
protein could not be disentangled for concomitant intake of isoﬂavones. 
We found a 37% increased risk of developing hypertension for higher animal protein intake 
in a subgroup of older-aged parcipants. It has been suggested that a high renal acid load, 
which could result from a diet rich in animal protein, has adverse eﬀects on blood pres-
sure.
34
 During ageing, kidney funcon declines
35,36
 which could aﬀect handling of high pro-
tein intake and, consequently, increase the risk of hypertension. Alternavely, we cannot ex-
clude residual confounding or eﬀect modiﬁcaon by discreonary salt use (see above). A 
more unfavourable dietary pa6ern with a high amount of meat protein could be associated 
with a higher salt intake. Salt sensivity increases with age
37
, and added salt may amplify an 
adverse eﬀect of animal or meat protein on blood pressure, especially in the elderly. 
In conclusion, we found li6le evidence for an overall associaon of dietary protein with inci-
dent hypertension in our general older populaon. People aged at least 70 years who had a 
high intake of animal protein, however, were at increased risk of developing hypertension. 
These ﬁndings need to be conﬁrmed in other populaon-based studies, preferably with a 
suﬃciently large range of protein intake and adjustment for use of added salt. 
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Background 
Inverse associaons between dietary protein and hypertension have been 
reported, which may be a6ributed to speciﬁc amino acids. 
Objec-ve 
We examined whether intake of glutamic acid, arginine, cysteine, lysine, and 
tyrosine was associated with blood pressure levels (n=3,086) and incident 
hypertension (n=1,810) in the Ro6erdam Study. 
Methods 
We calculated blood pressure levels in quarles of amino acid intake as percentage 
of total protein intake (protein%) with adjustment for age, gender, BMI, smoking, 
alcohol intake, educaon, and dietary factors. Subsequently, we used Cox 
proporonal models with the same adjustments to evaluate the associaons 
between speciﬁc amino acid intake and hypertension incidence. 
Results 
Glutamic acid contributed most to protein intake (21 protein%), whereas lysine 
provided 7%, arginine 5%, tyrosine 4% and cysteine 1.5%. A diﬀerence of ~0.3 
protein% in tyrosine intake was borderline signiﬁcantly related to a 2.4 mmHg 
lower systolic blood pressure (ptrend=0.05), but not to diastolic blood pressure 
(p=0.35). None of the other amino acids was associated to blood pressure. During 6 
years of follow-up (7,292 person years) 873 cases of hypertension developed. None 
of the amino acids were signiﬁcantly associated with incident hypertension (Hazard 
raos ranging from 0.81 to 1.18; all ptrend>0.2). 
Conclusion 
Our data do not support the hypothesis that dietary intakes of the individual amino 
acids glutamic acid, arginine, lysine, tyrosine, or cysteine as percentage of total 
protein intake are associated with blood pressure or hypertension incidence. 
Further evaluaons are needed to conﬁrm our ﬁndings and to ﬁnd out whether 
absolute intake of these amino acids is relevant for the prevenon of hypertension. 
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There is a wide consensus that blood pressure can be modiﬁed by means of diet and lifestyle 
modiﬁcaons such as weight loss, a reducon in salt intake and a dietary pa6ern rich in 
fruits and vegetables, such as the DASH diet.
1-3
 There is also evidence for a beneﬁcial asso-
ciaon between dietary protein and blood pressure.
4
 In the well-controlled OmniHeart 
cross-over trial, systolic blood pressure of 164 healthy US adults consuming a high protein 
diet for six weeks decreased 1.4 mmHg more compared with a diet high in carbohydrates.
5
 
In several observaonal studies the associaon between protein intake and blood pressure 
has been studied in more detail suggesng a beneﬁcial associaon for plant protein whereas 
no associaon was observed for animal protein.
6-9
  
The mechanisms via which types of dietary protein may diﬀerenally inﬂuence blood pres-
sure are largely unknown, but amino acid composion may play a role. In the INTERMAP 
study among 4,680 adults from China, Japan, USA, and UK, it was observed that among 
those consuming predominantly plant protein compared with animal protein, intake of glu-
tamic acid made up a higher percentage of total protein. In that populaon a 2 SD higher in-
take of glutamic acid (4.7% of total protein) was aNer adjustment for several lifestyle and 
dietary factors associated with 1.5 mmHg lower systolic blood pressure and 1.0 mmHg lower 
diastolic blood pressure (p<0.05).
10
 The hypothesised mechanism for this associaon was 
that glutamic acid is a precursor for arginine, which is in turn a precursor for the vasodilator 
nitric oxide.
11,12
 Also several other amino acids have been hypothesized to be involved in 
blood pressure regulaon. Lysine may compete with arginine in the transport system in the 
gut and herewith unfavourably aﬀect blood pressure.
11,13
 Binding of cysteine with excess al-
dehydes is suggested to beneﬁcially inﬂuence blood pressure.
14
 Finally, tyrosine may inﬂu-
ence catecholamine mechanism by acng as precursor of norepinephrine in the brain, which 
may reduce cardiovascular sympathec tone.
15
 Essenal amino acids (i.e. hisdine, isoleu-
cine, leucine, lysine, methionine, phenylalanine, threonine
16
) cannot be synthesized by the 
body, it could therefore be hypothesised that especially levels of these amino acids in the 
body can be modiﬁed by diet. However, except for lysine, no mechanisms have been de-
scribed through which these amino acids could inﬂuence blood pressure. 
Although dietary protein has been associated with blood pressure, it remains unclear whe-
ther speciﬁc amino acids are associated with blood pressure levels or hypertension inci-
dence. Hence, in the present study we examined whether dietary intakes of the individual 
amino acids glutamic acid, arginine, lysine, cysteine, and tyrosine were associated with 
blood pressure levels and incidence of hypertension in the populaon of the Ro6erdam 
Study. 
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The Ro6erdam Study 
The present analyses formed part of the Ro6erdam Study, a populaon-based cohort study 
evaluang the occurrence and progression of chronic diseases and their risk factors in peo-
ple aged≥55 y.
17
 In brief, between 1990 and mid 1993 all residents of a suburb of Ro6erdam 
in this age category were invited to parcipate and 7,983 people (78%) responded. Parci-
pants were interviewed at home and 89% was physically examined at the research centre. 
Wri6en informed consent was obtained
 
from all parcipants. The medical ethics commi6ee 
of Erasmus
 
University approved the study protocol. 
For the cross-seconal analysis on amino acid intake and blood pressure levels we excluded 
2,602 out of all 7,983 parcipants because of anhypertensive medicaon use and 601 par-
cipants because of incomplete blood pressure data. In addion we excluded 1,135 parci-
pants because of a history of diabetes mellitus, myocardial infarcon, or stroke and 559 par-
cipants because of incomplete dietary data, leaving 3,086 parcipants. 
Out of the original cohort, 6,418 parcipants (79%) were re-examined in 1993-1995 and 
1997-1999. For the analysis on amino acid intake and incident hypertension we excluded 
637 parcipants with incomplete blood pressure data at baseline or both follow-up periods, 
3,135 parcipants with hypertension at baseline, 581 parcipants because of a history of 
diabetes mellitus, myocardial infarcon, or stroke, and 255 parcipants because of incom-
plete dietary data or incomplete data on survival me, leaving 1,810 parcipants. 
 
Dietary assessment 
At baseline, parcipants completed a checklist at home about foods and drinks they had 
consumed at least twice a month during the preceding year, as well as dietary habits, use of 
alimentary supplements, and prescribed diets. Next, during their visit to the research centre, 
they underwent a standardized interview with a trained diecian based on the checklist, 
using a computerized 170-item semi-quantave food frequency quesonnaire (FFQ), taking 
seasonal variaons in fruit, vegetable and ﬁsh intake into account.
18
 For each item the fre-
quency was recorded in mes per day, week, or month. The normal serving for each item 
was expressed in natural units (for example, slice of bread or apple), household measures 
(for example, cup or spoon) or grams (cooked vegetables or mixed dishes). These dietary 
data were converted into total energy intake and nutrient intakes per day using the Dutch 
Food Composion Table of 1993.
19
 
In a validaon study the FFQ was compared with ﬁNeen 24h food records, collected over 
one year in six collecon periods of 2 or 3 consecuve days, and with 24h urinary urea ex-
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creon during four non-consecuve days.
20
 In short, correlaon coeﬃcients between the 
FFQ and mulple food records were at least 0.52 for the following nutrients: total protein, 
plant protein, polyunsaturated fa6y acids (PUFA), saturated fa6y acids (SFA), total carbohy-
drates, polysaccharides, potassium, calcium, ﬁbre, and magnesium.
20
 Moreover, 83% of par-
cipants were categorised in the same or adjacent quinle for energy adjusted total protein 
intake. None of the parcipants were classiﬁed in the extreme quinle. For energy adjusted 
plant protein intake, 73% of parcipants were categorised in the same or adjacent quinle 
and 1.3% in the extreme quinle.
20
 
We extended the Dutch Food Composion Table of 1996 with data on amino acid content. 
For this we used data from an exisng supplemental table for arginine
21
 and data from 
McCance and Widdowson’s that chemically analysed amino acid composion of 150 foods 
from the food groups grains, milk, eggs, meat, ﬁsh, vegetables, fruits, nuts and miscellane-
ous.
22
 We converted amino acid contents of these foods to the Dutch situaon according to 
total protein content of these foods from the Dutch Food Composion Table. Subsequently, 
we esmated amino acid composion of remaining foods based on those of the analysed 
foods using predeﬁned assumpons. Finally the amino acid data were linked to the Dutch 
Food Composion Table
23
, which in turn was linked to the data of the Ro6erdam Study. In 
this way, we were able to cover the content of 18 diﬀerent amino acids for 98% of foods in-
cluded in the Dutch food composion database. Intake of amino acids per parcipant was 
calculated by summing amino acid content of all consumed food items.  
 
blood pressure measurements 
blood pressure measurements were taken at the research centre by a trained research assis-
tant at baseline and during follow-up examinaons aNer 2 years and aNer 6 years.
17,24
 blood 
pressure was measured in duplicate at the right upper arm using a random-zero sphygmo-
manometer with a 32 x 17 cm cuﬀ, aNer the parcipant had been siPng quietly for at least 5 
minutes. Systolic blood pressure was recorded at the appearance of sounds (First-phase 
Korotkoﬀ) and diastolic blood pressure at the disappearance of sounds (FiNh-phase Korot-
koﬀ). Systolic and diastolic blood pressure were calculated as the average of the two mea-
surements. Hypertension was deﬁned as systolic blood pressure≥140 mmHg or diastolic 
blood pressure≥90 mmHg or the use of anhypertensive medicaon. At the research centre 
a physician ascertained the indicaon for which the medicaon had been prescribed. 
 
Collec-on of risk factor data 
Informaon on current health status, medical history, medicaon use, alcohol use, smoking 
behaviour, and educaon was obtained by trained research assistants. Height and body 
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weight were measured while the parcipant wore indoor clothing without shoes. BMI was 
calculated as weight in kg divided by the square of height in meters. Informaon on preva-
lent cardiovascular disease, deﬁned as a history of myocardial infarcon or stroke, was as-
sessed during a home interview and veriﬁed in medical records at the oﬃce of the general 
praconers. 
 
Data analysis 
Data analysis was performed using SAS version 9.1 (SAS Instute). Because absolute amino 
acid intakes are strongly correlated to total protein intake and, as a consequence, strongly 
posively correlated to each other (correlaons in the current study ranging from 0.81 to 
0.99), we expressed amino acid intake as percentage of total protein (protein%). We refer to 
this relave intake of amino acids when ‘intake’ is menoned in text and tables. To inves-
gate whether the intakes of amino acids of interest and other characteriscs were associa-
ted with the proporon of plant protein in the diet, we calculated these baseline characte-
riscs in quarles of this rao between plant and animal protein intake. Baseline characte-
riscs are presented in text and tables as mean and standard deviaon unless stated other-
wise. 
Mean blood pressure levels with 95% conﬁdence intervals (95%-CI) were obtained in quar-
les of amino acid intake (protein%). The ﬁrst model included adjustments for age 
(connuous) and gender. Model 2 addionally included BMI (connuous), educaon (low, 
intermediate, or high), smoking status (current, former, or never) and alcohol intake 
(terles). Model 3 (i.e. full model) was addionally adjusted for intake of energy, carbohy-
drates saturated fa6y acids, polyunsaturated fa6y acids, ﬁbre, calcium, magnesium, potas-
sium, and sodium (all connuous).  
The sample size for our prospecve analysis on amino acid intake and hypertension inci-
dence was smaller (n = 1,810) and amino acid intake was therefore divided into terles. For 
parcipants who did not develop hypertension during follow-up we computed survival me 
as years from baseline to the end of study period (i.e. 6-year examinaon visit). For parci-
pants who developed hypertension, we allocated 1 year of follow-up if hypertension was 
idenﬁed during the 2-year examinaon visit, and 4 years of follow-up if hypertension was 
idenﬁed during the 6-year examinaon visit. Cox proporonal hazard models were used to 
obtain hazard raos (HR) with 95%-CI for incident hypertension in terles of amino acid in-
take, using the same models as in our cross-seconal analysis. 
Because lysine competes with arginine in the transport system we hypothesized that a high 
intake of lysine compared to arginine might unfavourably inﬂuence blood pressure. For this 
reason we addionally examined whether the rao of these two amino acids was associated 
with blood pressure level and hypertension incidence. Furthermore, because we also hy-
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pothesized that diet can especially modify blood levels of essenal amino acids, we per-
formed a secondary analysis in which we calculated HRs with 95%-CI for incident hyperten-
sion in terles of essenal amino acid intake. 
To obtain a p-value for trend, median values of the terles or quarles of amino acid intake 
were assigned to individuals and entered connuously into the mulvariate models. Two-
sided p-values <0.05 were considered stascally signiﬁcant. 
 
R3C: 
Descrip-ve data 
The mean age of 3,086 Dutch adults included in our cross-seconal analysis was 66 ± 7 y and 
~40% were men. They had a mean BMI of 26 ± 3 kg/m
2
, with 56% of the parcipants being 
overweight. Mean blood pressure at baseline was 135/73 mmHg with 38% of parcipants 
having a blood pressure >140/90 mmHg. Baseline characteriscs across quarles of relave 
plant protein intake are shown in Table 6.1. With an increasing proporon of plant protein 
in the diet the proporon of men was higher whereas the percentage of current smokers, al-
cohol consumers and overweight individuals was lower. Total energy as well as carbohy-
drate, poly-unsaturated fat, magnesium, and ﬁbre intake increased across quarles of rela-
ve plant protein intake, whereas total protein, saturated fat and calcium intake decreased. 
Baseline characteriscs of 1,810 individuals included in our prospecve analysis were very 
similar, except that mean blood pressure was lower (i.e. 122 ± 12 mmHg systolic and 69 ± 9 
mmHg diastolic) because hypertensive parcipants were excluded at baseline. 
 
Amino acid intake 
The contribuon of the amino acids of interest to total protein intake is summarized in Fi-
gure 6.1. Glutamic acid contributed most to protein intake (21 protein%, 17 ± 4 g/d), 
whereas lysine provided 7 % (6 ± 1 g/d), arginine 5% (4 ± 1 g/d), tyrosine 4% (3 ± 1 g/d) and 
cysteine 1.5% (1 ± 0.3 g/d). Among those who consumed predominantly plant protein com-
pared with animal protein, intake of glutamic acid, arginine, and cysteine made up a higher 
percentage of protein, whereas intake of lysine was lower and tyrosine intake was constant 
over quarles. (Table 6.1). Variaons in amino acid intakes were quite small, with diﬀe-
rences between medians of the lowest and the highest quarles ranging from 0.3 protein% 
for tyrosine to 2.5 protein% for glutamic acid (Table 6.2). 
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Quar-les of the ra-o of plant to animal protein  
<0.43 
(n=771) 
0.43-0.53 
(n=772) 
0.53-0.67 
(n=772) 
>0.67 
(n=771) 
age, y 66 ± 8 66 ± 7 66 ± 7 67 ± 7 
Gender, % men 33 37 42 45 
BMI, kg/m2 26 ± 4 26 ± 3 26 ± 3 25 ± 3 
Overweight, % 65 57 56 48 
systolic BP, mmHg
1 
137 ± 22 135 ± 21 134 ± 20 135 ± 22 
Diastolic BP, mmHg
1 
74 ± 11 73 ± 11 73 ± 11 73 ± 11 
Current smoker, % 30 28 21 21 
Alcohol consumers, % 84 83 85 78 
Alcohol intake among consumers, 
g/d 
7.9 (1.4- 20.4) 7.8 (1.5- 17.8) 6.8 (1.5- 18.4) 6.2 (1.4- 15.7) 
      
Dietary intake     
Energy 7925 ± 2100 8251 ± 1946 8543 ± 2031 8853 ± 2266 
Total protein, en% (g/d) 19.2 ± 3.2 (88 ± 22) 17.2 ± 2.4 (82 ± 18) 16.2 ± 2.2 (80 ± 17) 14.9 ± 2.5 (77 ± 19) 
Plant protein, en% (g/d) 5.0 ± 0.9 (23 ± 6) 5.6 ± 0.8 (27 ± 6) 6.0 ± 0.8 (30 ± 6) 6.9 ± 1.5 (35 ± 10) 
animal protein, en% (g/d) 14.2 ± 2.6 (65 ± 18) 11.7 ± 1.7 (56 ± 12) 10.2 ± 1.4 (50 ± 11) 8.1 ± 1.7 (42 ± 12) 
glutamic acid, protein% (g/d) 20.2 ± 1.0 (17.8 ± 4.6) 20.6 ± 1.0 (17.0 ± 3.9) 20.9 ± 1.0 (16.7 ± 3.7) 21.4 ± 1.2 (16.4 ± 4.2) 
arginine, protein% (g/d) 5.2 ± 0.3 (4.5 ± 1.2) 5.2 ± 0.3 (4.3 ± 1.0) 5.3 ± 0.4 (4.2 ± 0.9) 5.5 ± 0.5 (4.3 ± 1.3) 
cysteine, protein% (g/d) 1.3 ± 0.1 (1.2 ± 0.3) 1.4 ± 0.1 (1.2 ± 0.3) 1.5 ± 0.1 (1.2 ± 0.2) 1.5 ± 0.1 (1.2 ± 0.3) 
lysine, protein% (g/d) 7.2 ± 0.3 (6.4 ± 1.6) 6.9 ± 0.2 (5.7 ± 1.2) 6.7 ± 0.2 (5.4 ± 1.1) 6.3 ± 0.3 (4.9 ± 1.3) 
tyrosine, protein% (g/d) 3.7 ± 0.1 (3.3 ± 0.9) 3.7 ± 0.1 (3.0 ± 0.7) 3.6 ± 0.1 (2.9 ± 0.6) 3.6 ± 0.1 (2.8 ± 0.7) 
total fat, en% (g/d) 36.1 ± 6.3 (78 ± 27) 36.2 ± 5.7 (81 ± 26) 35.6 ± 5.7 (83 ± 26) 35.3 ± 6.1 (85 ± 29) 
Saturated fat, en% (g/d) 15.0 ± 3.5 (33 ± 13) 14.5 ± 2.8 (33 ± 11) 14.1 ± 2.9 (33 ± 11) 13.3 ± 3.0 (32 ± 12) 
mono unsaturated fat, en% (g/d) 12.5 ± 2.7 (27 ± 10) 12.3 ± 2.5 (28 ± 10) 12.1 ± 2.4 (28 ± 10) 11.9 ± 2.9 (29 ± 12) 
poly unsaturated fat en% (g/d) 5.9 ± 2.6 (13 ± 6) 6.6 ± 2.7 (15 ± 7) 6.7 ± 2.7 (16 ± 8) 7.3 ± 2.7 (18 ± 9) 
Carbohydrates, en% (g/d) 40.9 ± 6.6 (190 ± 60) 43.2 ± 6.2 (209 ± 53) 45.1 ± 6.2 (225 ± 58) 47.3 ± 7.0 (244 ± 65) 
Sodium, mg/d
2 
2125 ± 657 2206 ± 659 2270 ± 655 2270 ± 654 
Potassium mg/d 3716 ± 873 3657 ± 766 3701 ± 754 3717 ± 880 
Magnesium, mg/d 299 ± 75 303 ± 70 315 ± 70 326 ± 80 
Calcium, mg/d 1309 ± 487 1153 ± 361 1092 ± 333 968 ± 319 
fibre, g/d 15 ± 4 16 ± 4 18 ± 5 20 ± 6 
Table 6.1. Baseline characteris-cs of 3,086 Dutch adults (≥55y) within the ROTTERDAM-
cohort 
En%= percentage of total energy intake; Protein%=percentage of total protein intake 
1
An-hypertensive medica-on users have been excluded; 
2
Sodium intake only from foods 
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Amino acid intake and blood pressure levels 
Results for the associaons between amino acid intake and blood pressure are summarized 
in Table 6.2. ANer adjustment for age, gender, lifestyle and dietary factors, we did not ob-
serve an associaon between intake of glutamic acid, arginine, or cysteine and blood pres-
sure levels; i.e. systolic blood pressure diﬀerence between highest and lowest quarle of in-
take ranging from -0.6 mmHg to +0.1 mmHg (all p>0.56). Parcipants with a median intake 
of 7.3 protein% lysine compared to those with a median intake of 6.3 protein% lysine 
showed a non-signiﬁcant higher blood pressure of +1.7 mmHg systolic and +1.0 mmHg dia-
stolic (ptrend=0.19 and 0.10 respecvely). Parcipants in the highest quarle of the arginine 
to lysine rao (0.86) had a non-signiﬁcant lower blood pressure compared to parcipants in 
the lowest quarle (rao 0.71); i.e. -1.6 mmHg systolic (ptrend=0.35) and -0.3 mmHg diastolic 
(ptrend=0.59). Parcipants with a median intake of 3.8 protein% of tyrosine, had a 2.4 mmHg 
lower systolic blood pressure compared to parcipants with a median intake of 3.5 protein% 
of tyrosine (ptrend=0.05), but without a diﬀerence in diastolic blood pressure (-0.4 mmHg, 
ptrend=0.35). 
 
Amino acid intake and hypertension incidence 
During 6 years of follow-up, a total of 873 cases were idenﬁed (7,292 person-years). None 
of the amino acids was signiﬁcantly related to hypertension incidence (Table 6.3). Parci-
pants with 7.2 protein% of lysine intake showed a non-signiﬁcant increased risk for incident 
hypertension, compared with parcipants with 6.4 protein% of intake (HR 0.15, 95%-CI 0.93-
Figure 6.1. Contribu-on of each amino acid of interest to total protein intake. 
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 N 
Median 
intake 
(protein%) Cases (N) 
Person-
years 
Hazard ra-o of hypertension (95%-CI)  
Model 1 Model 2 Model 3 
Glutamic acid  
T1 603 19.7 286 2481    
T2 604 20.7 312 2346 1.09 (0.93- 1.28) 1.13 (0.96- 1.33) 1.18 (0.99- 1.41) 
T3 603 21.8 275 2465 0.91 (0.77- 1.07) 0.95 (0.80- 1.13) 1.02 (0.83- 1.26) 
ptrend     0.23 0.52 0.76 
Arginine  
T1 603 5.0 289 2390 1.00 (ref)   1.00 (ref)   1.00 (ref)   
T2 604 5.3 289 2401 1.02 (0.87- 1.21) 1.02 (0.87- 1.20) 1.00 (0.83- 1.19) 
T3 603 5.6 295 2500 1.08 (0.92- 1.27) 1.07 (0.91- 1.27) 1.06 (0.85- 1.31) 
ptrend     0.36 0.40 0.81 
Lysine  
T1 603 6.4 277 2467 1.00 (ref)   1.00 (ref)   1.00 (ref)   
T2 604 6.8 286 2438 1.04 (0.89- 1.23) 1.01 (0.85- 1.19) 1.01 (0.84- 1.21) 
T3 603 7.2 310 2387 1.20 (1.02- 1.41) 1.15 (0.98- 1.36) 1.15 (0.93- 1.43) 
ptrend     0.03 0.10 0.20 
Arginine: Lysine  
T1 603 0.72 314 2287 1.00 (ref) 1.00 (ref) 1.00 (ref) 
T2 604 0.77 276 2498 0.85 (0.72- 1.00) 0.86 (0.73- 1.01) 0.81 (0.67- 0.97) 
T3 603 0.84 283 2506 0.89 (0.76- 1.05) 0.92 (0.78- 1.08) 0.86 (0.69- 1.07) 
ptrend     0.22 0.39 0.20 
Cysteine  
T1 603 1.4 291 2438 1.00 (ref)   1.00 (ref)   1.00 (ref)   
T2 604 1.4 291 2462 0.96 (0.82- 1.13) 0.98 (0.83- 1.15) 0.95 (0.79- 1.14) 
T3 603 1.5 291 2392 0.97 (0.82- 1.14) 1.02 (0.86- 1.21) 0.98 (0.77- 1.24) 
ptrend     0.73 0.81 0.83 
Tyrosine  
T1 603 3.5 310 2299 1.00 (ref)   1.00 (ref)   1.00 (ref)   
T2 604 3.7 275 2507 0.83 (0.71- 0.98) 0.83 (0.71- 0.98) 0.85 (0.71- 1.02) 
T3 603 3.8 288 2485 0.87 (0.74- 1.02) 0.86 (0.73- 1.01) 0.92 (0.73- 1.15) 
ptrend     0.08     0.06     0.17     
Table 6.3. Hazard ra-o of hypertension according to ter-les of amino acid intake aRer 6 
years of follow-up. 
Model 1: Adjusted for age (con-nuous) and gender; Model 2: Addi-onally adjusted for BMI (con-nuous), 
educa-onal level (low, intermediate, high), smoking (current, former, never), and alcohol consump-on (ter-les); 
Model 3: Addi-onally adjusted for total energy, carbohydrates, saturated fa6y acids poly-unsaturated fa6y acids, 
ﬁbre, calcium, magnesium, sodium (only from food) and potassium (all con-nuous). 
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1.43, ptrend=0.20). We observed a non-linear inverse associaon between the rao of argi-
nine to lysine and risk of hypertension; 1.00 (ref) for a median rao of 0.72; a 19% decreased 
risk for parcipants in with a median rao of 0.77 (HR=0.81, 95%-CI=0.67-0.97), and a bor-
derline signiﬁcant 14% lower risk for parcipants with a median rao of 0.84 (0.86, 0.69-
1.07; ptrend=0.20). 
With regard to essenal amino acids, none of these amino acids was signiﬁcantly associated 
with incident hypertension with HRs ranging from 0.91 to 1.10 (all ptrend>0.20; Supplemental 
Table I) 
 
D2C267 
In a general older Dutch populaon we found no associaon between the habitual intake of 
glutamic acid, arginine, lysine, and cysteine (expressed as protein%) with blood pressure. For 
tyrosine intake we found a borderline signiﬁcant inverse associaon with systolic blood 
pressure, but not with diastolic blood pressure. None of the examined amino acids was re-
lated to 6-year risk of hypertension. 
The Ro6erdam Study is a single centre populaon based cohort in which a wide range of da-
ta has been collected. In a validaon study using ﬁNeen 24h food records, the FFQ showed a 
good performance with respect to protein, with 83% of parcipants being categorised into 
the same or adjacent quinle of energy adjusted total protein intake, whereas none of the 
parcipants was classiﬁed into the extreme quinle. For energy adjusted plant protein in-
take these numbers were 73% and 1.3% respecvely.
20
 
Our esmate of amino acid intake was based on data from chemical analysis of 150 main 
foods from the following food groups: grains, milk, eggs, meat, ﬁsh, vegetables, fruits, nuts 
and miscellaneous.
22
 This may have introduced measurement error because of potenal 
changes in amino acid composion due to producon processes (e.g. producon of cheese 
from milk). Although we expect this measurement error to be small, we cannot exclude that 
this has led to misclassiﬁcaon of parcipants, and diluon of the associaons between ami-
no acid intake and blood pressure. Another possible explanaon for the absence of associa-
ons between amino acids and blood pressure or incident hypertension may be the small 
variaon in amino acid intakes in our cohort of older Dutch adults. Furthermore, we studied 
amino acids as a proporon of total protein intake because absolute intakes were strongly 
intercorrelated in our study (r between 0.81 and 0.99). However, we cannot exclude the 
possibility that absolute rather than relave amino acid intakes are relevant with regard to 
blood pressure. This queson can only be addressed in randomised controlled trials. 
Studies on the associaon between dietary amino acids and human blood pressure or hyper-
tension incidence are scarce. The relaon between glutamic acid intake and blood pressure 
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was invesgated in the INTERMAP study among 4,680 adults.
10
 In that study, mean glutamic 
acid intake was 20.1 protein% (15.7 g/d) ranging from 17.8 protein% in Japan to 24.1 pro-
tein% in China. ANer adjustment for dietary and lifestyle factors, blood pressure was 1.5 
mmHg lower with a 4.7 protein% (2 SD) higher glutamic acid intake (p<0.05). We could not 
conﬁrm this associaon, possibly because INTERMAP included parcipants from four diﬀe-
rent countries which resulted in a larger variaon in glutamic acid intake (1 SD=2.4 pro-
tein%) than in our cohort (1 SD= 1.1 protein%). 
We did not ﬁnd an associaon between arginine intake and blood pressure. Arginine is a 
precursor for the vasodilator nitric oxide.
25
 In a meta-analysis of 11 trials, the systolic blood 
pressure eﬀect of arginine supplementaon was −5.39 mm Hg (95% CI −8.54 to -2.25, P 
<0.01).
26
 However, arginine doses in these studies ranged between 4 and 24 g/d, which ex-
ceeds average dietary intake levels (e.g. 4 ± 1 g/d in the Ro6erdam Study). In an observa-
onal study among 806 Dutch elderly men (mean age ~71 y) a non-signiﬁcant systolic blood 
pressure diﬀerence of ~-2 mmHg (p=0.25) was found with a 2.2 g/d higher arginine intake.
21
 
In 1,981 Finnish men with a mean age of 53 ± 5 y, a 2.5 g/d higher arginine intake was rela-
ted to a 2.6 mmHg lower systolic blood pressure (p=0.07).
27
 In these studies, however, data 
were not adjusted for potenal confounders. 
In those parcipants included in our study consuming predominantly plant protein com-
pared with animal protein the percentage of lysine intake was lower, whereas the percen-
tage of arginine was somewhat higher. Our results suggested an unfavourable relaon be-
tween lysine intake and blood pressure or hypertension incidence. Moreover, we observed a 
tendency towards a beneﬁcial associaon with hypertension incidence for the rao of argi-
nine to lysine. This is in line with observaonal studies in which inverse associaons be-
tween plant protein and blood pressure were found, whereas no associaons were ob-
served for animal protein.
6-9
 However, our data were not stascally signiﬁcant and we 
therefore cannot draw ﬁrm conclusions. 
It has been proposed that tyrosine could act as a precursor of norepinephrine in the brain 
which reduces sympathec tone, thereby lowering blood pressure.
15
 However, in a trial in 
13 mildly hypertensive adults 2 weeks supplementaon of 7.5 g/d tyrosine did not aﬀect 
blood pressure.
28
 In the present study we observed an inverse associaon of tyrosine with 
systolic blood pressure levels, but not with diastolic blood pressure nor with incidence of hy-
pertension. Therefore, we cannot exclude the possibility that our ﬁndings for tyrosine are 
due to chance. 
In conclusion, our data do not support a role for relave intakes of the individual amino 
acids glutamic acid, arginine, lysine, tyrosine, and cysteine in hypertension prevenon. 
Whether absolute intake of these or other amino acids could inﬂuence blood pressure sll 
needs to be established. Further evaluaons, preferably in cohorts with more hetero-
The Ro6erdam Study 
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geneous eang habits and randomised controlled trials, could clarify the role that protein in-
take and speciﬁc amino acids might play in the prevenon and treatment of hypertension. 
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 N 
Median 
intake 
(protein%) Cases (n) 
Person-
years 
Hazard ra-o of hypertension (95% CI)  
Model 1 Model 2 Model 3 
His-dine  
T1 603 2.8 284 2459 1.00 (ref) 1.00 (ref) 1.00 (ref) 
T2 604 2.9 274 2476 1.00 (0.84-1.18) 0.96 (0.81-1.14) 0.94 (0.79-1.12) 
T3 603 3.0 315 2356 1.19 (1.01-1.40) 1.14 (0.97-1.35) 1.10 (0.91-1.33) 
ptrend     0.03 0.10 0.27 
Isoleucine  
T1 603 4.53 291 2370 1.00 (ref)  1.00 (ref)  1.00 (ref)  
T2 604 4.68 279 2546 0.87 (0.74-1.03) 0.86 (0.73-1.01) 0.88 (0.73-1.06) 
T3 603 4.82 303 2375 0.97 (0.82-1.14) 0.93 (0.79-1.10) 1.00 (0.80-1.27) 
ptrend     0.69 0.42 0.64 
Leucine  
T1 603 7.75 307 2336 1.00 (ref) 1.00 (ref) 1.00 (ref) 
T2 604 8.06 276 2500 0.84 (0.71-0.99) 0.81 (0.69-0.96) 0.83 (0.69-1.00) 
T3 603 8.37 290 2456 0.86 (0.73-1.02) 0.86 (0.73-1.01) 0.91 (0.71-1.17) 
ptrend     0.08 0.07 0.22 
Methionine  
T1 603 2.20 285 2502 1.00 (ref)  1.00 (ref)  1.00 (ref)  
T2 604 2.30 291 2440 1.01 (0.86-1.19) 0.98 (0.84-1.16) 0.96 (0.81-1.15) 
T3 603 2.39 297 2350 1.08 (0.91-1.26) 1.04 (0.88-1.23) 1.04 (0.85-1.28) 
ptrend     0.39 0.66 0.61 
Phenylalanine  
T1 603 4.60 307 2347 1.00 (ref)  1.00 (ref)  1.00 (ref)  
T2 604 4.74 280 2444 0.87 (0.74-1.02) 0.86 (0.73-1.02) 0.92 (0.77-1.10) 
T3 603 4.87 286 2500 0.85 (0.72-1.00) 0.87 (0.74-1.03) 1.00 (0.80-1.24) 
ptrend     0.05 0.11 0.54 
Threonine  
T1 603 3.99 302 2379 1.00 (ref)  1.00 (ref)  1.00 (ref)  
T2 604 4.12 274 2521 0.84 (0.71-0.99) 0.81 (0.69-0.96) 0.80 (0.67-0.96) 
T3 603 4.24 297 2392 0.96 (0.82-1.13) 0.94 (0.80-1.10) 0.92 (0.75-1.15) 
ptrend     0.59 0.39 0.30 
Supplemental table I: Hazard ra-o of hypertension according to ter-les of essen-al amino 
acid intake in 1,810 Dutch adults (≥55y) within the ROTTERDAM-cohort aRer 6 years of 
follow-up  
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 N  
Median 
intake 
(protein%)  Cases (n)  
Person-
years  Model 1 Model 2 Model 3 
Valine  
T1 603 5.38 292 2377 1.00 (ref) 1.00 (ref) 1.00 (ref) 
T2 604 5.61 291 2487 0.94 (0.80-1.10) 0.91 (0.77-1.07) 0.97 (0.81-1.18) 
T3 603 5.83 290 2427 0.92 (0.78-1.08) 0.92 (0.78-1.08) 1.07 (0.83-1.39) 
ptrend     0.32 0.32 0.96 
Hazard ra-o of hypertension (95% CI)   
Supplemental table I: Hazard ra-o of hypertension according to ter-les of essen-al amino 
acid intake in 1,810 Dutch adults (≥55y) within the ROTTERDAM-cohort aRer 6 years of 
follow-up (con-nued). 
Model 1: Adjusted for age (con-nuous) and gender; Model 2: Addi-onally adjusted for BMI (con-nuous), 
educa-onal level (low, intermediate, high), smoking (current, former, never), and alcohol consump-on (ter-les); 
Model 3: Addi-onally adjusted for total energy, carbohydrates, saturated fa6y acids poly-unsaturated fa6y acids, 
ﬁbre, calcium, magnesium, sodium (only from food) and potassium (all con-nuous). 
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Objec-ve 
In this fully controlled randomized mulple cross-over dietary intervenon study 
we aimed to idenfy potenal biomarkers for dietary protein from dairy, meat, and 
grain, which could be useful to esmate intake of these protein types in 
epidemiological studies.  
Methods 
ANer 9 days run-in, 13 men and 17 women (22±4y) received three high protein 
diets (aimed at ~18 en%) in random order for 1 week each, with ~14 en% 
originang from either meat, dairy, or grain. We used a two-step approach to 
idenfy biomarkers in urine and plasma. With principal component discriminant 
analysis (PCDA) we idenﬁed amino acids (AA) from the plasma or urinary amino 
acid proﬁle that were disncve between diets. Subsequently, aNer pooling total 
study data we applied mixed models to esmate the predicve value of those AAs 
for intake of protein types.  
Results 
A very good predicon could be made for the intake of meat protein by a 
regression model that included urinary carnosine, 1-methylhisdine, and 3-
methylhisdine (98% of variaon in intake explained). Furthermore, for dietary 
grain protein a model that included 7 amino acids (plasma lysine, valine, threonine, 
α-amino-butyric acid, proline, ornithine and arginine) made a good predicon (75% 
of variaon explained). We could not idenfy biomarkers for dairy protein intake.  
Conclusion 
Speciﬁc combinaons of urinary and plasma AAs may be potenally useful 
biomarkers for meat and grain protein intake, respecvely. These ﬁndings need to 
be cross-validated in other dietary intervenon studies. 
A fully controlled dietary intervenon study 
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There is increasing interest in the role of dietary protein and speciﬁc types of protein (e.g. 
from animal or plant sources) in health and disease
1-4
. Observaonal epidemiological studies 
in this ﬁeld oNen rely on food frequency quesonnaires (FFQ) or dietary recalls to esmate 
habitual intake of (types of) protein. Such memory-based methods, however, are prone to 
errors which can lead to misclassiﬁcaon of parcipants which could weaken the associa-
ons between intake of protein types and health outcomes. 
5,6
 Therefore, markers of intake 
for these protein types in biological ssues or ﬂuids, could provide more objecve indices of 
true intake. Several metabolic compounds, i.e. urinary carnosine
7
, 1-methylhisdine
8
, 3-
methylhisdine
7,8
, taurine
9,10
, sulphate
7
, creanine
7
, and serum creane
7,11
, have been pro-
posed as biomarkers for meat protein intake (Table 7.1). Furthermore, the rao between 
natural stable isotopes of nitrogen (
14
N/
15
N) may be an indicator for the rao between plant 
and animal protein intake.
12,13
 However, none of these potenal biomarkers have suﬃcient-
ly been validated. Biomarkers for other major protein types, i.e. meat, dairy and grain pro-
tein, are lacking. 
Urine  
Carnosine The dipepde, beta-alanyl-hisdine (carnosine), is present in muscle and nerve ssues in 
most vertebrates.
7
 Because dietary intake of nerve ssues usually are limited, urinary 
carnosine might be a potenal marker of muscle intake from animals.
7 
1-Methylhisdine 1-Methylhisdine (1MH) forms a dipepde with β-alanine, anserine.
8
 Anserine occurs in 
the skeletal muscle of several species but not in man. Therefore, urinary 1-methylhisdine 
is a potenal biomarker for meat protein intake. 
3-Methylhisdine Urinary excreon of 3-methylhisdine (3-MH) has been suggested as marker of meat 
consumpon because it is synthesized in the muscle of mammals and released and 
excreted in urine aNer intake of muscle protein.
23 
Taurine 
 
Taurine is present in animal ssues in high levels.
9
 About 40% of taurine, fed as such, is 
recovered in the urine.
10 
Sulphate A high content of cysteine and methionine in proteins leads to an increased degradaon to 
sulphate and sulphite by the intesnal microbiota. Since animal proteins are rich in sulphur
-containing amino acids, urinary excreon of inorganic sulphate might reﬂect meat protein 
intake.
7 
Creanine Meat contains creane and creane phosphate, which parally decomposes to creanine 
during cooking.
7
 Urinary creanine excreon may increase aNer (cooked) meat intake.
7 
Rao of natural 
stable isotopes of 
Nitrogen (
14
N/
15
N) 
Ca6le urine has shown that there is a depleon of 
15
N relave to their diet.
12
 It has 
therefore been hypothesised that animals incorporate dietary 
15
N preferenally over 
dietary 
14
N.
 
Indeed it has been found that the level of the 
15
N stable natural isotope 
increases
 
by x 3‰ up every step in the food chain.
13
 Possibly the proporon of 
15
N in urine 
reﬂects the rao of animal and plant protein in the diet. However, data on this subject are 
scarce. 
Creane Meat contains creane and creane phosphate.
7
 In a study of 60 male and female 
vegetarians and 99 age-matched omnivores, omnivorous individuals had a higher serum 
creane compared to vegetarians.
7,11
 Therefore plasma creane might be a biomarker for 
meat protein intake. 
Blood  
Table 7.1; Overview of postulated biomarkers. 
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We conducted a fully controlled dietary intervenon study to idenfy potenal biomarkers 
for intake of dairy protein, meat protein, and grain protein, which could be useful for further 
epidemiological studies. We focused on these types of protein because these are the main 
sources of protein in the Dutch populaon, with approximately 26% of total protein intake 
originang from dairy, 25% from meat, and 18% from grain
14
. The proteins were provided to 
the parcipants in a food-based sePng in order to mimic a real life situaon. 
 
M32: 71 93G61 
Study popula-on 
Parcipants were recruited within a 10-km radius from the university campus. Men and 
women between 18-40 years old with a BMI between 18.5 and 30 kg/m2 were invited to 
parcipate. We used quesonnaires to collect informaon about general characteriscs and 
medical status. Individuals suﬀering from chronic disease(s) or using prescribed medicaon 
were excluded. We also excluded women who were pregnant, lactang or not using oral 
contracepves. Liver- and kidney funcon markers were checked for abnormalies in a fas-
ted blood sample before the start of the study. All parcipants gave wri6en informed con-
sent before the screening was performed.  
 
Study design 
The Biomarker Study was a fully controlled randomized mulple cross-over dietary interven-
on study, which was conducted between 21 March and 20 April 2011 at Wageningen Uni-
versity, The Netherlands. An overview of the study design is given in Figure 7.1. The study 
lasted 30 days and consisted of four dietary periods: a run-in period of 9 days and three sub-
sequent intervenon periods of 7 days each that were applied in random order. The parci-
pants were allocated to one of the six diet orders by block randomisaon with a block size of 
5 and with straﬁcaon for gender. On the last day of each treatment period urine was col-
lected for 24 hours and a fasng blood sample was taken. The medical ethics commi6ee of 
Wageningen University, The Netherlands approved the design and the aim of the study, 
which was registered in the NIH clinical trial database (ClinicalTrials.gov number. 
NCT01314040). 
 
Dietary interven-on 
Menus were designed for ten levels of energy intake ranging from 7 to 16 MJ/d. The parci-
pants were allocated to an energy intake level close to their habitual energy intake, which 
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was esmated before start of the study using an FFQ
15
. From Monday ll Friday parcipants 
consumed their hot meal at lunchme at Wageningen University supervised by diecians 
who ensured that the complete meal was consumed. Breakfast, bread meals, snacks, beve-
rages, and all meals for Saturdays and Sundays were provided in take-home packages. Par-
cipants were carefully instructed how to prepare the hot meals during the weekends. 
When parcipants had incidentally increased energy requirements, e.g. because of sports, a 
bread bun (500 kJ/bun) was provided with the same relave macronutrient composion as 
the intervenon diet of the parcipant. During the whole study we supplied 90% of daily 
energy intake to the parcipants. To cover the remaining 10% of daily energy needs parci-
pants were obliged to choose foods that were low in protein content (< 0.6 g protein per 
poron) from a restricted list. They recorded these foods in a diary in which they also noted 
any deviaons from the study protocol. Body weight was measured twice every week with 
indoor clothing, without shoes and with empty pockets on a digital balance accurate to 0.1 
kg (Seck Bascule MT, USA). If necessary, energy intake was adjusted to limit changes in 
weight to less than 0.2 kg. 
Figure 7.1. Flow diagram of par-cipants in the Biomarker Study. 
 ARer 9 days run-in par-cipants were randomised in one of six diet orders. Each interven-on diet was 
consumed for 7 days. The run in diet was aimed at ~15 en% protein, whereas the interven-on diets 
were aimed at ~18 en% protein of which ~14 en% originated from the source of interest. ARer each 
dietary period 24h urine and blood were collected. 
 1
Urine data of the run in period of one par-cipant was excluded because he reported incomplete urine 
collec-on; 
2
Two par-cipants (a man and a woman) discon-nued the interven-on because of 
diﬃcul-es with the fact that they were not allowed to choose their own food; 
3
The data of the dairy 
protein period of one par-cipant was excluded from analysis because of a 130% higher nitrogen 
excre-on than expected based on chemical analysis of the diet; 
4
The data of the grain protein period 
of one par-cipant was excluded because of a knee surgery on the day before collec-on; 
5
The urine 
data of the dairy protein period of one par-cipant was excluded because of a mistake in urine 
handling. 
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Diet composi-on and chemical analyses of duplicate por-ons 
The total protein content of the run-in diet was aimed at 15 en%. The intervenon diets had 
a protein content aimed at ~18 en% with ~14 en% coming from either dairy, meat, or grain. 
During the dairy protein based diet the main sources of protein were milk and milk products, 
yoghurt, and cheese. In addion, a whey protein isolate was added to the dessert (~4 en%, 
Nectar, Syntrax, Sco6 City, MO, USA). In the meat protein based diet the main protein 
sources were pork, beef, and chicken. The main protein sources in the grain protein based 
diet were wheat, bran, rice, and corn. Addionally, the diet contained legumes (chickpeas, 
lenls), contribung 3.6 en% of protein. A wheat protein isolate was added to the dessert, 
the dressing and a drink (~7 en%, Ulmate Nutrion Inc., USA). 
Duplicate porons of each intervenon diet with an energy level of 11 MJ were collected 
daily and analysed for energy, fat, dry ma6er, ash, and dietary ﬁber, according to oﬃcial 
methods of analysis (AOAC).
16
 Furthermore, nitrogen was determined by the Kjeldahl me-
thod (Kjeltec 2300, Foss, Denmark), and the amount of protein was calculated using a con-
version factor of 6.25. Carbohydrate content of the diets was calculated by diﬀerence. 
Amino acid composion was measured using ion-exchange chromatography and derivased 
post-column (TRIS/AZA, JEOL AminoTac JLC/500-V, Jeol, Japan), aNer hydrolysis of the sam-
ples with hydrochloric acid (6 mol/L) using norvaline as internal standard. Detecon was 
performed at 570 nm (proline at 440 nm). For the determinaon of cysne and methionine, 
hydrolysis was preceded by oxidaon with performic acid. For analysis of tryptophan sam-
ples were hydrolysed by heang at 119 °C in a nitrogen atmosphere with a barium hydroxide 
soluon using 5-methyl tryptophan as internal standard. Samples were analysed by HPLC 
(HPLC-pump: Waters 616, auto sampler Waters 717, Waters Corporaon, Milford, USA) with 
ﬂuorescence detecon excitaon 300 nm, emission 330 nm (ﬂuorescence detector: Jasco FP
-1520, Jasco Benelux b.v., De Meern, The Netherlands; column: Nucleosil C18, PN 89161, 
Grace Davison Discovery Science, Deerﬁeld, Ireland). The nutrients in the free-choice items 
were calculated (NEVO, 2006
17
) and added to the analysed values (Table 7.2). 
Because actual intake of total protein did not exactly meet the target intake, leading to 
diﬀerences across the diet periods, we adjusted all our analyses for nitrogen excreon, so 
that biomarkers for protein types could be idenﬁed independent of protein quanty of the 
diets. 
 
Urine sampling and analysis 
Urine was collected during 24h at the ﬁnal day of each intervenon period. Before collecon 
3 ml of chlorhexidine digluconate (19-21% m/V) was added to each urine container of 2 li-
tres as a preservave. Parcipants were instructed to discard the ﬁrst voiding in the morning 
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 Run in 
Dairy protein 
based diet 
Meat protein 
based diet 
Grain protein 
based diet 
Energy, MJ/d 10.9 11.1 11.0 11.1 
     
Macronutrients     
Total protein (analysed), en% (g/kg/d) 15.1 (1.4) 19.1 (1.8) 22.5 (2.1) 16.7 (1.6) 
Animal protein
1
, en% (g/kg/d) 9.2 (0.9) 15.9 (1.5) 17.2 (1.6) 3.1 (0.3) 
Dairy protein
1
, en% (g/kg/d) 4.4 (0.4) 15.2 (1.4) 1.5 (0.1) 1.5 (0.1) 
Meat protein
1
, en% (g/kg/d) 4.5 (0.4) 1.2 (0.1) 15.7 (1.5) 1.5
 
(0.1) 
Plant protein
1
, en% (g/kg/d) 4.9 (0.5) 3.3 (0.3) 3.7 (0.3) 15.6 (1.5) 
Grain protein
1
, en% (g/kg/d) 4.3 (0.4) 1.3 (0.1) 1.5 (0.1) 14.2 (1.3)
2 
Fat, en% (g/kg/d) 30.4 (1.3) 30.9 (1.3) 29.9 (1.3) 27.8 (1.2) 
Carbohydrate, en% (g/kg/d) 53.0 (4.9) 48.5 (4.6) 43.0 (4.1) 54.1 (5.1) 
     
Amino acids     
Isoleucine, protein% (mg/kg/d) 4.3 (60) 5.3 (96) 4.3 (92) 3.7 (59) 
Leucine, protein% (mg/kg/d) 7.8 (110) 9.8 (177) 7.5 (160) 7.1 (112) 
Lysine, protein% (mg/kg/d) 6.2 (87) 8.1 (146) 7.4 (158) 3.4 (53) 
Methionine, protein% (mg/kg/d) 2.2 (31) 2.5 (45) 2.4 (51) 1.8 (28) 
Cysteine, protein% (mg/kg/d) 1.3 (18) 1.4 (25) 1.0 (22) 1.9 (30) 
Phenylalanine, protein% (mg/kg/d) 4.4 (61) 4.6 (84) 3.9 (82) 4.7 (74) 
Tyrosine, protein% (mg/kg/d) 3.5 (49) 4.3 (78) 3.0 (63) 3.2 (51) 
Threonine, protein% (mg/kg/d) 3.8 (53) 4.9 (88) 4.0 (86) 3.1 (49) 
Tryptophan, protein% (mg/kg/d) 1.2 (17) 1.5 (27) 1.2 (25) 1.1 (18) 
Valine, protein% (mg/kg/d) 5.0 (70) 6.1 (110) 4.8 (101) 4.4 (69) 
Arginine, protein% (mg/kg/d) 4.9 (69) 3.9 (71) 5.7 (121) 4.6 (73) 
Hisdine, protein% (mg/kg/d) 2.7 (38) 2.5 (46) 3.0 (64) 2.2 (35) 
Alanine, protein% (mg/kg/d) 4.3 (60) 4.2 (76) 5.2 (111) 3.6 (56) 
Asparc acid, protein% (mg/kg/d) 7.7 (108) 9.4 (170) 8.9 (189) 5.7 (90) 
Glutamic acid, protein% (mg/kg/d) 20.9 (293) 21.7 (391) 16.3 (346) 27.9 (440) 
Glycine, protein% (mg/kg/d) 3.7 (52) 2.7 (49) 4.7 (99) 4.0 (63) 
Proline, protein% (mg/kg/d) 7.2 (102) 9.0 (163) 5.0 (106) 9.6 (151) 
Serine, protein% (mg/kg/d) 4.4 (62) 5.3 (95) 3.9 (82) 4.6 (73) 
Table 7.2. Mean daily intakes of energy, macronutrients, and amino acids during the 
Biomarker study. 
Mean nutrient intakes are based on chemical analysis of duplicate por-ons and calcula-ons of free choice foods. 
Mean intakes are given as energy percentage with mean intake per kilogram bodyweight between brackets. 
1
Mean nutrient intake only based on calculated nutrient content of foods, because types of protein cannot be 
dis-nguished in chemical analysis; 
2
3.6 en% of protein came from chickpeas and len-ls (food based) 
Protein%=percentage of total protein intake. 
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aNer waking up, and to note the me. Subsequently they collected all urine up to and in-
cluding the voiding on the same me the next day. Urine was kept cool in a cooling bag with 
a cooling element during the 24 hours of collecon. Subsequently, urine samples were 
stored at -80°C unl analyses. Total nitrogen was analysed by the Kjeldahl method (Kjeltec 
2300, Foss, Denmark) and used as a marker of dietary compliance. Parcipants with 50% 
higher or lower nitrogen excreon than expected based on chemical analysis of the diets 
were considered non-compliant and excluded from analysis. 
Urinary creanine was analysed by the Jaﬀé reacon using reagents from Roche Diagnoscs 
(Mannheim, Germany) on a Roche-Hitachi Modular P device (Roche, Mannheim, Germany) 
from the same manufacturer. Furthermore, the levels of urinary amino acids were analysed 
by a triple-quadrupole mass spectrometer (type API 4000 AB SCIEX, Foster City, California 
94404-1121, USA) aNer separaon of amino acids by isocrac HPLC (Agilent 1100LC, Agilent 
Technologies Deutschland GmbH, Böblingen, Germany). Isotope analysis (
14
N/
15
N) was con-
ducted by Europe 20/20 Stable Isotope Analyser coupled with a 
15
N sample combuson unit 
(Europa Scienﬁc Ltd, Crewe, Cheshire, UK). 
 
Blood sampling and analysis 
At the ﬁnal morning of each study period a fasng blood sample was obtained from the an-
tecubital vein of the forearm. From 22.00 hours the evening before, parcipants were not 
allowed to consume foods or drinks except for water. Blood was sampled in vacutainer 
tubes (BD Vacutainer, Plymouth, UK) containing clot acvator for serum and in tubes con-
taining Potassium Ethylene Diamine Tetra Acid (K2EDTA) for plasma. K2EDTA plasma tubes 
were stored ice-chilled and centrifuged for 10 minutes at 1190xg at 4°C, within 60 minutes 
aNer venepuncture. Serum tubes were stored in a dark condion for approximately 1.5 
hours and then centrifuged for 10 minutes at 1550xg at 20°C. Plasma and urine samples 
were stored at -80°C unl analysis. 
Creane in serum was analysed measuring the Barrit reacon aNer addion of 1-naphthol 
and photometrically quanﬁed at 546 nm (Hitachi U-1800 spectrophotometer, Hitachi High-
Technologies Europe GmbH, Mannheim, Germany). Finally, amino acid proﬁle in plasma was 
analysed by a triple-quadrupole mass spectrometer (type API 4000 AB SCIEX, Foster City, 
California 94404-1121, USA) aNer separaon of amino acids by isocrac HPLC (Agilent 
1100LC, Agilent Technologies Deutschland GmbH, Böblingen, Germany).  
 
Sta-s-cal analysis 
To idenfy biomarkers that may be useful to esmate intake of protein types we used a two
-step approach. With principal component discriminant analysis (PCDA) we idenﬁed amino 
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acids from the urinary and plasma amino acid proﬁles that were disncve between diets. 
For individual biomarkers that did not belong to the amino acid proﬁle (i.e. urinary crea-
nine, sulphate, ‰
15
N and serum creane) we invesgated whether there were diﬀerences 
between intervenon diets using ANCOVA. As a second step we applied mixed models aNer 
pooling total study data to esmate the predicve value of selected amino acids and indivi-
dual biomarkers for intake of protein types. 
PCDA analyses were performed in the Matlab environment (R2008b, 1984-2008, The Math-
works Inc, Nack, MA, USA) using the PLS toolbox for Matlab version 5.0.3 (r 6466, 1995-
2008, Eigenvector Research Inc, Wenatchee, WA, USA). We performed ANCOVA and mixed 
models using the SAS stascal soNware package (SAS version 9.2, SAS Instute, Cary, NC). 
 
Prepara-on of data 
Urinary excreon data of amino acids and sulphate were adjusted for creanine excreon to 
account for potenal incompleteness of 24h urine collecons. Furthermore these data were 
adjusted for total nitrogen excreon to take into account the unintended diﬀerences in pro-
tein content of intervenon diets that were revealed by chemical analysis of the duplicate 
porons. Plasma amino acid levels and serum creane were not correlated to total protein 
intake and were therefore not adjusted for diﬀerences in protein content of the diets. Mis-
sing data due to levels below detecon limit were replaced by detecon limit divided by 2. 
For PCDA analysis of amino acid proﬁles, levels of amino acids were calculated relave to 
the run in period [(diet-run-in)/ run in*100] and data were mean-centered per person to re-
move between subject variaon. Furthermore, auto scaling of all amino acids was per-
formed by dividing the values by their own standard deviaon. 
 
Iden-ﬁca-on of amino acids that are dis-nc-ve between diets 
Principal component analysis (PCA)
18
 was used to screen all data sets in order to detect out-
liers or pa6erns present in the data. Principal component discriminant analysis (PCDA) clas-
siﬁcaon was applied to invesgate diet diﬀerences. The validity of the PCDA model was 
tested using a ten-fold venean blind cross validaon (CV). This resulted in a percentage of 
samples that could be classiﬁed in the right diet based on the urinary or plasma amino acid 
proﬁles. 
In PCDA analysis, loadings of the discriminant (a linear combinaon of all amino acids from 
the proﬁle) reﬂect the inﬂuence of the original variables on diﬀerences between diets, which 
allowed us to idenfy speciﬁc amino acids that might be disncve for intake of one of the 
protein types of interest.
19,20
 We considered loadings >4 for further analysis. 
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Iden-ﬁca-on of individual biomarkers that are diﬀerent between diets 
For individual biomarkers that did not belong to the amino acid proﬁle (i.e. urinary crea-
nine, sulphate, ‰
15
N and serum creane) we invesgated whether there were diﬀerences 
between intervenon diets using ANCOVA. Because of non-normality data were log-
transformed. In case a signiﬁcant diet eﬀect was found, paral tests, corrected for mulple 
comparisons using Tukey-Kramer, were used to idenfy the diﬀerences. We considered a 
two sided p-value<0.05 stascally signiﬁcant. 
 
Predic-ve value of selected amino acids and individual markers 
To explore whether amino acids with a loading>4 or individual compounds that were signiﬁ-
cantly diﬀerent between diets would be interesng as biomarkers, we evaluated their pre-
dicve value for the intake of one of the protein types. We modelled the compounds of in-
terest against intake of protein types using mixed model analysis with parcipant number as 
random factor and data of all diets in one model. Subsequently we calculated the amount of 
explained variaon in intake using the method of Snijders and Bosker.
21 
 
R3C: 
The study involved 13 men and 17 women with a mean age of 22±4 y and a BMI of 21.6±2.2 
kg/m
2 
(Figure 7.1). ANer the ﬁrst intervenon period one male and one female parcipant 
withdrew, because they could no longer adhere to the prescribed diet. Furthermore, for one 
parcipant urine data of the run in period were excluded from analysis because he reported 
incomplete urine collecon. For another parcipant data of the grain protein period were 
excluded because of a knee surgery on the day before collecon, and data of the dairy pro-
tein period of a third parcipant were excluded because of a 130% higher nitrogen excreon 
than expected based on chemical analysis of the diet. Finally for one parcipant urine data 
of the dairy protein period were excluded because of a mistake in urine handling. 
In Table 7.3 amino acid intake and amino acid levels in plasma and in urine are shown aNer 
adjustment for total protein intake (amino acid intake) or total nitrogen and creanine ex-
creon (levels in urine). Baseline values without adjustment are given in Supplemental table 
1. PCA analysis revealed no gender diﬀerences or other pa6erns that were not due to diet 
diﬀerences. 
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Dairy protein 
based diet 
Meat protein 
based diet 
Grain protein 
based diet 
 Total energy (MJ/d) 11.1 11.0 11.1 
 Total protein (g/kg/d) 1.8 2.1 1.6 
Dietary amino acids  
Isoleucine Intake (mg/kg/day
1
) 95.1 86.6 61.0 
 Plasma levels (mg/dl) 0.86 ±0.03 0.84 ±0.03 0.84 ±0.03 
 Urinary excreon (mg/24h
2
) 1.6 ±0.1 1.6 ±0.1 1.8 ±0.1 
Leucine Intake (mg/kg/day
1
) 174.7 149.5 115.1 
 Plasma levels (mg/dl) 1.46 ±0.06 1.45 ±0.06 1.38 ±0.06 
 Urinary excreon (mg/24h
2
) 5.7 ±0.3 4.7 ±0.3 4.5 ±0.3 
Lysine Intake (mg/kg/day
1
) 144.3 149.7 56.1 
 Plasma levels (mg/dl) 2.60 ±0.07 2.61 ±0.07 1.90 ±0.07 
 Urinary excreon (mg/24h
2
) 15.2 ±2.7 18.3 ±2.6 11.5 ±2.4 
Methionine Intake (mg/kg/day
1
) 44.2 48.1 29.3 
 Plasma levels (mg/dl) 0.41 ±0.01 0.39 ±0.01 0.40 ±0.01 
 Urinary excreon (mg/24h
2
) 2.6 ±0.2 2.7 ±0.2 2.6 ±0.1 
Cysne Intake (mg/kg/day
1
) 25.1 20.0 30.6 
 Plasma levels (mg/dl) 0.49 ±0.02 0.51 ±0.02 0.47 ±0.02 
 Urinary excreon (mg/24h
2
) 10.2 ±0.5 8.9 ±0.5 10.8 ±0.4 
Phenylalanine Intake (mg/kg/day
1
) 82.3 76.7 76.2 
 Plasma levels (mg/dl) 0.93 ±0.02 0.87 ±0.02 0.87 ±0.02 
 Urinary excreon (mg/24h
2
) 8.8 ±0.4 8.1 ±0.4 9.9 ±0.4 
Tyrosine Intake (mg/kg/day
1
) 77.2 58.4 52.1 
 Plasma levels (mg/dl) 0.81 ±0.04 0.74 ±0.04 0.82 ±0.04 
 Urinary excreon (mg/24h
2
) 13.3 ±1.1 9.5 ±1.1 15.5 ±1.0 
Threonine Intake (mg/kg/day
1
) 86.4 80.8 50.7 
 Plasma levels (mg/dl) 1.72 ±0.06 1.75 ±0.06 1.38 ±0.06 
 Urinary excreon (mg/24h
2
) 28.0 ±3.2 30.6 ±3.1 19.6 ±2.9 
Tryptophan Intake (mg/kg/day
1
) 26.4 23.1 18.2 
 Plasma levels (mg/dl) 1.17 ±0.03 1.12 ±0.03 1.10 ±0.03 
 Urinary excreon (mg/24h
2
) 13.2 ±1.1 11.9 ±1.1 13.5 ±1.0 
Valine Intake (mg/kg/day
1
) 108.2 95.2 71.3 
 Plasma levels (mg/dl) 2.64 ±0.08 2.60 ±0.08 2.23 ±0.08 
 Urinary excreon (mg/24h
2
) 7.9 ±0.3 6.7 ±0.3 6.3 ±0.3 
Arginine Intake (mg/kg/day
1
) 69.4 115.5 75.2 
 Plasma levels (mg/dl) 1.34 ±0.05 1.37 ±0.05 1.50 ±0.05 
 Urinary excreon (mg/24h
2
) 4.4 ±0.2 3.5 ±0.2 2.9 ±0.2 
Hisdine Intake (mg/kg/day
1
) 45.0 61.2 36.1 
 Plasma levels (mg/dl) 1.26 ±0.04 1.33 ±0.04 1.28 ±0.04 
 Urinary excreon (mg/24h
2
) 109.2 ±11.2 138.1 ±10.8 128.5 ±10.2 
Alanine Intake (mg/kg/day
1
) 74.6 105.6 58.2 
 Plasma levels (mg/dl) 2.86 ±0.11 2.84 ±0.11 2.94 ±0.11 
 Urinary excreon (mg/24h
2
) 31.4 ±2.6 29.3 ±2.5 31.2 ±2.3 
Table 7.3. Overview of mean amino acid intake (adjusted for total protein intake), plasma 
levels, and urinary excre-on (adjusted for total nitrogen excre-on). 
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Dairy protein 
based diet 
Meat protein 
based diet 
Grain protein 
based diet 
Dietary amino acids (con-nued) 
Asparc acid Intake (mg/kg/day
1
) 167.8 179.4 93.1 
 Plasma levels (mg/dl) 0.10 ±0.01 0.11 ±0.01 0.09 ±0.01 
 Urinary excreon (mg/24h
2
) 1.4 ±0.1 1.3 ±0.1 1.0 ±0.1 
Asparagine Plasma levels (mg/dl) 0.70 ±0.02 0.68 ±0.02 0.65 ±0.02 
 Urinary excreon (mg/24h
2
) 19.8 ±3.2 20.4 ±3.1 15.0 ±2.9 
Glutamic acid Intake (mg/kg/day
1
) 384.8 319.4 449.2 
 Plasma levels (mg/dl) 0.87 ±0.04 0.90 ±0.04 0.89 ±0.04 
 Urinary excreon (mg/24h
2
) 7.0 ±0.4 6.8 ±0.4 6.1 ±0.4 
Glutamine Plasma levels (mg/dl) 7.26 ±0.25 7.18 ±0.25 7.48 ±0.25 
 Urinary excreon (mg/24h
2
) 121.4 ±7.7 113.6 ±7.4 126.8 ±7.0 
Glycine Intake (mg/kg/day
1
) 48.5 95.0 64.1 
 Plasma levels (mg/dl) 1.25 ±0.07 1.36 ±0.07 1.43 ±0.07 
 Urinary excreon (mg/24h
2
) 75.7 ±6.7 81.0 ±6.4 88.3 ±6.1 
Proline Intake (mg/kg/day
1
) 160.4 97.3 154.1 
 Plasma levels (mg/dl) 2.45 ±0.11 1.95 ±0.11 2.83 ±0.11 
 Urinary excreon (mg/24h
2
) 1.7 ±0.2 1.2 ±0.2 2.0 ±0.2 
Serine Intake (mg/kg/day
1
) 93.5 76.9 74.5 
 Plasma levels (mg/dl) 1.06 ±0.05 1.19 ±0.05 1.19 ±0.05 
 Urinary excreon (mg/24h
2
) 43.4 ±3.4 44.9 ±3.3 48.4 ±3.1 
Metabolites  
Orinithine Plasma levels (mg/dl) 0.41 ±0.03 0.42 ±0.03 0.49 ±0.03 
 Urinary excreon (mg/24h
2
) 1.5 ±0.1 1.3 ±0.1 1.6 ±0.1 
Citrulline Plasma levels (mg/dl) 0.47 ±0.02 0.47 ±0.02 0.47 ±0.02 
 Urinary excreon (mg/24h
2
) 1.0 ±0.1 1.2 ±0.1 1.0 ±0.1 
Hydroxyproline Plasma levels (mg/dl) 0.11 ±0.01 0.22 ±0.01 0.15 ±0.01 
 Urinary excreon (mg/24h
2
) 1.0 ±0.1 1.0 ±0.1 1.0 ±0.1 
Phosphoethanolamine Plasma levels (mg/dl) 0.10 ±0.01 0.11 ±0.01 0.11 ±0.01 
 Urinary excreon (mg/24h
2
) 3.2 ±0.3 3.6 ±0.3 3.0 ±0.3 
α-Aminobutyric acid Plasma levels (mg/dl) 0.21 ±0.01 0.23 ±0.01 0.16 ±0.01 
 Urinary excreon (mg/24h
2
) 1.7 ±0.2 1.6 ±0.2 1.7 ±0.1 
Taurine Plasma levels (mg/dl) 1.4 ±0.1 1.4 ±0.1 1.3 ±0.1 
 Urinary excreon (mg/24h
2
) 63.7 ±29.5 125.6 ±28.4 88.2 ±26.7 
Sarcosine Urinary excreon (mg/24h
2
) 1.0 ±0.1 1.0 ±0.1 1.0 ±0.1 
Carnosine Urinary excreon (mg/24h
2
) 3.9 ±3.1 41.1 ±3.0 8.6 ±2.8 
1-Methylhisdine Urinary excreon (mg/24h
2
) 28.3 ±8.1 178.9 ±7.8 44.4 ±7.3 
3-Methylhisdine Urinary excreon (mg/24h
2
) 36.2 ±2.4 81.0 ±2.3 44.7 ±2.2 
Table 7.3. Overview of mean amino acid intake (adjusted for total protein intake), plasma 
levels, and urinary excre-on (adjusted for total nitrogen excre-on), (con-nued). 
1
Adjusted for total protein intake by means of ANCOVA; 
2
Adjusted for total nitrogen and crea-nine excre-on by 
means of ANCOVA 
A fully controlled dietary intervenon study 
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Iden-ﬁca-on of urinary amino acids that are dis-nc-ve between diets 
The results from PCDA analysis of urinary amino acid proﬁles are depicted in Figure 7.2. In 
cross validaon of the PCDA model 70% of parcipants were correctly classiﬁed in the dairy 
protein based diet, 93% in the meat protein based diet, and 80% in the grain protein based 
diet. The diﬀerences between the meat protein based diet and the other two diets were 
mainly observed in the values of discriminant 1. Several of the amino acids that have been 
suggested as biomarkers for meat protein had an absolute loading >4 in the direcon of the 
meat protein based diet (i.e. 1-methylhisdine, 3-methylhisdine, and carnosine, Table 7.4). 
Amino acids that had an absolute loading >4 in the direcon of the other two diets were 
proline and cysteine. Because in the values of discriminant 2 diets could not be separated it 
was not possible to idenfy potenal biomarkers for the other two diets. 
 
Iden-ﬁca-on of plasma amino acids that largely inﬂuence diet diﬀerences 
For the plasma amino acid proﬁles results are depicted in Figure 7.3. The percentage of par-
cipants that was correctly classiﬁed was 86% for the dairy protein based diet, 88% for the 
meat protein based diet, and 96% for the grain protein based diet. The diﬀerences between 
the grain protein based diet and the other two diets were mainly observed in the values of 
discriminant 1, and amino acids that had an absolute loading >4 in the direcon of the grain 
protein diet were proline, ornithine, and arginine (Table 7.5). Amino acids with an absolute 
loading in the direcon of the other two diets were lysine, valine, threonine, and α-
aminobutyric acid. Because in the values of discriminant 2 diets could not be separated it 
was not possible to idenfy potenal biomarkers for the other two diets. 
 
Iden-ﬁca-on of individual biomarkers that are diﬀerent between diets 
In Table 7.6 the 24h urinary excreon of nitrogen, sulphate, and creanine are shown. ANer 
adjustment for total nitrogen and creanine excreon, 24h urinary sulphate was 3.4 to 4.0 
mmol lower during the meat protein based diet compared to the other two diets (p<0.01). 
Furthermore, urinary creanine levels were 0.2 to 0.3 g lower in the dairy protein based diet 
(p<0.01), and the proporon of 
15
N was slightly lower in the grain protein based diet com-
pared to the other two diets (0.002 to 0.003 ‰) with a borderline signiﬁcant diet-eﬀect 
(p=0.06). The paral tests, however, did not show a signiﬁcant diﬀerence (p=0.08 for grain 
vs. dairy, p=0.11 for grain vs. meat). 
The serum creane levels during the diﬀerent diets are shown in Table 7.6. During the meat 
protein diet creane levels were 0.16 to 0.19mg/dl higher than during the other two diets 
(p<0.01). 
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Variable Loadings D1
1 
Variable (con-nued) Loadings D1
1
 (con-nued)
 
Carnosine -7.99 Glutamine  2.83 
1-Methylhisdine  -7.26 Serine  2.84 
3-Methylhisdine  -4.24 Citrulline  2.90 
Taurine -3.92 Leucine  2.91 
Lysine 0.18 Isoleucine  3.13 
Threonine  1.56 Tryptophan 3.14 
Hisdine  1.67 Asparc acid  3.23 
Phosphoethanolamine 1.85 Phenylalanine  3.25 
Methionine  2.14 Sarcosine  3.35 
Aspargarine  2.21 Hydroxyproline  3.35 
Glycine  2.39 Ornithine  3.78 
Arginine  2.46 Glutamic acid 3.82 
Alanine  2.48 Tyrosine  3.98 
α-Aminobutyric acid 2.69 Proline  4.02 
Valine  2.78 Cysne  4.03 
Table 7.4. Urinary amino acid excre-on rela-ve to run in: PCDA loadings of D1 in Figure 7.2 
In PCDA analysis, loadings (or weights) of the discriminant (a linear combina-on of all amino acids from the proﬁle) 
reﬂect the inﬂuence of the original variables on diﬀerences between diets. 
1
High nega-ve values indicate a high inﬂuence of the amino acid on classiﬁca-on in the meat protein based diet, 
whereas high posi-ve values indicate a high inﬂuence on classiﬁca-on in one of the two other diets. 
Figure 7.2. PCDA score plot for urinary amino acid proﬁles. 
 Values of the two discriminant components from PCDA analysis that explained most varia-on in 
urinary amino acid proﬁles. Each dot represents a linear combina-on of all urinary amino acid levels 
in one par-cipant during one dietary period. Based on their urinary amino acid proﬁles 93% of 
par-cipants was correctly classiﬁed in the meat protein based diet, 70% in the dairy protein based 
diet and 80% in the grain protein based diet.  
 D1=discriminant 1 and D2=discriminant 2. 
A fully controlled dietary intervenon study 
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Figure 7.3. PCDA score plot for plasma amino acid proﬁles. 
 Values of the two discriminant components from PCDA analysis that explained most varia-on in 
urinary amino acid proﬁles. Each dot represents a linear combina-on of all plasma amino acid levels 
in one par-cipant during one dietary period. Based on their plasma amino acid proﬁles 96% of 
par-cipants was correctly classiﬁed in the grain protein based diet, 88% in the meat protein based 
diet and 86% in the dairy protein based diet. 
 D1=discriminant 1 and D2=discriminant 2.  
Variable Loadings D1
1 
Variable (con-nued) Loadings D1
1
 (con-nued) 
Lysine  -6.84 Glutamic acid  0.05 
Valine  -6.60 Phosphoethanolamine 0.83 
Threonine  -6.32 Citrulline  0.87 
α-Aminobutyric acid -6.26 Methionine  1.09 
Cysne  -3.97 Serine  1.24 
Leucine  -3.21 Isoleucine  1.45 
Hydroxyproline  -3.04 Glycine  1.46 
Aspargarine  -2.39 Alanine  1.48 
Taurine  -2.05 Glutamine  2.55 
Asparc acid  -1.67 Tyrosine  2.67 
Phenylalanine  -1.49 Arginine  4.17 
Hisdine  -1.08 Ornithine  4.37 
Tryptophan -0.46 Proline  7.20 
Table 7.5. Plasma amino acid levels rela-ve to run in: PCDA loadings of D1 in Figure 7.3 
In PCDA analysis, loadings (or weights) of the discriminant (a linear combina-on of all amino acids from the proﬁle) 
reﬂect the inﬂuence of the original variables on diﬀerences between diets. 
1
High posi-ve values indicate a high inﬂuence of the concerned amino acid on the classiﬁca-on in the grain protein 
based diet, whereas high nega-ve values indicate a high inﬂuence on classiﬁca-on in one of the two other diets. 
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Predic-ve value of selected amino acids and individual markers 
A combinaon of the three urinary AAs with absolute loadings >4 in the direcon of the 
meat protein diet, i.e. 1-methylhisdine, 3-methylhisdine, and carnosine, explained 98% of 
variaon in meat protein intake during the study (Table 7.7), which was more than was ex-
plained by each of these amino acids separately (69%, 72%, and 34% respecvely). Adding 
proline and cysne to the model did not explain extra variaon. For dietary grain protein the 
combinaon of proline, arginine, and ornithine, explained 24% of variaon in grain protein 
intake, whereas a combinaon of all 7 amino acids with the highest loadings in PCDA analy-
sis (plasma proline, lysine, valine, threonine and α-aminobuteric acid, ornithine and argi-
nine) explained 75% of variaon in intake. With regard to variaon in dairy protein intake, 
urinary creanine did not explain any variaon in intake. 
 
D2C267 
In this fully diet-controlled intervenon study among 30 young healthy adults a very good 
predicon could be made for the intake of meat protein by a regression model that included 
urinary carnosine, 1-methylhisdine, and 3-methylhisdine (98% of variaon in intake ex-
plained). Furthermore, for dietary grain protein a model that included 7 amino acids (plasma 
lysine, valine, threonine, α-amino-butyric acid, proline, ornithine and arginine) made a good 
predicon (75% of variaon explained). We could not idenfy biomarkers for dairy protein 
intake. 
Strengths of this study were the strictly controlled diets, the low dropout rate (n=2) and 
good compliance to the diets as indicated by nitrogen excreon. In addion, the mulvariate 
analysis of amino acid proﬁles made it possible to study a wide range of biomarkers at the 
  Dairy protein based 
diet 
Meat protein based 
diet  
Grain protein based 
diet 
p-value 
Urine  
Sulphate, mmol/24h
1 
35.9 ±1.4 31.9 ±1.3
a 
35.3 ±1.2 <0.01 
Creanine g/24h
2 
1.3 ±0.1
a 
1.6 ±0.1 1.5 ±0.1 <0.01 
‰15N 3.685 ±0.002 3.684 ±0.002 3.683 ±0.002 0.06 
Serum  
Creane, mg/dl 0.56 ±0.04 0.72 ±0.04
a 
0.53 ±0.04 <0.01 
Table 7.6. Levels of Postulated biomarkers during each diet. 
Data are presented as mean ± SE. 
1
Adjusted for crea-nine excre-on and nitrogen excre-on; 
2
Adjusted for nitrogen excre-on. 
a
Diet diﬀerent from both other diets p<0.01. 
A fully controlled dietary intervenon study 
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same me, taking correlaons between these biomarkers into account. Because each pro-
tein type contains all amino acids in diﬀerent proporons it is not possible to idenfy a 
single amino acid or amino acid derivate that indicates whether or not a certain protein type 
is consumed. However, in this study we could idenfy combinaons of amino acids that may 
be used to rank individuals according to intake of a protein type. 
A limitaon of the study, however, was the diﬀerence in total protein intake across the in-
tervenon periods. We accounted for this diﬀerence by adjusng urinary data for total ni-
trogen excreon so that biomarkers for protein intake could be idenﬁed independent of 
protein quanty of the diets. Furthermore, we observed a signiﬁcantly lower creanine ex-
creon during the dairy protein based diet. Nevertheless, in regression analysis urinary 
creanine did not explain any variaon in dairy protein intake. We therefore considered 
these diﬀerences between diets to be chance ﬁndings and adjusted all urinary excreon 
data for creanine excreon to account for incompleteness of urine collecon. 
Meat protein intake was best predicted by a regression model that included urinary carno-
sine, 1-methylhisdine, and 3-methylhisdine. In literature, urinary carnosine, 1-
methylthisdine and 3-methylhisdine have been proposed as biomarkers for meat protein 
intake. In an exploratory study in one healthy man urinary carnosine was increased aNer in-
geson of muscle protein, although the increase was only a small proporon of carnosine in-
Intake 
variable 
(protein%) Specimen Regression model 
% explained 
varia-on in 
intake (R
2
) 
Regression models for amino acids with loadings >4 in PCDA analysis  
Meat protein Urine -16.5+1.0 * Carnosine (mg/24h)+ 0.2 * 1-methylhisdine (mg/24h)+ 0.5 
* 3-methylhisdine (mg/24h)
1 
98 
Meat protein Urine -10.9+0.9 * Carnosine (mg/24h)+0.2 * 1-methylhisdine (mg/24h) +0.5 
* 3-methylhisdine (mg/24h)-2.8 * proline (mg/24h)-0.3 * cysne 
(mg/24h)
2 
98 
Grain protein Plasma -42.4+23.3 * Proline (mg/dl)+13.5 * Arginine (mg/dl)+6.8 * Ornithine 
(mg/dl)
1 
24 
Grain protein Plasma 99.0+ 19.9 * Proline (mg/dl)+ 43.1 * Arginine (mg/dl)+ 39.9 * Ornithine 
(mg/dl)- 32.9 * Lysine (mg/dl)- 42.1 * α-aminobutyric acid (mg/dl)- 20.9 
* threonine (mg/dl)- 27.9 * valine (mg/dl)
2 
75 
Meat protein Urine -2.4+1.2 * Sulphate (mg/24h) 11 
Meat protein Serum 11.4+ 42.5 * Creane (mg/dl) 4 
Dairy protein Urine 43.7-8.2 * Creanine (mg/24h) 0 
Regression models for individual biomarkers that were signiﬁcantly diﬀerent between diets  
Table 7.7. Regression models of poten-ally interes-ng biomarkers from ANOVA and PCDA 
analysis with protein types, and explained varia-on in intake. 
1
Regression model containing AAs with PCDA loadings >4 in the direcon of the diet of interest; 
2
Regression model 
containing all AAs with absolute PCDA loadings >4. 
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gested.
22
 In 33 non-diabec obese parcipants a linear relaonship was found between 
meat protein intake and 3-methylhisdine excreon with an increment of 1.34 μmoles/g of 
ingested protein
23
, and in a Swedish study among 5 healthy adults, a strong linear relaon-
ship was found between meat intake (beef, pork, chicken and plaice) and 3-methylhisdine 
and 1-methylhisdine excreon.
8
 In the current study, a combinaon of these three amino 
acids explained 98% of variaon in meat protein intake, which was more than the variaon 
explained by each of these amino acids per se. The combinaon of the three amino acids 
may be a useful biomarker for intake of meat protein that warrants validaon in controlled 
studies with diﬀerent levels of meat protein intake. 
It has been shown that aNer intake of 1-methylhisdine, and 3-methylhisdine from meat, 
these amino acids are rapidly excreted in urine and fasng plasma levels are therefore very 
low 
7,22-24
, which is why these plasma levels were not measured in the current study. This 
may partly explain why in the plasma amino acid proﬁle the grain protein diet showed the 
best separaon from the other diets, in contrast to the urinary proﬁle where the meat pro-
tein diet showed the best separaon. A regression model with a combinaon of plasma con-
centraons of 7 amino acids (lysine, valine, threonine, α-aminobutyric acid, proline, orni-
thine and arginine) explained 75% of variaon in grain protein intake. Compared with the 
other two diets our grain protein diet had a lower content of the essenal amino acids ly-
sine, threonine, and valine, methionine which was reﬂected in lower plasma levels of the 
ﬁrst three amino acids and in the level of plasma α-aminobutyric acid, which is derived pri-
marily from methionine and serine.
25
  Furthermore, glutamic acid was relavely high in the 
grain protein diet which was reﬂected in a higher excreon of proline, arginine and ornithine 
for which glutamic acid is a precursor.
26
 Nevertheless, we should be careful in interpreng 
these results. Because grains added much bulk to the diet we replenished the grain protein 
based diet with legumes (chickpeas, lenls; 3.6 en% legume protein) to reach 14 en% of 
plant protein. Addionally, this was the only diet that focused on protein of plant origin, and 
markers that we idenﬁed as potenal biomarkers for grain protein may in reality reﬂect 
plant protein in general. These results need conﬁrmaon in other studies with a range in 
grain protein intake closer to the habitual intake, in which it is not necessary to add protein 
from other plant sources. Furthermore, plasma amino acid levels need to be compared be-
tween a grain protein based diet and a diet that contains protein from other plant sources. 
A potenal marker for which data in humans up to date are scarce is the rao of 
14
N/
15
N sta-
ble isotopes in urine as a biomarker for the proporon of plant and animal protein in the 
diet. There is evidence that human hair and bones reﬂect the proporon of animal protein in 
the diet
27
 and in ca6le urine diﬀerences in 
15
N isotope levels have been found in response to 
a maize or a grass diet.
28
 In line with the hypothesis that the proporon of 
15
N increases with 
higher animal protein intake, we observed in the current study a tendency toward a lower 
percentage of urinary 
15
N during the grain protein based diet compared to the other two 
diets. However, this diﬀerence was too small to be signiﬁcant. Possibly a dietary period of 
A fully controlled dietary intervenon study 
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one week was too short to reach the maximum eﬀect of diet on urinary stable isotope rao. 
In ca6le the urinary 
15
N required 12 days to reach the new equilibrium aNer dietary 
changes.
28
 This potenal biomarker needs to be invesgated in a study with longer dietary 
periods. 
In the current study among 30 young healthy adults we idenﬁed a combinaon of three 
amino acids in urine as potenally useful biomarkers for the intake of meat protein and a 
combinaon of seven amino acids in plasma as potenally useful biomarkers for the intake 
of grain protein. We did not ﬁnd biomarkers for dairy protein intake. Further studies are 
needed to validate these ﬁndings and to invesgate whether these biomarkers are also use-
ful within lower ranges of intake as observed in populaon based studies. 
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Dairy protein 
based diet 
Meat protein 
based diet 
Grain protein 
based diet 
 Total energy (MJ/d) 11.1 11.0 11.1 
 Total protein (g/kg/d) 1.8 2.1 1.6 
Dietary amino acids  
Isoleucine Intake (mg/kg/day) 96.4 92.2 59.1 
 Plasma levels (mg/dl) 0.86 ±0.04 0.84 ±0.04 0.84 ±0.04 
 Urinary levels (mg/24h) 1.6 ±0.2 2.1 ±0.2 1.5 ±0.2 
Leucine Intake (mg/kg/day) 177.0 159.6 111.6 
 Plasma levels (mg/dl) 1.46 ±0.06 1.45 ±0.06 1.38 ±0.05 
 Urinary levels (mg/24h) 5.7 ±0.5 6.0 ±0.5 3.9 ±0.3 
Lysine Intake (mg/kg/day) 146.2 157.7 53.2 
 Plasma levels (mg/dl) 2.60 ±0.07 2.61 ±0.06 1.90 ±0.07 
 Urinary levels (mg/24h) 17.4 ±3.9 24.1 ±3.0 9.0 ±1.3 
Methionine Intake (mg/kg/day) 44.8 50.9 28.3 
 Plasma levels (mg/dl) 0.41 ±0.01 0.39 ±0.01 0.40 ±0.01 
 Urinary levels (mg/24h) 2.6 ±0.2 3.3 ±0.3 2.3 ±0.2 
Cysne Intake (mg/kg/day) 25.5 21.7 30.0 
 Plasma levels (mg/dl) 0.49 ±0.02 0.51 ±0.01 0.47 ±0.01 
 Urinary levels (mg/24h) 9.8 ±0.7 11.0 ±0.7 9.7 ±0.7 
Phenylalanine Intake (mg/kg/day) 83.5 82.0 74.3 
 Plasma levels (mg/dl) 0.93 ±0.02 0.87 ±0.02 0.87 ±0.02 
 Urinary levels (mg/24h) 8.8 ±0.5 10.1 ±0.6 8.9 ±0.6 
Tyrosine Intake (mg/kg/day) 78.2 62.8 50.5 
 Plasma levels (mg/dl) 0.81 ±0.04 0.74 ±0.04 0.82 ±0.05 
 Urinary levels (mg/24h) 13.5 ±1.6 14.4 ±1.5 13.1 ±1.5 
Threonine Intake (mg/kg/day) 87.5 85.8 48.9 
 Plasma levels (mg/dl) 1.72 ±0.07 1.75 ±0.07 1.38 ±0.05 
 Urinary levels (mg/24h) 27.7 ±3.4 34.4 ±4.5 17.7 ±1.4 
Tryptophan Intake (mg/kg/day) 26.8 24.8 17.6 
 Plasma levels (mg/dl) 1.17 ±0.04 1.12 ±0.02 1.10 ±0.04 
 Urinary levels (mg/24h) 12.6 ±1.2 15.1 ±1.4 11.8 ±1.2 
Valine Intake (mg/kg/day) 109.6 101.5 69.1 
 Plasma levels (mg/dl) 2.64 ±0.08 2.60 ±0.09 2.23 ±0.08 
 Urinary levels (mg/24h) 7.7 ±0.4 8.2 ±0.5 5.5 ±0.4 
Arginine Intake (mg/kg/day) 70.7 121.2 73.2 
 Plasma levels (mg/dl) 1.34 ±0.05 1.37 ±0.05 1.50 ±0.06 
 Urinary levels (mg/24h) 4.3 ±0.3 4.0 ±0.3 2.7 ±0.2 
Hisdine Intake (mg/kg/day) 45.7 64.5 35.0 
 Plasma levels (mg/dl) 1.26 ±0.06 1.33 ±0.04 1.28 ±0.04 
 Urinary levels (mg/24h) 113.7 ±11.7 164.9 ±13.5 116.0 ±9.8 
Alanine Intake (mg/kg/day) 75.8 110.7 56.4 
 Plasma levels (mg/dl) 2.86 ±0.11 2.84 ±0.09 2.94 ±0.11 
 Urinary levels (mg/24h) 31.3 ±3.1 36.5 ±3.2 27.6 ±2.6 
Supplemental table 1. Overview of amino acid intake, plasma levels, and urinary excre-on, 
unadjusted for total protein intake and total nitrogen and crea-nine excre-on. 
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Dairy protein 
based diet 
Meat protein 
based diet 
Grain protein 
based diet 
Dietary amino acids  (con-nued) 
Asparc acid Intake (mg/kg/day) 170.0 189.0 89.6 
 Plasma levels (mg/dl) 0.10 ±0.01 0.11 ±0.02 0.09 ±0.01 
 Urinary levels (mg/24h) 1.4 ±0.1 1.4 ±0.2 1.0 ±0.1 
Asparagine Plasma levels (mg/dl) 0.70 ±0.02 0.68 ±0.02 0.65 ±0.02 
 Urinary levels (mg/24h) 19.4 ±3.2 23.4 ±4.1 13.5 ±1.6 
Glutamic acid Intake (mg/kg/day) 390.8 345.5 440.0 
 Plasma levels (mg/dl) 0.87 ±0.04 0.90 ±0.04 0.89 ±0.04 
 Urinary levels (mg/24h) 6.7 ±0.4 7.3 ±0.4 5.9 ±0.3 
Glutamine Plasma levels (mg/dl) 7.26 ±0.25 7.18 ±0.24 7.48 ±0.26 
 Urinary levels (mg/24h) 119.9 ±9.9 145.6 ±11.2 110.6 ±9.7 
Glycine Intake (mg/kg/day) 49.5 99.1 62.7 
 Plasma levels (mg/dl) 1.25 ±0.06 1.36 ±0.07 1.43 ±0.07 
 Urinary levels (mg/24h) 76.6 ±6.6 103.9 ±9.4 77.1 ±7.9 
Proline Intake (mg/kg/day) 162.5 106.4 150.9 
 Plasma levels (mg/dl) 2.45 ±0.11 1.95 ±0.07 2.83 ±0.15 
 Urinary levels (mg/24h) 1.6 ±0.2 1.4 ±0.1 1.9 ±0.4 
Serine Intake (mg/kg/day) 94.8 82.4 72.6 
 Plasma levels (mg/dl) 1.06 ±0.03 1.19 ±0.06 1.19 ±0.05 
 Urinary levels (mg/24h) 42.3 ±3.6 55.2 ±5.2 43.1 ±3.3 
metabolites  
Orinithine Plasma levels (mg/dl) 0.41 ±0.02 0.42 ±0.02 0.49 ±0.03 
 Urinary levels (mg/24h) 1.5 ±0.2 1.6 ±0.2 1.4 ±0.1 
Citrulline Plasma levels (mg/dl) 0.47 ±0.02 0.47 ±0.03 0.47 ±0.02 
 Urinary levels (mg/24h) 1.1 ±0.1 1.3 ±0.1 0.9 ±0.1 
Hydroxyproline Plasma levels (mg/dl) 0.11 ±0.01 0.22 ±0.01 0.15 ±0.01 
 Urinary levels (mg/24h) 1.1 ±0.1 1.1 ±0.1 0.9 ±0.1 
Phsophoethanolamine Plasma levels (mg/dl) 0.10 ±0.01 0.11 ±0.01 0.11 ±0.01 
 Urinary levels (mg/24h) 3.4 ±0.3 4.4 ±0.4 2.7 ±0.3 
Sarcosine Plasma levels (mg/dl)    
 Urinary levels (mg/24h) 1.1 ±0.1 1.1 ±0.1 0.9 ±0.1 
α-aminobutyric acid Plasma levels (mg/dl) 0.21 ±0.01 0.23 ±0.01 0.16 ±0.01 
  Urinary levels (mg/24h) 1.8 ±0.2 2.2 ±0.2 1.4 ±0.1 
Taurine Plasma levels (mg/dl) 1.37 ±0.09 1.37 ±0.08 1.35 ±0.07 
 Urinary excreon (mg/24h) 71.8 ±20.5 138.9 ±25.8 82.9 ±26.3 
Sarcosine Urinary excreon (mg/24h) 1.1 ±0.1 1.1 ±0.1 0.9 ±0.1 
Carnosine Urinary excreon (mg/24h) 4.5 ±0.4 47.5 ±5.8 5.5 ±0.8 
1-Methylhisdine Urinary excreon (mg/24h) 33.9 ±2.9 1.95.3 ±14.2 37.2 ±3.4 
3-Methylhisdine Urinary excreon (mg/24h) 35.7 ±2.5 95.2 ±5.5 37.6 ±2.9 
Supplemental table 1. Overview of amino acid intake, plasma levels, and urinary excre-on, 
unadjusted for total protein intake and total nitrogen and crea-nine excre-on (con-nued). 
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Elevated blood pressure is a major risk factor for cardiovascular diseases. In 2002 
the World Health Organisaon esmated that worldwide about 62% of 
cerebrovascular disease and 49% of ischaemic heart disease were a6ributable to 
subopmal blood pressure (i.e. systolic blood pressure levels >115 mmHg).
1,2
 
Prevenon of high blood pressure by healthy lifestyle and diet, therefore, can have 
a substanal public health impact; it has been esmated that a populaon-wide 
reducon in systolic blood pressure of only 2 mmHg is expected to result in a 6% 
reducon in fatal stroke, and a 4% reducon in fatal coronary heart disease.
3
 
The present thesis focused on the potenal role of dietary protein in reducing 
populaon blood pressure. As discussed in Chapter 1 the objecves were 1) to 
examine whether habitual intake of dietary protein is related to blood pressure 
level or incidence of hypertension, 2) to examine whether plant and animal 
protein, protein from speciﬁc sources (dairy, meat, and grain), or speciﬁc amino 
acids are diﬀerenally related to blood pressure levels or hypertension incidence, 
and 3) to examine whether subject characteriscs like age, gender, BMI, and 
hypertensive status, could modify the associaon between dietary protein and 
blood pressure. In this last chapter we ﬁrst give a brief overview of the main 
ﬁndings. Subsequently, we present several meta-analyses that we conducted for 
total protein and protein types in relaon to blood pressure or incident 
hypertension, based on our own ﬁndings and data presented in the literature unl 
January 2012. Finally, the implicaons of our ﬁndings for public health are 
discussed. 
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In a systemac review of exisng literature on protein intake and blood pressure (Chapter 2) 
we concluded that dietary protein could have a small beneﬁcial eﬀect on blood pressure. 
This conclusion was mainly based on observaonal studies that used urinary biomarkers for 
protein intake and randomized controlled trials that used carbohydrates as the control 
treatment. Observaonal data suggested a more beneﬁcial role of plant protein compared 
to animal protein, although residual confounding (e.g. from other macronutrients, ﬁber, or 
ﬂavonoids) could not be excluded. Li6le was known about protein from speciﬁc sources (e.g. 
dairy, meat, and grain) in relaon to blood pressure. There was some evidence that blood 
pressure in hypertensives and at an older age could be more sensive to dietary protein, but 
more data was needed on subject characteriscs that can modify the blood pressure eﬀect 
of dietary protein. 
We conducted a cross-seconal study in ~20,000 Dutch adults of the MORGEN cohort 
(Chapter 3) and two longitudinal studies in ~3,500 Dutch adults (Doenchem cohort, Chap-
ter 4) and in ~2,000 older Dutch adults of the Ro6erdam Study (Chapter 5 and 6) to examine 
the associaons of diﬀerent types of protein and amino acids with blood pressure or inci-
dent hypertension and to idenfy potenal eﬀect modiﬁers. The main results of these stu-
dies are summarized in Table 8.1. Intake of total protein and animal protein were not rela-
ted to blood pressure or incident hypertension. A higher energy adjusted plant protein in-
take of 14 grams (2.5 en%) was associated with 1.8/1.0 mmHg lower blood pressure in our 
cross-seconal analysis (Chapter 3), and this associaon was more pronounced in hyperten-
sives (pinteracon<0.01). In longitudinal analysis, however, there was no associaon between 
plant protein and incident hypertension (Chapter 4 and 5). When focusing more in detail on 
protein from speciﬁc sources (Chapter 3-6, Table 8.1), meat protein was not associated with 
blood pressure or hypertension. Results for dairy protein were inconsistent across the diﬀe-
rent studies, and the signiﬁcant associaons that we observed were probably due to chance. 
Cross-seconally, grain protein was inversely associated with diastolic blood pressure only 
(Chapter 3) and in longitudinal analysis a higher grain protein intake was associated with a 
lower risk of hypertension in a general populaon (HR: 0.85, 95% CI: 0.73 to 1.00, Chapter 
4), but not in older adults (Chapter 5). Although ﬁndings for grain protein were inconclusive, 
we cannot exclude an inverse associaon. Finally, none of the invesgated amino acids (i.e. 
glutamic acid, arginine, lysine, tyrosine, cysteine, and essenal amino acids) were associated 
with blood pressure levels or incidence of hypertension (Chapter 6). 
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Chap-
ter 
Cohort
1 
Design N Mean 
intake
2 
Delta intake
3 
Results
4 
Eﬀect modiﬁca-on 
Total protein  
3 MORGEN CS 20,820 15 29 (Q5 vs. Q1) -0.8/-0.3  
4 Doenchem P 3,588 15 20 (T3 vs. T1) 1.01 (0.85-1.19)  
5 Ro6erdam P 2,241 17 13 (1 SD) 1.03 (0.92-1.15) 1.34* for age >70y 
Plant protein  
3 MORGEN CS 20,820 6 14 (Q5 vs. Q1) -1.8*/-1* -3.6* in hypertensives 
4 Doenchem P 3,588 6 9 (T3 vs. T1) 0.96 (0.80-1.16)  
5 Ro6erdam P 2,241 6 6 (1 SD) 1.03 (0.93-1.13)  
Animal protein  
3 MORGEN CS 20,820 9 32 (Q5 vs. Q1) -0.6/-0.1  
4 Doenchem P 3,588 9 22 (T3 vs. T1) 0.97 (0.81-1.15)  
5 Ro6erdam P 2,241 11 13 (1 SD) 1.02 (0.91-1.15) 1.37* for age >70y 
Dairy protein  
3 MORGEN CS 20,820 4 27 (Q5 vs. Q1) +1.6*/+0.4  
4 Doenchem P 3,588 4 19 (T3 vs. T1) 1.00 (0.81-1.25)  
5 Ro6erdam P 2,241 5 11 (1 SD) 0.91 (0.82-1.01)  
Meat protein  
3 MORGEN CS 20,820 4 23 (Q5 vs. Q1) 0.0/-0.2  
4 Doenchem P 3,588 4 16 (T3 vs. T1) 0.99 (0.85-1.16)  
5 Ro6erdam P 2,241 4 9 (1 SD) 1.02 (0.93-1.10) 1.29* for age >70y 
Grain protein  
3 MORGEN CS 20,820 3 13 (Q5 vs. Q1) -0.2/-0.6*  
4 Doenchem P 3,588 3 8 (T3 vs. T1) 0.85 (0.73-1.00)*  
5 Ro6erdam P 2,241 3 3 (1 SD) 1.02 (0.95-1.08)  
Glutamic acid  
6 Ro6erdam CS 3,086 21 2.1 (Q4 vs. Q1) -0.6/-1  
6 Ro6erdam P 1,810 21 2.1 (T3 vs. T1) 1.02 (0.83-1.26)  
Arginine  
6 Ro6erdam CS 3,086 5 0.7 (Q4 vs. Q1) -0.5/+0.4  
6 Ro6erdam P 1,810 5 0.6 (T3 vs. T1) 1.06 (0.85-1.31)  
Lysine  
6 Ro6erdam CS 3,086 7 0.8 (Q4 vs. Q1)  +1.7/+1  
6 Ro6erdam P 1,810 7 0.8 (T3 vs. T1) 1.15 (0.93-1.43)  
Cysteine  
6 Ro6erdam CS 3,086 1 0.2 (Q4 vs. Q1) +0.1/-0.2  
6 Ro6erdam P 1,810 1 0.1 (T3 vs. T1) 0.98 (0.77-1.24)  
6 Ro6erdam CS 3,086 4 0.2 (Q4 vs. Q1) -2.4*/-0.4  
6 Ro6erdam P 1,810 4 0.3 (T3 vs. T1) 0.92 (0.73-1.15)  
Tyrosine  
Table 8.1. Main ﬁndings of the observa-onal studies described in this thesis. 
CS=cross-seconal; P=prospecve; Q5=quinles; Q4 is quarles; T3=terles; SD=standard deviaon 
*Ptrend <0.05. 
1
MORGEN and Doenchem: Populaon based cohort of Dutch adults aged 25 to 65 y; Ro6erdam: Populaon based 
cohort of Dutch older adults aged ≥55 y; 
2
In percentage of energy for studies on protein and in percentage of 
protein for studies on amino acids; 
3
Diﬀerence in intake between the highest and the lowest quanle in grams per 
day (adjusted for energy according to the residual method) for studies on protein and in percentage of protein for 
studies on amino acids.; 
4
For cross-seconal studies: Δsystolic blood pressure/Δdiastolic blood pressure (mmHg); 
for prospecve studies: HR (95%-CI). 
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To put our ﬁndings in the context of all available literature we summarized the total body of 
evidence in a series of meta-analyses. We idenﬁed 43 studies on the relaon between pro-
tein intake and blood pressure levels or hypertension incidence that were published unl 
January 2012. Five papers of cross-seconal studies were excluded because data on systolic 
blood pressure or standard errors were missing.
4-8
 Two papers of prospecve studies were 
excluded because a yearly change in blood pressure was reported instead of a relave 
risk.
9,10
 Six trials were excluded because 1) exact data on actual protein intake could not be 
extracted
11
, 2) no isocaloric macronutrient replacement occurred
12-15
, or 3) data were not 
suﬃcient to calculate the blood pressure response
16
. Finally, one trial could not be included 
in the meta-analysis because in the control diet protein was replaced by a mix of carbohy-
drates and fat instead of one macronutrient only.
17
 
We aggregated data from 8 cross-seconal studies (Table 8.2) and 4 prospecve studies 
(Table 8.3) in a meta-analysis on intake of total protein or protein types and blood pressure 
levels or hypertension incidence. In addion, we pooled the results of 17 randomized con-
trolled trials (Table 8.4) for which we also conducted a metaregression analysis on protein 
dose and study duraon. Furthermore, to check whether blood pressure response to protein 
supplementaon was modiﬁed by subject characteriscs we conducted a meta-regression 
analysis on age, gender (% males), BMI, and inial systolic blood pressure level. For each 
type of protein the meta-analysis ﬁndings are summarized below, followed by a crical dis-
cussion of methodological issues, and discrepancies between studies. 
 
Total dietary protein 
Summary of results 
The combined results of cross-seconal studies showed a signiﬁcant inverse associaon of 
total dietary protein with blood pressure, although the associaon was small with a pooled 
esmate of -0.20 mmHg systolic (95%-CI: -0.39 to -0.01) per 25 grams (~1 SD) of protein in-
take (Figure 8.1). Prospecvely, there was no associaon between total protein intake and 
incidence of hypertension (pooled HR=0.99, 95%-CI=0.96 to 1.02, Figure 8.2). In intervenon 
studies that used carbohydrate as the control treatment, the pooled blood pressure eﬀect 
was -2.11 mmHg systolic (95%-CI=-2.86 to -1.37, Figure 8.3) for a weighed mean contrast in 
protein intake of 41 g/d. Metaregression analyses showed no associaons of dose or study 
duraon with blood pressure response (Table 8.5). Trials with a fat control (mainly mono-
unsaturated fa6y acids) showed no eﬀect of protein intake on blood pressure (pooled es-
mate=-0.04 mmHg, 95%-CI=-2.20 to +2.12, Figure 8.4). 
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Figure 8.1. Fully adjusted diﬀerence in systolic blood pressure (ΔSBP) with consump-on of 25 
grams (~1 SD) higher total protein intake in 6 cross-sec-onal studies. 
 For details of the studies see Table 8.2. 
 
1
Weights are from random eﬀects analysis. 
Figure 8.2. Fully adjusted rela-ve risk of hypertension (RR) with 25 grams (~1 SD) higher total 
protein intake in 3 longitudinal studies. 
 For details of the studies see Table 8.3. 
 
1
Weights are from random eﬀects analysis. 
General Discussion 
8 
163 
Figure 8.3. Net change in systolic blood pressure (ΔSBP change) with consump-on of protein 
compared to carbohydrates in 14 randomized controlled trials. 
 For details of the studies see Table 8.4. 
 In the studies of Pal et al.
67
, and He et al.
30
 two interven-on arms were included that were compared 
to the same control group. In the study of Meckling et al. two interven-on arms were included that 
were each compared to their own control group (interven-on with and without exercise in both 
interven-on and control group). 
 
1
Weights are from random eﬀects analysis. 
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Methodological issues of observa-onal studies on total protein intake 
In most observaonal studies dietary protein intake was adjusted for total energy to account 
for confounding by caloric intake or energy-related determinants of blood pressure, such as 
physical acvity. However, it cannot be excluded that the absolute amount of protein intake 
(per kilogram of body weight) rather than energy adjusted protein is the determinant of in-
terest in relaon to blood pressure (see the discussion on amino acids below). If so, there is 
a possibility that adjustment for total energy, which we considered necessary, resulted in 
misclassiﬁcaon for protein intake and a6enuaon of the associaons. 
Results from cross-seconal studies suggest a (small) beneﬁcial associaon of total protein 
with blood pressure levels, whereas results of prospecve studies did not show an associa-
on with incidence of hypertension. Possibly, the associaons in prospecve studies were 
weaker because of a lower blood pressure in these populaons due to the exclusion of hy-
pertensive parcipants at baseline. Furthermore, small associaons may have been missed 
in prospecve studies because of the use of incident hypertension as a dichotomous end-
point (deﬁned as blood pressure ≥140/90 mmHg or use of anhypertensive medicaon). 
This approach has the advantage that parcipants who started anhypertensive medicaon 
during follow-up can be included in the analysis without causing bias, but a disadvantage is 
that blood pressure changes closely around the cut-oﬀ point are emphasized, whereas 
changes further away from the cut-oﬀ point are ignored. Consequently, small blood pres-
sure diﬀerences may have been more diﬃcult to detect. 
 
Discrepancies between observa-onal and trial data on total protein intake 
Trials with a carbohydrate control provided stronger evidence for an inverse relaon of pro-
tein intake with blood pressure than observaonal studies, which may be partly a6ributable 
to the inclusion of more sensive individuals with (pre)hypertension, overweight, or obesity 
 Coeﬃcient 95%-CI p-value 
Mean age, y +0.2 -0.3 to +0.8 0.30 
Men, % -5.7 -20 to +9 0.37 
BMI +0.1 -0.9 to +1.0 0.86 
Mean baseline SBP +0.04 -0.3 to +0.4 0.81 
Duraon, wk -0.1 -0.3 to +0.1 0.30 
Δprotein, g/d -0.1 -0.3 to +0.1 0.30 
Table 8.5. Characteris-cs associated with net change in blood pressure in trials with 
carbohydrates as control: univariate meta-regression analysis. 
SBP=systolic blood pressure; Δprotein=diﬀerence in protein intake between interven-on and control group. 
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(Table 8.4). Furthermore, in trials mostly supplements or fully controlled diets were used, 
and a6enuaon of blood pressure eﬀects because of exposure misclassiﬁcaon does not oc-
cur, in contrast to observaonal studies where protein intake is measured using memory 
based methods. Finally, the contrast in protein intake was generally larger in trials with a 
weighed mean contrast in intake of 41 g/d (range: 28 to 74 g/d, Table 8.4) versus a contrast 
of 25 g/d (~1 SD) that was used in the meta-analyses of the observaonal studies. The high 
doses that were used in trials may also explain the lack of a dose response eﬀect if blood 
pressure would mainly respond to protein within the low intake range or below a certain 
threshold. 
 
Subs-tu-on of macronutrients 
Given a constant energy intake, a blood pressure eﬀect aNer intake of protein will be rela-
ve to the intake of fat, carbohydrates, or both. The results of the meta-analysis indicate a 
stronger blood pressure eﬀect of protein when it is exchanged for carbohydrates (Figure 
8.3) than when it is exchanged for fat (mainly mono-unsaturated fa6y acids, Figure 8.4). It is 
therefore well possible that a decreased carbohydrate intake rather than an increased pro-
tein intake plays a role in blood pressure reducon. In observaonal studies in which asso-
ciaons are adjusted for energy, however, a higher protein is likely to be accompanied with 
a lower intake of both carbohydrates and fa6y acids. Because protein may not reduce blood 
pressure compared to fat this may explain the generally weaker associaons in observao-
nal studies. 
Figure 8.4. Net change in systolic blood pressure (ΔSBP change) with consump-on of protein 
compared to fat (mainly mono-unsaturated fa6y acids) in 3 randomized 
controlled trials. 
 For details of the studies see Table 8.4. 
 
1
Weights are from random eﬀects analysis. 
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Possibly, the type of carbohydrate in the control diet also is a determinant of the blood pres-
sure eﬀect of protein. Blood pressure eﬀects were more pronounced in trials in which glu-
cose or maltodextrine were used as a control than in trials that were diet-based and had a 
mix of carbohydrates in the control diet (Figure 8.5). The increase of protein at the expense 
of carbohydrates (especially ‘fast’ carbohydrates like sucrose and maltodextrine) reduces 
the glycemic index of diets, which may result in an a6enuated insulin response. Because 
there is some evidence for an unfavourable eﬀect of insulin on blood pressure this may ex-
plain a blood pressure lowering eﬀect of such diets.
18
 However, it cannot be excluded that 
the generally more controlled dose in the supplement-based trials rather than the type of 
carbohydrates accounted for the stronger blood pressure eﬀects (Figure 8.5). 
 
Total protein; conclusions and sugges-ons for further research 
The totality of evidence, especially from trials, indicates that total dietary protein may have 
a beneﬁcial eﬀect on blood pressure if it is consumed instead of carbohydrates, although no 
Figure 8.5. Net change in systolic blood pressure (ΔSBP change) with consump-on of protein 
compared to carbohydrates in 14 randomized controlled trials, stra-ﬁed by inter-
ven-on type. 
 For details of the studies see Table 8.4. 
 
1
Weights are from random eﬀects analysis. 
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dose-response relaonship could be found. However, it cannot be excluded that a lower car-
bohydrate intake, rather than a higher protein intake reduces blood pressure. The queson 
whether dietary protein per se inﬂuences blood pressure is diﬃcult to answer on basis of 
observaonal studies. Trials with mulple control treatments like OmniHeart
19
 may shed 
light on this complex issue. Also unravelling of blood pressure regulang pathways that can 
be linked to dietary protein could help to solve this queson. Furthermore, it is worthwhile 
to invesgate whether replacement of protein by diﬀerent types of carbohydrate, e.g. ‘fast’ 
carbohydrates (e.g. sucrose and maltodextrine), or complex carbohydrates diﬀerenally 
aﬀects blood pressure. 
 
Plant versus animal protein 
Summary of results 
Results of the meta-analysis did not suggest diﬀerent eﬀects of plant protein or animal pro-
tein on blood pressure or risk of hypertension. In cross-seconal studies a small, but non-
signiﬁcant, inverse associaon of -0.52 mmHg systolic per 11 grams (~1 SD) was found for 
plant protein (95%-CI; -1.10 to +0.05, Figure 8.6), whereas animal protein was not associa-
ted with blood pressure (Figure 8.7). The pooled esmates in prospecve studies did not 
show a relaon with incident hypertension for plant protein (HR: 0.96, 95%-CI 0.89 to 1.03; 
Figure 8.8) or animal protein (HR: 0.98, 0.95 to 1.02; Figure 8.9). When analysing trials in 
strata of protein type there was no signiﬁcant diﬀerence between the blood pressure eﬀects 
of plant and animal protein (plant protein: -1.95 mmHg systolic, 95%-CI= -3.21 to -0.69; ani-
mal protein: -2.20 mmHg, 95%-CI= -3.36 to -1.03, Figure 8.10). 
 
Heterogeneity between cross-sec-onal studies on plant and animal protein 
There was substanal heterogeneity in the meta-analysis of cross-seconal studies on plant 
protein (I
2
=75%, p=0.01, Figure 8.6) and animal protein (I
2
=55%, p=0.07, Figure 8.7). This 
was mainly due to the study of Umesawa et al.
20
 in 7,585 Japanese adults that showed an in-
verse associaon with blood pressure for animal protein and a direct associaon for plant 
protein. ANer exclusion of that study heterogeneity was strongly reduced to 17% for plant 
protein (p=0.31) and 0% for animal protein (p=0.61). In addion, pooled esmates changed 
toward a larger and signiﬁcant diﬀerence between protein types, i.e. -0.73 mmHg systolic 
per SD (95%-CI: -1.08 to -0.38) for plant protein and +0.24 mmHg (-0.09 to +0.57) for animal 
protein. The deviant esmates in the study of Umesawa et al.
20
 may be a6ributable to the 
eang habits in Japan, where ~ 24% of animal protein intake comes from ﬁsh
21
, whereas in 
China and in Western countries ~6% of animal protein intake is derived from ﬁsh.
21
 Fish may 
be more beneﬁcial to blood pressure than meat
22
, which may explain the inverse associaon 
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Figure 8.6. Fully adjusted diﬀerence in systolic blood pressure (ΔSBP) with consump-on of 11 
grams (~1 SD) higher plant protein intake in 7 cross-sec-onal studies. 
 For details of the studies see Table 8.2). 
 
1
Weights are from random eﬀects analysis. 
Figure 8.7. Fully adjusted diﬀerence in systolic blood pressure (ΔSBP) with consump-on of 23 
grams (~1 SD) higher animal protein intake in 5 cross-sec-onal studies. 
 For details of the studies see Table 8.2). 
 
1
Weights are from random eﬀects analysis. 
General Discussion 
8 
169 
Figure 8.9. Fully adjusted rela-ve risk of hypertension (RR) with 23 grams (~1 SD) higher ani-
mal protein intake in 4 longitudinal studies. 
 For details of the studies see Table 8.3). 
 
1
Weights are from random eﬀects analysis. 
Figure 8.8. Fully adjusted rela-ve risk of hypertension (RR) with 11 grams (~1 SD) higher 
plant protein intake in 4 longitudinal studies. 
 For details of the studies see Table 8.3). 
 
1
Weights are from random eﬀects analysis. 
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between animal protein and blood pressure in the study of Umesawa et al. A more beneﬁ-
cial inﬂuence of plant protein compared to animal protein on blood pressure may, there-
fore, only be present in countries with a more westernized diet. 
Plant protein: a healthy diet indicator? 
In cross-seconal studies an inverse associaon was found for plant protein, whereas there 
was no associaon for animal protein.
23,24
 A major drawback of a cross-seconal design is 
that dietary intake and blood pressure are measured at the same moment in me. It is pos-
sible that parcipants at increased cardiovascular risk intenonally changed their diets to-
ward a more plant based diet that is known to be healthy. This could have biased the asso-
ciaons for plant protein toward no associaon. However, individuals on anhypertensive 
Figure 8.10. Net change in systolic blood pressure (ΔSBP change) with consump-on of pro-
tein compared to carbohydrates in 14 randomized controlled trials, stra-ﬁed by 
protein type. 
 For details of the studies see Table 8.4). 
 
1
Weights are from random eﬀects analysis. 
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treatment were excluded from the analysis and elevated blood pressure is oNen asympto-
mac, which makes intenonal dietary changes unlikely. Therefore, we think that the ob-
served diﬀerences between plant and animal protein in cross-seconal studies cannot be ex-
plained on basis of reverse causaon. 
Another methodological aspect of observaonal studies is residual confounding from factors 
that are strongly correlated to intake of protein types. Individuals in Western countries who 
consume a diet rich in plant protein probably have a healthier lifestyle than those who con-
sume much animal protein. In most observaonal studies, including the ones described in 
this thesis, adjustments were made for nutrients that are indicators of a healthy lifestyle, 
such as dietary ﬁbre and potassium. However, incomplete adjustment for lifestyle factors or 
dietary factors, such as polyphenols that are abundant in plant food, may have resulted in 
residual confounding. This could have inﬂuenced the ﬁndings for plant protein toward a 
more beneﬁcial associaon with blood pressure. 
 
Does plant protein decrease the risk of hypertension? 
Two prospecve studies on protein types and hypertension incidence from the literature 
showed inverse associaons for plant protein intake, whereas for animal protein no such as-
sociaon was observed. In 810 untreated pre- or mild hypertensives of the PREMIER study a 
~28% reducon in hypertension risk aNer 18 months of follow-up was observed per 11 
grams of plant protein intake (~1 SD, p=0.08, Figure 8.8) aNer adjustment for major con-
founders like sodium and potassium.
24
 In 5,880 university graduates of the SUN cohort 2-
year risk of hypertension was 16% lower per 11 grams of plant protein intake (p=0.06).
25
 The 
prospecve studies presented in this thesis that involved over 3,500 general Dutch adults 
and over 2,000 older adults (Chapter 4 and 5 respecvely), however, did not show diﬀe-
rences between plant and animal protein. When pooling all data, the relave risk for hyper-
tension per SD was 0.96 (95%-CI: 0.89 to 1.03) for plant protein and 0.98 (0.95 to 1.02) for 
animal protein. There are several possible explanaons why our ﬁndings diﬀer from other 
prospecve studies. The lower risk with higher plant protein intake in the study of Wang et 
al.
24
 may be related to the fact that only individuals with elevated blood pressure were in-
cluded who could be more sensive to blood pressure lowering eﬀects of plant protein. In 
the study by Alonso et al.
25
 among Spanish university graduates, the type of plant protein 
sources may play a role. In Spain, on average, more legumes are consumed
26
, and residual 
confounding from correlated healthy nutrients cannot be excluded. Whether high intake of 
plant protein indeed reduces the risk of hypertension thus sll needs to be established. 
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Randomized controlled trials of plant versus animal protein 
In a well-designed randomized trial the inﬂuence of residual confounding is minimized. Four 
trials have been published in which the blood pressure eﬀects of protein from plant and ani-
mal sources were directly compared.
27-30
 Three trials included only a small number of parci-
pants (n≤25), which may explain why no signiﬁcant eﬀect on blood pressure was found in 
those trials.
27-29
 In a large cross-over trial among 352 adults with elevated blood pressure 
(~127/82 mmHg), 40 grams of soy protein per day for 8 weeks did not change blood pres-
sure compared to 40 grams of milk protein (+0.4, 95%-CI: -1.0 to +1.7) However, in a Wes-
tern diet soy protein makes only a small contribuon to total intake of plant protein (~2.5% 
in the MORGEN cohort, unpublished data), and it is therefore not jusﬁed to draw the con-
clusion that plant and animal protein have similar blood pressure eﬀects. It has been es-
mated that grain protein contributes ~53% to plant protein intake in the Netherlands 
(Chapter 3), with other important sources being potatoes (10%), vegetables (8%), and fruits 
(10%). Up to date no trial has been conducted that examined the blood pressure eﬀect of 
dietary plant protein originang from these sources compared with a balanced mix of ani-
mal protein. 
To gain more insight in the eﬀect of plant and animal protein we conducted a meta-analysis 
of trials with a carbohydrate control, straﬁed by type of protein in the intervenon diet 
(Figure 8.10). We did not ﬁnd a signiﬁcant diﬀerent eﬀect between trials with protein inter-
venons from plant or animal sources. However, the protein source in all plant protein trials 
was again soy, and results cannot be generalised to total plant protein. 
 
Plant versus animal protein; conclusions and sugges-ons for further research 
In the past, several observaonal studies that invesgated dietary protein types in relaon 
to blood pressure levels or incidence of hypertension have found an inverse associaon for 
plant protein, but not for animal protein.
9,23-25
 On the other hand, results from the meta-
analyses did not provide evidence for a diﬀerenal eﬀect. Deﬁnive conclusions cannot be 
drawn because of methodological issues that have been described above, and because trials 
invesgang plant protein used soy as the sole source, whereas soy intake is low in the 
Netherlands and in many other Western countries. Future trials should therefore include a 
mix of plant and animal protein sources that be6er reﬂect habitual intakes in Western popu-
laons. 
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Protein from speciﬁc sources 
Summary of results 
The number of available blood pressure studies on protein from speciﬁc food sources was 
insuﬃcient to conduct a meta-analysis. A parallel trial involving 64 hospital staﬀ members
31
 
and a cross-over trial in 35 men
32
 have been published on meat protein compared to other 
protein sources, showing no signiﬁcant results (Chapter 2). This is in line with the lack of as-
sociaon for meat protein in our own observaonal studies (Chapter 3-5, and Table 8.1). Al-
so for dairy protein we did not ﬁnd an associaon with blood pressure or incident hyperten-
sion (Chapter 3-5, Table 8.1). One cross-over trial was published on dairy protein that 
showed a blood pressure lowering eﬀect of -2.30 (95% CI: -3.36 to -1.03) aNer 33 gram milk 
protein supplementaon compared to a carbohydrate supplement in 352 US adults.
30
 For 
grain protein we found a small inverse associaon with diastolic (but not systolic) blood 
pressure levels in over 20,000 Dutch adults (Chapter 3). In addion, in our prospecve ana-
lysis in 3,588 Dutch adults 8 grams higher energy adjusted grain protein intake was associa-
ted with 15% lower hypertension risk (95%-CI: 0.73 to 1.00, Chapter 4). However, we could 
not conﬁrm this associaon in a prospecve analysis among 2,241 Dutch older adults 
(Chapter 5). In summary, we were the ﬁrst to study protein from several speciﬁc sources in 
relaon to blood pressure showing a possible beneﬁcial associaon with grain protein but 
not with protein from other major sources (Table 8.1). 
 
Exposure assessment and biomarkers for protein from speciﬁc sources 
The FFQs that were used in the studies described in this thesis were not designed to es-
mate intake of protein from speciﬁc sources. Moreover, the intake of plant foods, and con-
sequently plant protein, may have been over-reported because of social desirability. Such 
errors could partly explain a6enuated associaons and inconclusive ﬁndings in our epide-
miological studies. Objecve biomarkers of intake could provide a be6er esmaon of die-
tary protein from speciﬁc sources. However, such biomarkers are currently not available. 
This thesis includes a fully controlled dietary intervenon study (Chapter 7) in which we 
aimed to idenfy new biomarkers for meat protein, dairy protein and grain protein. This re-
sulted in a combinaon of 3 urinary amino acids as a potenal biomarker for meat protein 
intake and a combinaon of 7 plasma amino acids as a potenal biomarker for grain protein 
intake. We could not idenfy a reliable biomarker for dairy protein intake. These biomarkers 
need to be conﬁrmed in a trial in which diﬀerent levels of these protein types are given un-
der strictly controlled condions. ANer such a validaon study these biomarkers may be 
used to calibrate or validate FFQs in future epidemiological studies, to assess intake of these 
protein types more accurately. 
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Protein from speciﬁc sources; conclusions and sugges-ons for further research 
The studies described in Chapters 3 to 5 of this thesis were the ﬁrst that examined protein 
from several speciﬁc sources (meat, dairy, grain) in relaon to blood pressure levels or inci-
dence of hypertension. The results for these protein types were inconclusive, which may be 
due to errors in exposure assessment because FFQs were not designed to esmate intakes 
for these speciﬁc protein types. We conducted a study in which we idenﬁed combinaons 
of urinary or plasma amino acids as potenal biomarkers for meat and grain protein intake. 
If these biomarkers prove to be valid within normal ranges of dietary intake, they may be 
used to calibrate or validate FFQs in future epidemiological studies to assess intake of these 
protein types more accurately. 
 
Amino acids 
Summary of results 
The number of available observaonal blood pressure studies on speciﬁc amino acids was 
insuﬃcient to conduct a meta-analysis. One observaonal study has been published sho-
wing an inverse associaon with blood pressure for glutamic acid
33
, whereas in other studies 
no associaon was observed for arginine (two studies)
34,35
 and methionine (one study)
36
. Al-
so trials on the blood pressure eﬀect of speciﬁc amino acids in humans are scarce, except for 
trials on arginine which is a precursor for the vasodilator nitric oxide. In a recently published 
meta-analysis of 11 arginine supplementaon trials, a pooled blood pressure eﬀect 
of -5.4/-2.7 mmHg was found.
37
 Furthermore, in a trial involving 13 untreated hypertensives 
two weeks with 7.5 g/d tyrosine supplementaon did not aﬀect blood pressure.
38
 In Chapter 
6 of this thesis we examined whether dietary intakes of the individual amino acids glutamic 
acid, arginine, lysine, cysteine, and tyrosine were associated with blood pressure and inci-
dence of hypertension in a populaon of ~3,000 older Dutch adults of the Ro6erdam Study. 
We found no associaon of the habitual intake of glutamic acid, arginine, lysine, cysteine, 
and essenal amino acids (expressed as protein%) with blood pressure level (Table 8.1). For 
tyrosine intake we observed a borderline signiﬁcant inverse associaon with systolic blood 
pressure, but not with diastolic blood pressure. None of the examined amino acids was re-
lated to 6-year risk of hypertension (Table 8.1). 
 
Intake of amino acids rela-ve to total dietary protein 
All amino acids are available from almost all types of food that contain protein, although in 
diﬀerent proporons. Absolute amino acid intakes (i.e. expressed in g/d) are, therefore, 
strongly correlated to total protein intake and consequently to each other. Because of mul-
collinearity it is not possible to esmate the associaon with blood pressure for absolute in-
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takes of single amino acids in an observaonal study. We therefore expressed amino acid in-
take as a percentage of total protein intake and assessed the relaon between relave ami-
no acid intake and blood pressure. However, for those amino acids that are precursors for 
blood pressure regulang compounds (e.g. arginine which is a precursor for nitric oxide) ab-
solute intakes may be more important than relave intakes for blood pressure. If this is the 
case, parcipants in our study have not been correctly classiﬁed for absolute amino acid in-
take, which could explain the null ﬁndings. 
The relaon between absolute amino acid intake and blood pressure can be invesgated in 
randomized controlled trials in which individual amino acids are supplemented. Unl now, 
trials have mainly focussed on arginine. However, in the meta-analysis on these trials there 
was substanal heterogeneity (I
2
=73%, p<0.001) due to two studies with large systolic blood 
pressure reducons of -18 mmHg aNer 9 g/d arginine supplementaon and -23 mmHg aNer 
6 g/d arginine supplementaon, respecvely.
39,40
 In a sensivity analysis excluding these two 
studies, the beneﬁcial blood pressure eﬀect was sll signiﬁcant (pooled blood pressure 
eﬀect of −3.3 mmHg; 95% CI −4.9 to −1.9).
37
 It should be noted, however, that arginine do-
ses in these studies ranged between 4 and 24 g/d, which exceeds contrasts that can be 
reached by diet (e.g. 1 SD in the Ro6erdam Study was 1 g/d). Whether arginine from the 
usual diet inﬂuences blood pressure levels is not yet clear. In another trial, tyrosine supple-
mentaon was invesgated in relaon to blood pressure. ANer 2 weeks of 7.5 g/d supple-
mentaon in 13 mildly hypertensive adults, no signiﬁcant eﬀect on blood pressure was 
found compared to placebo (lactose).
38
 However, the lack of a signiﬁcant eﬀect (-3 mmHg as 
esmated from graph) may be due to the small sample size of this study.  
 
Amino acids; conclusions and sugges-ons for further research 
In an observaonal analysis in a populaon-based cohort of ~3,000 Dutch older adults, we 
did not observe signiﬁcant associaons for glutamic acid, arginine, lysine, tyrosine, cysteine, 
or essenal amino acids with blood pressure. Because of mulcollinearity we expressed in-
take of these amino acids as a percentage of total protein intake, which may explain the null 
ﬁndings if absolute intakes (i.e. expressed in g/d) are more important for blood pressure. Ar-
ginine supplementaon was signiﬁcantly related to blood pressure in a recently published 
meta-analysis of randomized controlled trials.
37
 However, in these trials high doses of argi-
nine were given. Blood pressure trials with dietary doses of arginine are needed to judge the 
relevance of this amino acid for populaon blood pressure. The same holds for other amino 
acids, for which li6le is known in relaon to blood pressure. 
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Subject characteris(cs that modify the blood pressure response to dietary protein 
We conducted a metaregression analysis of protein trials with a carbohydrate control to 
idenfy subject characteriscs that may modify the blood pressure response to dietary pro-
tein. However, mean age, gender (% males), BMI, and inial blood pressure were not signiﬁ-
cantly related to treatment eﬀect. For age, gender, and BMI this is in agreement with our 
ﬁndings in this thesis. However with regard to inial blood pressure there is a contrast with 
the cross-seconal analysis in the MORGEN cohort in which the inverse associaons of plant 
protein with blood pressure were more pronounced in hypertensives than in normotensives. 
Similarly, in the OmniHeart trial the blood pressure eﬀect of a high protein diet (about half 
from plant sources) compared to a high carbohydrate diet was stronger in hypertensives 
than in prehypertensives. The fact that our metaregression analysis was based on aggregate 
trial data with possibly large blood pressure ranges within individual studies may have 
blurred the associaons of baseline blood pressure with treatment eﬀect. Presenng results 
of observaonal studies and trials in strata of baseline blood pressure is warranted to ﬁnd 
out whether those with higher blood pressure show a stronger response to increased pro-
tein intake. 
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The prevalence of hypertension is high and increasing. In 2008, the World Health Organisa-
on esmated that ~33% of Dutch adult men and 23% of women had a high blood pressure 
(≥140/90).
41
 In 2002 approximately 7.1 million deaths, about 13% of the total, were esma-
Figure 8.11. Risk for stroke in the Nurses’ Health Study (Iso, 200180) and the Health Profes-
sionals Follow-up Study (Preis, 2010
42
) in quin-les of total, plant, and animal 
protein intake. 
For each quin-le the median protein intake is given. 
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ted to be a6ributable to high blood pressure.
2
 Hypertension is usually without symptoms 
and remains oNen undetected, whereas cardiovascular risk already increases from a systolic 
blood pressure of 115 mmHg.
1
 Populaon-wide lifestyle and dietary changes that eﬀecvely 
prevent a rise in blood pressure, starng already in youth, will have a substanal public 
health impact. In the present thesis we invesgated the inﬂuence of dietary protein on 
blood pressure. In this paragraph we discuss our ﬁndings in the context of recommended 
protein intake, taking into account types of dietary protein. 
Figure 8.12. Hazard ra-o for Coronary heart disease in the Nurses’ Health Study (Hu, 1999
45
) 
and the Health Professionals Follow-up Study (Preis, 2010
43
) in quin-les of total, 
plant, and animal protein intake. 
 For each quin-le the median protein intake is given. 
Figure 8.13. Hazard ra-o for total mortality from coronary heart disease in the Iowa Wom-
en’s Health Study (Kelemen, 2005)
46
 in quin-les of total, plant, and animal pro-
tein intake. 
 For each quin-le the median protein intake is given. 
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Should we increase total protein intake? 
Results from this thesis suggests a small beneﬁcial eﬀect of protein on blood pressure if it is 
consumed instead of carbohydrates, and this beneﬁcial eﬀect may be most pronounced in 
hypertensives. Whether total dietary protein also inﬂuences cardiovascular disease risk has 
been examined by several large observaonal studies, but no consistent associaons were 
found.
42-46
 In the Health Professionals Follow-Up study among 43,960 US men no associaon 
was observed between total protein intake and risk of stroke (Figure 8.11).
42
 For coronary 
heart disease, a total protein intake of 24 en% compared to an intake of 15 en% resulted in a 
hazard rao of 0.74 (95%-CI: 0.59 to 0.95) in the Nurses’ Health Study among 85,764 US 
women (Figure 8.12).
45
 However, in the Health Professionals Follow-Up study and in the 
Iowa Women’s Health study in 29,017 postmenopausal women there was no associaon be-
tween total protein intake and coronary heart disease (Figures 8.12 and 8.13).
43,46
 It may be 
concluded, therefore, that a high intake of protein does not increase the risk of cardiovascu-
lar diseases. Protein intake, especially intake from animal sources, was relavely high in the 
US studies, i.e. ~19 en% (~13 en% from animal sources) in the Health Professionals Follow-
Up study
42,43
, and ~18 en% (~13 en% from animal sources) in the Iowa Women’s Health 
Study
46
. For the Nurses’ Health Study total protein intake was not reported, but animal pro-
tein intake was ~61 g/d (intake in en% not reported).
44,45
 Protein intake in the Netherlands is 
considerably lower, being ~15 en% (~73 g/d for women and ~96 g/d for men), with ~10 en% 
(~46 g/d for women and ~60 g/d for men) originang from animal sources.
47
 Possibly, the 
high intake of protein from animal sources, and concomitant intake of saturated fat, could 
explain why no associaon with coronary heart disease was found in several large US stu-
dies. 
Although protein may be beneﬁcial for blood pressure, there is also concern that high pro-
tein intake may promote renal damage by chronically increased glomerular pressure and hy-
perﬁltraon.
48
 In the Nurses’ Health Study, total protein intake was associated with accele-
rated renal funcon decline during 11 years of follow-up in 489 women with mild renal in-
suﬃciency (deﬁned as glomerular ﬁltraon rate (GFR) between 55 and 80 mL/ min per 1.73 
m
2
) with a change in esmated GFR of -1.69 mL/min with 10 g/d higher protein intake.
49
 
Trials with high protein diets in paents with mild kidney impairment are lacking, possibly 
because this type of intervenon is considered unethical. In those with healthy kidneys, on 
the other hand, protein intake is unlikely to be harmful. This was conﬁrmed in 1,135 women 
from the Nurses’ Health Study with normal renal funcon in whom protein intake was not 
related to renal funcon decline.
49
 It is possible that protein-induced changes in renal ﬁltra-
on are a normal adapve mechanism within the funcon limits of a healthy kidney.
50
 
In 2006 the Health Council of the Netherlands recommended a dietary protein intake be-
tween 8 and 11 en% (~0.8 g/kg body weight) dependent on age and gender, with an upper 
level of 25 en%.
51,52
 These recommendaons are primarily intended to guarantee an ade-
quate intake of essenal amino acids and nitrogen to build up necessary proteins in the 
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body.
51,52
 In Europe total protein intake is ample suﬃcient, ranging between 12 and 23 en% 
with intake in the Netherlands being ~15 en%.
26,47
 Whether an increased protein intake at 
the expense of carbohydrates should be considered for the purpose of hypertension preven-
on is unclear and premature because there are no data available on the opmal protein 
dose. Trials in which several doses of protein are consumed instead of carbohydrates are 
warranted. In addion, in these trials a6enon should be paid to what is the best type of 
carbohydrate to be replaced. 
 
Should protein mainly be derived from plant sources? 
This thesis provides evidence for a more beneﬁcial eﬀect of plant protein (e.g. from grain) 
on blood pressure compared to animal protein, although data were not conclusive. In the 
Iowa Women’s Health study an inverse associaon with fatal coronary heart disease was 
found for plant protein with a 30% lower risk in the highest quinle (6.1 en% of intake) com-
pared to the lowest quinle (3.7 en% of intake, ptrend=0.02, Figure 8.13).
46
 On the other 
hand, in the Nurses’ Health study and the Health Professional Follow-up Study no signiﬁcant 
associaons were found between plant protein and stroke or total coronary heart disease 
(Figure 8.11 and 8.12).
42, 43, 45, 80
 However, as discussed previously, plant protein intake in the 
US cohorts was low compared to animal protein, which may have inﬂuenced the associa-
ons. Prospecve data on plant protein intake and risk of cardiovascular diseases in the 
Netherlands are lacking. 
Randomized controlled trials are warranted that directly compare plant protein with animal 
protein in relaon to blood pressure, using protein sources that reﬂect habitual intakes in 
Western populaons. Furthermore, the use of biomarkers in future observaonal studies 
may result in more robust esmates for protein intake from speciﬁc sources. Finally, whe-
ther a diﬀerenal eﬀect of plant protein and animal protein is due to speciﬁc amino acids re-
mains to be established in trials. 
The Dutch dietary guidelines do not include recommendaons for the intake of speciﬁc 
types of protein. For the purpose of hypertension prevenon, recommendaons to increase 
plant protein intake would be premature based on data presented in this thesis. Neverthe-
less, increased intake of plant foods is desirable because it is a major source of vitamins, 
polyphenols, ﬁber, potassium and magnesium, all being nutrients that have been associated 
with lower blood pressure and a be6er cardiovascular health proﬁle.
53,54
 Also from an eco-
logical perspecve a more plant based diet is preferable. The ecologic load of animal pro-
tein, especially from meat, is large compared to that of plant protein with a need of 6 kg 
plant protein for the producon of 1 kg meat protein.
55,56
 Therefore, the Health Council of 
the Netherlands recommended in 2011 a diet in which plant foods are emphasized, al-
though they considered it not necessary to remove dairy and meat completely from the 
Chapter 8 
180 
diet.
55
 A point of concern with regard to a more plant based diet, however, might be the low 
amount of lysine, an essenal amino acid. Where recommendaons for protein intake in 
omnivores are between 8 and 11 en%, lacto-ovo vegetarians may have a 1.2 mes higher 
need of dietary proteins. Nevertheless, it has been esmated that vegetarians in the US and 
the UK have an average protein intake of ~13 en%, which is suﬃcient according to the guide-
lines.
57,58
 Therefore, lysine deﬁciency may not be a point of concern in a diet that is rich in 
plant foods. On the other hand, most plant foods are not only low in lysine, but also in other 
nutrients like iron, calcium, vitamin B12 and riboﬂavin. Legumes, that are relavely high in 
lysine, and meat replacers that are usually enriched with these micronutrients may be used 
to ensure suﬃcient intakes.
55 
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Results from this thesis suggest a small beneﬁcial eﬀect of protein on blood pressure if con-
sumed instead of carbohydrates. Plant protein, e.g. from grain, may be more beneﬁcial to 
blood pressure than animal protein but data are too limited to draw ﬁrm conclusions. ANer 
validaon, future epidemiological studies could make use of biomarkers as more robust es-
mates for protein from speciﬁc sources and amino acid intakes. Furthermore, randomized 
controlled trials are warranted to examine the blood pressure eﬀect of speciﬁc types of pro-
tein, reﬂecng habitual intakes in western sociees. Furthermore, trials should include 
diﬀerent types of carbohydrate as control. At present, a prudent diet for the prevenon of 
hypertension with adequate amounts of dietary protein, preferable from plant sources, is 
recommended. 
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• A healthy diet can substanally lower blood pressure. 
• Findings on dietary protein and blood pressure are inconsistent, although data 
from studies using biomarkers for intake and trials suggest a small inverse 
associaon. 
• In the large OmniHeart trial blood pressure decreased more aNer a high 
protein diet than aNer a high carbohydrate diet, but no diﬀerence in blood 
pressure eﬀect was found compared to a diet high in mono-unsaturated fa6y 
acids. (Appel et al, N Engl J Med 1997) 
• Observaonal data suggest that plant protein may be beneﬁcial to blood 
pressure. 
• The eﬀect of protein intake from speciﬁc sources like dairy, meat or grains on 
blood pressure is largely unknown. 
• The blood pressure eﬀect of amino acids, within the normal range of dietary 
intake, is unknown. 
• Data on subject characteriscs that may modulate the blood pressure eﬀect of 
dietary protein are scarce. 
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• Data from a comprehensive meta-analysis show a beneﬁcial blood pressure 
eﬀect of protein compared to carbohydrates, but not compared to (mono-
unsaturated) fat. 
• Plant protein, e.g. from grain, may beneﬁcially inﬂuence blood pressure. 
• Speciﬁc combinaons of urinary and plasma amino acids may be potenally 
useful biomarkers for meat and grain protein intake. 
• Individuals who already have an elevated blood pressure are likely to beneﬁt 
more from a beneﬁcial eﬀect of (plant) protein on blood pressure. 
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• More data are needed to conclude whether protein from diﬀerent sources are 
important for populaon blood pressure. 
• Trials are warranted that compare plant and animal protein from a mix of 
protein sources that reﬂect habitual intakes in Western populaons. 
• Trials are warranted in which the eﬀect of protein is compared to diﬀerent 
types of carbohydrates. 
• Urinary and plasma biomarkers of speciﬁc types of protein need to be 
validated in in a trial in which diﬀerent levels of meat and grain protein are 
given under strictly controlled condions. 
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Een verhoogde bloeddruk is een belangrijke risicofactor voor het krijgen van hart- en vaat-
ziekten en nierschade. Een bloeddruk lager dan 120 mmHg systolisch en 80 mmHg diasto-
lisch wordt gezien als opmaal. Er is sprake van hypertensie bij bloeddrukwaarden van 
140/90 mmHg of hoger, of wanneer anhypertensieve medicae gebruikt wordt. Naar 
schaPng is 33% van de mannen en 23% van de vrouwen in Nederland hypertensief. De toe-
name in cardiovasculair risico beperkt zich echter niet tot deze groep, maar is al meetbaar 
vanaf ‘normale’ systolische bloeddrukwaarden van 115 mmHg. Een geringe daling van 2 
mmHg in de gemiddelde systolische bloeddruk in de algehele bevolking kan het aantal fatale 
hersenbloedingen met 6% verlagen en het aantal fatale coronaire hartziekten met 4%. 
Voeding en leefsjl zijn van groot belang voor een gezonde bloeddruk. Bekende maatrege-
len zijn voldoende beweging, een gezond gewicht, het eten van voldoende groente en fruit, 
en mag zout– en alcoholgebruik. Ook zijn er aanwijzingen dat voedingseiwit een rol speelt 
bij het handhaven van een gezonde bloeddruk. In Nederland wordt ongeveer 85 gram per 
dag aan eiwit gegeten, hetgeen overeenkomt met 15% van de totale dagelijkse energie-
inname. Twee derde van dit eiwit is van dierlijke oorsprong en een derde is van plantaardige 
oorsprong. De belangrijkste bronnen van dierlijk eiwit zijn zuivel (42%, ~24 gram/dag) en 
vlees (40%, ~22 gram/dag) terwijl het plantaardige eiwit vooral uit granen komt (48%, ~13 
gram/dag).  
Dit proefschriN richt zich op de mogelijke rol van voedingseiwit in relae tot de bloeddruk in 
de Nederlandse bevolking. Deze relae is onderzocht voor de totale eiwinname, als ook 
voor de inname van plantaardig en dierlijk eiwit, eiwit uit speciﬁeke bronnen (in het bijzon-
der zuivel, vlees en granen) en speciﬁeke aminozuren. Daarnaast is onderzocht of leeNijd, 
geslacht,  overgewicht en de hoogte van de bloeddruk deze verbanden kunnen beïnvloeden. 
 
Hoofdstuk 2 van dit proefschriN bestaat uit een systemasch literatuuroverzicht over de 
mogelijke invloed van voedingseiwit op de bloeddruk. Uit intervenestudies bleek dat extra 
eiwit de bloeddruk kan verlagen. Ook waren er aanwijzingen dat plantaardig eiwit gunsger 
is voor de bloeddruk dan dierlijk eiwit. Er was weinig bekend over de bloeddrukeﬀecten van 
eiwit uit speciﬁeke bronnen zoals zuivel, vlees en granen.  
In de hoofdstukken 3, 4 en 5 van dit proefschriN worden drie epidemiologische studies be-
schreven waarin de inname van totaal en typen eiwit in relae tot de bloeddruk en/of het ri-
sico op hypertensie is onderzocht. In hoofdstuk 3 zijn dwarsdoorsnede-gegevens gebruikt 
van 20.820 Nederlandse volwassenen in de leeNijd van 25 tot en met 65 jaar uit het MOR-
GEN onderzoek (Monitoring van Risicofactoren en Gezondheid in Nederland) van het RIVM. 
Vervolgens is in hoofdstuk 4 het verband tussen totaal eiwit en typen eiwit en het risico op 
hypertensie onderzocht in 3.588 van deze deelnemers die 15 jaar waren gevolgd 
(Doenchem Cohort Studie). Hetzelfde verband is bestudeerd bij 2.241 deelnemers van 55 
jaar en ouder van de Ro6erdam Study die 6 jaar waren gevolgd (hoofdstuk 5). Voor totaal of 
dierlijk eiwit vonden we in geen van deze studies een verband met de bloeddruk of het risico 
op hypertensie. In personen met een relaef hoge inname van plantaardig eiwit (>36 gram /
dag) was de bloeddruk circa 2 mmHg lager dan in personen met een relaef lage inname 
(<27 gram/dag). Plantaardig eiwit was echter niet gerelateerd aan het risico op hypertensie 
(hoofdstuk 4 en 5). Er was geen duidelijk verband van zuiveleiwit of vleeseiwit met de 
bloeddruk of het risico op hypertensie (hoofdstuk 3, 4, 5). Wel was voor graaneiwit het risi-
co op hypertensie ongeveer 15% lager bij  een relaef hoge inname (>18 gram/dag) vergele-
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ken met een lage inname (<14 gram/dag) 
In hoofdstuk 6 onderzochten we bij 3.086 deelnemers van 55 jaar en ouder van de Ro6er-
dam Study of speciﬁeke aminozuren uit de voeding samenhingen met het risico op hyper-
tensie, waarbij de aminozuurinname werd uitgedrukt als percentage van de totale eiwinna-
me. Van de bestudeerde aminozuren droeg glutaminezuur het meest bij aan de totale eiwit-
inname (21%), gevolgd door lysine (7%), arginine (5%), tyrosine (4%) en cysteine (1,5%). 
Geen van deze aminozuren liet een signiﬁcant verband zien met hypertensie (relaeve risi-
co’s variërend tussen 0,81 – 1,18 voor het hoogste versus het laagste kwarel van inname). 
Door middel van biomerkers in lichaamsweefsels kan de inname van voedingsstoﬀen op een 
objeceve manier worden geschat, wat de validiteit van epidemiologisch onderzoek kan ver-
groten. Voor de inname van typen eiwit waren geen gevalideerde biomerkers bekend. In 
een gecontroleerde voedingsintervene (hoofdstuk 7) is bij 30 personen in de leeNijd van 
18 tot en met 40 jaar gedurende 4 weken de inname van verschillende typen voedingseiwit 
sterk verhoogd met als doel het vaststellen van biomerkers voor eiwit uit zuivel, vlees en 
granen. Hieruit bleek dat een combinae van aminozuren in 24-uursurine (carnosine, 1-
methylhisdine en 3-methylhisdine) een betrouwbare schaPng levert van de inname van 
vleeseiwit. Een combinae van 7 aminozuren in het bloedplasma (lysine, valine, threonine, α
-aminoboterzuur, proline, ornithine en arginine) is mogelijk geschikt voor het scha6en van 
de inname van graaneiwit. Voor eiwit uit zuivel konden we geen biomerkers vaststellen. 
 
In hoofdstuk 8 is een kwantaeve samenvaPng gegeven van de stand van zaken rondom 
eiwit en bloeddruk, na toevoeging van de studies uit dit proefschriN. In meta-analyses van 
epidemiologische studies werd geen verband gevonden tussen de totale inname van eiwit 
en de bloeddruk of het risico op hypertensie. In een meta-analyse van 14 gecontroleerde in-
tervenestudies was een verhoogde eiwinname (~41 gram/dag) ten koste van koolhydra-
ten echter gerelateerd aan een gemiddeld 2,1 mmHg (95%-betrouwbaarheidsinterval: -2,9 
tot -1,4 mmHg) lagere systolische bloeddruk. Wat betreN typen eiwit zagen we voor plant-
aardig eiwit in epidemiologische studies een klein gunsg verband met de bloeddruk, maar 
niet voor dierlijk eiwit. Hoewel oudere studies een gunsg verband lieten zien tussen plant-
aardig eiwit en het risico op hypertensie, was die samenhang verdwenen na toevoeging van 
de resultaten uit dit proefschriN. Er waren nog te weinig studies uitgevoerd om een meta-
analyse te kunnen doen voor eiwit uit speciﬁeke bronnen zoals granen, vlees en zuivel. 
 
Samengevat suggereren de diverse onderzoeksresultaten dat eiwit gunsg is voor de bloed-
druk als het wordt geconsumeerd in plaats van koolhydraten. Toekomsg onderzoek moet 
uitwijzen welke typen koolhydraten het beste vervangen kunnen worden. Het vervangen 
van dierlijk door plantaardig eiwit, bijvoorbeeld uit granen, kan mogelijk ook bijdragen aan 
een gezondere bloeddruk, maar op basis van de huidige resultaten is het prematuur om 
plantaardig eiwit aan te bevelen voor de prevene van hypertensie. Wel is bekend dat een 
voedingspatroon met meer plantaardige producten het risico op hypertensie en hart- en 
vaatziekten verlaagt. Het is daarom aan te bevelen om voldoende eiwit uit voornamelijk 
plantaardige bronnen te consumeren. 
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